Week 2 Flashcards

1
Q

Prevalence of bacterial pathogens in causing gastroenteritis

  • *which is the only one that reside in human? Other reside in animals
  • what is most common 5
A
  1. Salmonella
  2. Campylobacter
  3. Shigella *** reside in humans
  4. Cryptosporidium
  5. ST producing E. Coli
  6. Vibrio
  7. YERSINIAE
  8. Listeria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the 3 mechanisms for gastroenteritis

A
  1. Interference with the secretory and absoptive properties of intestine by adherence and/or enterotoxin, usually associated with effacement.
  2. Invasion of the mucosal enterocytes
  3. Penetration of organisms through the mucosa, where they multiply in cells of the mucosa- associated lymphoid tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the link between CFTR and cholera toxin in causing the GI infections

Fluid secretion in GI tract (how?) 
How many CFTR mutations? (Differentiate class II vs class VI) ? What is the similarity of mutation in class II and VI
A
Fluid secretion in GI tract 
A. cAMP controls activity of CFTR 
– Na reabsorption. 
– the secretion of chloride and CFTR bicarbonate into the gut.
B. Key points 
- Amount of Cl secreted = amount of water in GI 
- Gs or AC to increase Cl secretion 
- CFTR
  • There are about 2000 types of CFTR mutations.
  • They can be classified into six groups.
  • 70% DF508
  • Class II: Abnormal protein folding, processing, and trafficking.
  • Class VI: Altered function in regulation of ion channels.
  • The ΔF508 mutation is both a class II and class VI mutation (serve as ion channel regulator esp sodium channel)

**The functions of CFTR are tissue-specific
- Activity of epithelial SODIUM CHANNEL ENaC is linked with CFTR
In cystic fibrosis;
I) Lumen of sweat duct - increased Na+ and Cl-
II) Airway - dehydrated mucus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Identify toxin

  • Impairs the normal absorption activity of the intestine.
  • Activates adenylate cyclase which converts ATP to cAMP.
  • CTX and other virulence genes are carried on a single stranded DNA phage.

**DESCRIBE TOXIN TRANSPORT and signalling

A

CHOLERA ENTEROTOXIN

Cholera RETROGRADE toxin transport and signaling

  • B subunits binds to a ganglioside on cell surface.
  • A subunit enters via endocytosis.
  • In ER, A is reduced by protein disulfide isomerase (PDI).
  • A is refolded in cytosol, and interacts with ADP ribosylation factor (ARF) to ribosylate and activate the stimulatory GSa protein
  • Adenylate cyclase becomes locked in active state resulting in uncontrolled production of cAMP, causing massive flux of Cl, bicarbonate, Na
  • *Ultimate result - watery diarrhea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Identify bacteria

  • Gram negative
  • Comma-shaped
  • Facultative anaerobic
  • Fermentative
  • Oxidase positive
  • Motile by a single polar flagellum (H antigen)
  • Salt- or freshwater

**Identify toxins (differentiate the 2 toxins)

A

VIBRIO CHOLERA
• O antigens: 150 O groups.
• V. cholera O1 and O139: CLASSIC CHOLERA
• V. cholera O1 can be further subdivided into two biotypes: el tor and cholerae.
• O1 has three serotypes; (Ogawa, Inaba, and Hikojima).
• Serotype O139 is encapsulated.

O199 vs O1
Blot A; Pulsed-field electrophoresis gel
- O139 banding patterns differed from O1 banding
Blot B; southern blot
- O139 specific probe hybridized at the same position in O139 strains
- O1 strains did not hybridize

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Identify pathogenesis of condition

Clinical manifestation

  • Sudden onset of massive diarrhea.
  • Very significant loss of protein- free fluid (patient can lose 20 liter of water per day).
  • The loss of fluid lead to dehydration, acidosis and shock.
  • The watery diarrhea is speckled with flakes of mucus and epithelial cells (“rice-water” stool) heavily loaded with vibrios.
A

Vibrio cholera

Pathogenesis
• Only 5µg of cholera toxin is needed to cause severe
symptoms.
• V. cholerae targets the intestine because the bacterium
requires low pH environment for proliferation.
• Can survive enzymatic activities of gastric secretions.
• Can survive the peristaltic action of the intestines.

Patho of cholera and ETEC 
• Enterotoxigenic E. coli two toxins differentiated based on heat stability
• Colonization factor (Cfa) 
• Toxin-coregulated pilus (TcpA).
• Cholera toxin (Ctx) 
• Labile toxin (LTA) 
• Adenylate cyclase (AC).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Identify other virulence factors and transmission of condition

Treatment
• Death is often due to severe dehydration and electrolyte imbalance. Treatment consists of prompt, adequate replacement of water and electrolytes, either orally or intravenously.
• It’s a self-limiting disease. As long as you can deal with dehydration. Within one week, it will clear itself.
• Doxycycline or tetracycline-adults.
• Furazolidone-pregnant women.
• Trimethoprim-sulfamethoxazole- children
• Vaccines are not effective (Need IgA - has 4 identical binding site to cross link toxin - specific for mucosal surface)**enterotoxin don’t usually have effective vaccines

A

Vibrio cholera

Other virulence factors
• TCP pili- toxin coregulated pili, occurs in bundles and are localized to one end of bacterial surface.
• Hemagglutinin that can act as an adhesins.
• Accessory colonization factor (chromsomal), membrane proteins (adhesion?)
• Other chromosomal virulence genes (zot and ace).

Transmission
• V. cholerae grow in estuarine and marine environment.
• Asymptomatic carrier.
• For colonization to occur, large numbers of bacilli are needed (one billion!).
• Gastric acidity reduced, infectious inoculum less.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Identify bacterial

**Primary septicemia skin lesions
• Rapidly progressive wound infections after exposure to contaminated seawater
• The wound infections are characterized by initial swelling, erythema, and pain followed by the development of vesicles or bullae and eventual tissue necrosis.
• Mortality: 50%

**common during what condition?
Acquired by eating what?
Result in what conditions?

A

Vibrio vulnificus
• V. vulnificus is most frequently implicated in the
outbreaks from the United States.
• V. vulnificus can be acquired by eating raw or
undercooked shellfish, or directly by contaminating open
wounds while swimming or cleaning shellfish.
• Results in Cellulitis, wound infection, or septicemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Identify condition

  • typically causes gastroenteritis after
    consumption of contaminated raw oysters and clams from
    the northeastern and Pacific northwestern coasts of the
    United States.

Less frequent results?
Pt with liver disease or immunocompromised?

A

Vibrio parahaemolyticus

• Less frequently, V. parahaemolyticus causes wound
infections that are generally less severe than V. vulnificus
wound infections.
• However, in persons with liver disease or
immunocompromising conditions, V. parahaemolyticus
wound infections can lead to death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Identify bacteria

Aerobic 
Motile 
Non-encapsulated 
Spores 
Clinical Diseases:
- Emetic food poisoning    
- Diarrhea food poisoning    
- Eye infections

**identify virulence factors and treatment

A

BACILLUS CEREUS
**re-heating Chinese friedrice

Virulence factors

  • Spore formation:
  • Enzymes:Lecithinase (phospholipase C)
  • Enterotoxins-exotoxin
  • Necrotic toxin:vascular permeability action, heat labile
  • Cereolysin: a hemolysin which disrupts cholesterol of cell membrane

Treatment

  • Fluid and electrolyte replacement if necessary
  • Treatment with vancomycin, ciprofloxin and gentamycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  • Gram-positive, cluster-forming coccus
  • Nonmotile, nonsporeforming facultative anaerobe
  • Ferments glucose to produce mainly lactic acid
  • Ferments mannitol (distinguishes from S. epidermidis)
  • catalase positive; coagulase positive
  • golden yellow colony on agar
  • normal flora of humans found on nasal passages, skin and mucous membranes
  • pathogen of humans, causes a wide range of suppurative infections, as well as food poisoning and toxic shock syndrome
  • *identify enterotoxin (A-E, TST1)
  • *which toxin is not food associated?
A

Staphylococcal Enterotoxins

A - most commonly associated with food poisoning
B - associated with staphylococca Enterocolitis (rare)
C - Rare, associated with contaminated milk products
D - Second most common, alone or in combination with A, associated with contaminated milk products
E - Rare, associated with contaminated milk products
TSST -1 ; toxic shock syndrome toxin, not food associated

  • Typical antigen response< 1% T cells.
  • Superantigens may stimulate up to 20% of T cells, leading to release of cytokines such as TNF, IL-1, IL-2, and IFN-g in such large amounts (cytokine storm).
  • Massive vasodilation and shock.
  • Enterotoxin A-E : acts on brain vomit center, inhibits intestinal water absorption.
  • TSST-1 and GAS pyrogenic exotoxin A or C
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe

  1. Enterotoxins - food positioning
  2. Exotoxins - Genetics
  3. Toxoid vaccines
A
  1. Enterotoxins - food positioning
    - Food will not appear or taste tinten. **MEAN INCUBATION = 4 hrs
    - last for 24 hrs severe vomiting, diarrhea (NON BLOODY)
    - abdominal cramp or nausea NO FEVER
    - only 30-50% of S.aureus strains producing them
2. Exotoxins - Genetics 
• Many exotoxin genes not part of chromosome 
• Plasmid-encoded 
- E.coli heat labile toxin 
• Bacteriophage-encoded 
- corynbacterium diphtheria 
- Strep pyrogens erythromycin 
- E.coli shiva-like toxin 
- botulinum toxin
- cholera toxin 
  1. Toxoid vaccines
    - Toxoid = inactivated bacterial toxins
    - Used for vaccination
    - Used to prevent diphtheria and tetanus
    - Part of DTaP combined immunization;
    D - diphtheria
    T - tetanus
    AP - acellular pertussis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe liver blood flow

Weight
A. Toward liver
B. Within parenchyma
C. Away from liver

A

**Liver weight; 1400 - 1600 grams

Liver’s Blood Flow

  1. Dual blood supply to the liver through porta hepatis (hilum of liver)
    a. Portal vein (60-70%)
    b. Hepatic artery (30-40%)
  2. Within the parenchyma branches travel in parallel through portal tracts vessels and sinusoids
  3. Away from the liver via central vein → hepatic veins → IVC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hepatic architecture

  1. The hexagonal anatomical unit of the liver
    - center vs periphery
  2. The triangular functional unit of the liver
    - center vs periphery
    * *ZONE 1-3 (metabolic zones)
    - which zone is first exposed to toxins
    - which is more involved in bile synthesis
    - which is the least oxygenated zone?
    - which is susceptible to ischemia?
    - closed to artery? Closed to vein?
A
  1. Lobule; HEXAGONAL anatomic unit
    a. The central vein (or terminal hepatic venule) in the center
    b. Portal tracts at the periphery
  2. ACINUS; TRIANGULAR functional unit
    - The portal tract at the center & central vein at the periphery
    - Three metabolic zones in the acinus

(1) ZONE 1
(a) Immediately around the portal tract
(b) First area exposed to and affected by toxins
(c) Hepatocytes most specialized in drug detoxification
(d) MOST oxygenated zone

(2) ZONE 2: intermediate zone

(3) ZONE 3
(a) Immediately around the central vein
(b) Bile synthesized in this zone
(c) Hepatocytes most specialized in bile formation
(d) LEAST oxygenated zone; most susceptible to ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Portal tract (portal triad)

What immediately surround portal tract?

A

a. Bile ducts
b. Hepatic arteriole (small muscular artery)
c. Portal venule (largest structure in the portal tract)

**Limiting Plate: hepatocytes immediately surrounding the PT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Liver parenchyma

Hepatocytes vs sinusoids vs space of disse vs bile canaliculi vs lymphocytes

  • kupffer cells where?
  • hepatic stellate cells where? (Responsible for fibrosis)
  • bile canaliculi begin in what zone? Drain into?
A

LIVER PARENCHYMA

a. Hepatocytes
(1) Arranged in sheets, plates or cords
(2) Cords normally 1 to 2 cells in thickness

b. Sinusoids
(1) Vascular spaces between the hepatocyte cords
(2) Blood travels from the portal tract to the central vein
(3) Lined by a sheet of fenestrated endothelial cells
(4) Antigen presenting KUPFFER CELLS on the luminal aspect of the endothelium

c. Space of Disse
(1) Between the sinusoidal endothelial cells and the hepatocytes (2) Location of fat-containing HEPATIC STELLATE CELLS (Ito cells or perisinusoidal cells)
(a) Major source of collagen
(b) Activation into fibrogenic cells during hepatic fibrosis

d. Bile canaliculi
(1) Located in the grooves between the hepatocytes
(2) Begin in the centrilobular region (Zone 3)
(3) Separated from vascular space by tight junctions
(4) Drain into the ductular structures (canals of Hering) connecting the canaliculi to the portal terminal bile ducts (Zone 1) to hepatic ducts

e. Lymphocytes (up to 22% of cells other than hepatocytes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe physiology of the liver

A
  1. Involved in glucose homeostasis
  2. Synthesizes most serum proteins
  3. Stores glycogen, triglycerides, iron, copper, lipid-soluble vitamins (A,D,E,K)
  4. Catabolizes hormones and proteins and detoxifies drugs and chemicals
  5. Excretes various products (conjugated bilirubin, bile salts, cholesterol and electrolytes) as bile
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Features of hepatic disease

General
Mechanisms fo hepatic Injury and repair (list 4)

A

General

  • Susceptible to circulatory, metabolic, microbial, neoplastic and toxic processes
  • Usually slow process with signs/symptoms occurring weeks to years after injury

Mechanisms of Hepatic Injury and repair

  1. Hepatocyte necrosis and apoptosis
  2. Inflammation - HEPATITIS - injury to hepatocytes by an influx of acute and/or chronic inflammatory cells
  3. Regeneration
  4. Fibrosis (scar formation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Mechanism of hepatic injury and repair
Types of hepatocyte necrosis and apoptosis (3)

A. Coagulative necrosis, macrophage cluster around
B. Shrunken eosinophilic acidophil bodies (e.g councilman bodies)
C. Cellular debris, macrophages (5)
- which zone around terminal hepatic venule ?
- piecemeal necrosis?
- from serious injury and may herald onset of cirrhosis (portal-to-portal, portal-to-central and central-to-central)
- involve most of liver?

A

a. Ischemia leads to coagulative necrosis, macrophages cluster around
b. Apoptosis: Shrunken eosinophilic acidophil bodies (e.g.Councilman bodies)

c. Patterns (zones) of necrosis (filled with cellular debris, macrophages)
(1) CENTRILOBULAR (around central vein) necrosis may be due to ischemia or various drugs or toxins
(2) INTERFACE HEPATITIS (PIECEMEAL NECROSIS) - immediately around the portal tract involving the limiting plate
(3) BRIDGING NECROSIS - from serious injury and may herald onset of cirrhosis (portal-to-portal, portal-to-central and central-to-central)
(4) SUBMASSIVE NECROSIS - involves entire lobe
(5) MASSIVE NECROSIS - involves most of the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Mechanism of hepatic injury and repair

  1. Hepatitis
    - viral vs alcoholic?
  2. Can hepatocytes regenerate?
A
  1. Inflammation - HEPATITIS - injury to hepatocytes by an influx of acute and/or chronic inflammatory cells
    - neutrophils; alcoholic hepatitis
    - lymphocytes - viral hepatitis
  2. Regeneration
    a. Via mitotic replication of hepatocytes adjacent to ones that have died
    b. Hepatocytes are stem cell-like in their ability to regenerate
    c. Hepatocytes may reach replicative senescence in long-standing chronic disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Mechanism of hepatic injury

  • what cells responsible for fibrosis
A

Fibrosis (Scar formation)

a. A response of hepatic stellate cells (Ito cells) to inflammation or toxins
b. The activated hepatic stellate cell becomes a myofibroblast
c. Scar deposition begins in and around portal tracts and central veins and extends into the sinusoids
d. Generally irreversible
e. Eventually fibrosis surrounds regenerating hepatocytes forming nodules
f. Regenerating nodules surrounded by dense scar tissue = cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How much functional capacity of liver must be lost before hepatic failure occurs?

**definition and causes (3) of the following

Morphology

  1. Gross - small, shrunken liver (700g)
  2. Microscopic
    - massive hepatic necrosis
    - may or may not be scar formation and regeneration depending on length of time of development
A

Acute Liver failure; Approximately 80-90% of functional capacity must be lost before hepatic failure occurs

Definition; acute liver illness + encephalopathy + coagulopathy within 6 months of liver injury

Causes

  1. Drugs/toxins (acetaminophen [50% of cases of alf in US], halothane, rifampin, isoniazid, monamine oxidase, industrials, Amanita)
  2. Hepatitis A and B
  3. Autoimmune hepatitis
  4. Unknown etiology; lead to cryptogenic cirrhosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Identify LIFE THREATENING CONSEQUENCES of the following (4)

Clinical

a. Jaundice and scleral icterus
b. Hypoalbuminemia
c. Hyperammonemia
d. Fetor hepaticus (odor of thiols on breath from portosystemic shunting of thiols into lungs in portal htn)
e. Impaired estrogen metabolism causing:
(1) Palmar erythema (local vasodilatation)
(2) Spider angiomas (central pulsating dilated arteriole with radiating smaller vessels)
(3) Hypogonadism and gynecomastia in males

A

ACUTE LIVER FAILURE

Life threatening consequences
1. Multisystem organ failure

  1. Coagulopathy with bleeding due to:
    (a) Decreased synthesis of clotting factors
    (b) DIC (when liver is unable to remove activated coagulation
    factors from circulation)
  2. Hepatic encephalopathy (elevated ammonia levels)
    (a) Subtle behavior abnormalities to coma and death
    (b) Neurological signs include rigidity, hyperreflexia and
    ASTERIXIS (flapping, nonrhythmic tremor of the hand that occurs with dorsiflexion of the wrists)
    (c) Can be reversed if underlying condition corrected
  3. Hepatorenal syndrome
    (a) Acute renal failure in patients with severe liver disease who
    have NO intrinsic renal abnormalities
    (b) Sodium retention, decreased renal perfusion and decreased glomerular filtration rate (GFR)
    (c) Decreased renal perfusion secondary to systemic
    vasodilation, vasoconstriction of the afferent renal arterioles and increased activation of renin-angiotensin axis causing vasoconstriction
    (d) Decreased urine output initially with subsequent increasing blood urea nitrogen (BUN) and creatinine
    (e) Median survival of ~ 2 weeks in the rapid form and ~ 6 months in the insidious form
    (f) Treatment: liver transplantation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Identify liver condition

Morphology

a. 3 main morphologic features
(1) Bridging fibrous septa
(2) Parenchymal nodules (< 3 mm micronodules to macronodules) (3) Disruption of ENTIRE liver architecture
b. Varies among diseases
c. May correspond to Child-Pugh classification
d. Narrow fibrous septa separating large islands of intact hepatic parenchyma – less portal hypertension
e. Broad bands of fibrosis with less intervening parenchyma – more portal htn
f. Rarely, regression of cirrhosis may occur when underlying disease is cured

**list child Pugh classification? (3) - classify what?

A

CHRONIC LIVER FAILURE AND CIRRHOSIS

General

a. Primarily due to alcoholic liver disease, chronic hepatitis B, chronic hepatitis C, non-alcoholic fatty liver disease, biliary disease and iron overload
b. Not all cirrhosis leads to chronic liver failure and death
(1) Child-Pugh classification of cirrhosis
(a) Class A – well compensated
(b) Class B – partially compensated
(c) Class C – decompensated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Identify clinical features

Primarily due to alcoholic liver disease, chronic hepatitis B, chronic hepatitis C, non-alcoholic fatty liver disease, biliary disease and iron overload

A

CHRONIC LIVER FAILURE AND CIRRHOSIS

Clinical

a. May be clinically silent to symptomatic (anorexia, weight loss, weakness)
b. Jaundice and subsequent pruritus, sometimes severe
c. Impaired estrogen metabolism, hyperestrogenemia
(1) Palmar erythema (vasodilation)
(2) Spider angiomata
(3) In men: hypergonadism and gynecomastia
d. Advanced disease leads to death via:
(1) Same causes as acute liver failure
(2) Hepatocellular carcinoma (HCC)
(3) GI hemorrhage
(4) Bacterial infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Identify liver condition

Due to sustained increased resistance to portal blood flow in sinusoids
a. Contraction of vascular smooth muscle cells and myofibroblasts (stellate)
b. Disruption of blood flow by scarring and parenchymal nodules c. Sinusoidal remodeling and anastomosis of arterial and portal system
(1) Causes shunting of arterial pressures to the low pressure venous system
(2) Disrupts metabolic exchange between sinusoidal blood and
hepatocytes

**Due to?

A

PORTAL HYPERTENSION

Due to ⭡ portal venous blood flow secondary to a hyperdynamic circulation

a. Due to arterial vasodilation in splanchnic circulation via nitrous oxide
b. Leads to increased splanchnic arterial blood flow → increased venous efflux into the portal venous system → ⭡ portal venous pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Identify 3 causes of condition

Major clinical consequences

a. Ascites
b. Portosystemic venous shunts
c. Congestive splenomegaly
d. Hepatic encephalopathy

A

PORTAL HYPERTENSION
*3 causes

A. Pre-hepatic causes

  1. Portal vein thrombosis
  2. Massive splenomegaly

B. Post-hepatic causes

  1. Severe right sided heart failure
  2. Constructive pericarditis
  3. Hepatic vein outflow obstruction (Budd-Chiari syndrome)

C. Intrahepatic cause - CIRRHOSIS (most common cause)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Identify consequence of portal hypertension

  • *excess serous fluid in peritoneal cavity
  • what does increased neutrophils suggest? Bloody fluid?
  • pathogenesis
A

ASCITES; excess serous fluid in the peritoneal cavity

a. Increased neutrophils suggests secondary infection
b. Bloody fluid suggests disseminated intra-abdominal cancer
c. Pathogenesis
(1) Sinusoidal hypertension drives fluid into the space of Disse which is removed by hepatic lymphatics
(2) Movement of protein-rich hepatic lymph into the peritoneal cavity
(3) Splanchnic vasodilation and hyperdynamic circulation (decreased bp - release of vasoconstrictors, activation of renin-angiotensin, secretion of ADH - increased perfusion pressure of interstitial capillaries - extravasation of fluid into abdominal cavity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Identify consequence of portal hypertension

**Increased pressure causes reverse of flow from portal to systemic circulation via collateral and new vessels

A

PORTOSYSTEMIC SHUNTS; increased pressure causes reverse of flow from portal to systemic circulation via collateral and new vessels

a. Rectum - causing HEMORRHOIDS (dilated veins)
b. Falciform ligament of the liver involving the periumbilical and abdominal wall collaterals - causing CAPUT MEDUSAE
c. Esophagogastric junction - causing ESOPHAGEAL VARICES (40% of pts with advanced cirrhosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Identify consequence of portal hypertension

**may cause thrombocytopenia or pancytopenia

A

SPLENOMEGALY

  • SPLEEM can be up to 1000gm (normal - 150gm)
  • may cause thrombocytopenia or pancytopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Identify condition of liver

  1. Included chronic liver disease, hypoxemia and intrapulmonary vascular dilation (IPVD)
  2. Vascular dilation - increased blood flow and decreased time for oxygen diffusion - V/Q mismatch - left to right shunting - hypoxemia, dyspnea
  3. Maybe due to increased nitrous oxide in the lung
A

HEPATOPULMONARY SYNDROME

**Another life threatening consequence of liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Identify condition of liver

  1. Signs of acute liver failure in patients with stable, well-compensated advanced chronic liver disease
  2. Large volumes of functioning liver parenchyma are vulnerable because of borderline vascular supply
  3. Causes: superinfection with HepD in patient with chronic HepB, septic shock (decreased bp and perfusion), heart failure, drug or toxic injury etc
  4. Short term mortality is 50%
A

Acute on chronic liver failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Memory pneumonic for CAUSES OF LIVER FAILURE

A

ABCDEF causes of liver failure

A - Acetaminophen, hepatitis A, autoimmune hepatitis, alcoholic liver disease
B - Hepatitis B
C - Hepatitis C, cryptogenic
D - Drugs/toxins, hepatitis D
E - Hepatitis E, esoteric causes (Wilson disease, Budd-Chiari)
F - Fatty change of the microvesicular type (fatty liver of pregnancy, valproate, tetracycline, Reye syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Summarize liver function tests (10

5 main LFTs
Other 5 - other test that evaluate liver status

A
  1. Albumin
  2. Bilirubin
  3. Alkaline phosphates
  4. GGT (gamma glutamyltransferase)
  5. Transaminases (AST and ALT)
  6. Ammonia
  7. Prothrombin time (PT) and activated partial thrombophlebitis time (aPTT)
  8. Serum globulin
  9. Urine urobilinogen levels
  10. CBC (complete blood count
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Identify liver function test

  1. A. Decreased levels due to decreased synthesis in chronic liver disease
    B. Also decreased in malnutrition, renal and GI diseases & severe burns
  2. A. Serum levels are an indicator of hepatic uptake mechanisms, metabolism and excretory functions
A
  1. Albumin
    Chronic liver disease
    • Degree of hypoalbuminemia correlates with severity of chronic liver disease
    • NOT a good indicator of acute hepatic dysfunction
  2. Bilirubin
    * *from heme degradation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What causes increased direct (6) vs indirect bilirubin (6)

A

Increased direct (conjugated) bilirubin

a. Hepatitis (viral or ischemic causes) or cirrhosis
b. Drug-induced and pregnancy-induced cholestasis c. Sepsis d. Inherited disorders (Dubin-Johnson, Rotor)
e. Biliary cirrhosis and sclerosing cholangitis
f. Obstruction (tumor, stone, etc.)

Increased indirect (unconjugated) bilirubin

a. Hemolysis or ineffective erythropoiesis
b. Prolonged fasting
c. Inherited disorders (Crigler-Najjar syndromes, Gilbert syndrome)
d. Sepsis
e. Hepatitis or cirrhosis
f. Drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Identify LFTs

A.

  1. Correlates with alkaline phosphatase activity & sensitive for alcoholic disease
  2. Greater sensitivity for hepatobiliary disease (biliary obstruction)

B.

  1. Elevated levels due to defective detoxification pathways and portosystemic shunting in severe liver disease
  2. Increased levels support the diagnosis of HEPATIC ENCEPHALOPATHY

C.
• Associated with cellular membranes
• Good indicator for cholestasis, biliary obstruction ( faster than bilirubin) and infiltrative diseases (cancer, granulomas)
• Other causes of  levels: bone, kidney, GI, placental and WBC conditions

A

A. GGT (gamma glutamyltransferase)

B. Ammonia

C. Alkaline phosphatase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Identify LFT

Most indicative of HEPATOCELLULAR DAMAGE & correlates well with disease severity

a. Increased in viral hepatitis, toxic injury and hepatic vein obstruction
b. Also increased in biliary obstruction
* *describe 3 types

A

TRANSAMINASES
A. AST (formerly SGOT) and ALT (formerly SGPT)
B. ALT (8-20); more specific for LIVER INJURY than AST
C. AST (8-20); elevated more than twice as much as ALT in ALCOHOL INJURY (memory device: Another Scotch & Tonic)

ALT - liver injury
AST - alcohol injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Identify LFTs

A. What are the changes in PT and aPTT

B.

  1. Increased levels often seen with chronic liver disease
  2. Marked increase with autoimmune hepatitis

C.

  1. Increased in hepatocellular damage
  2. Decreased in biliary obstruction

D. Changes in CBC

A

A. Prothrombin time (PT) and activated Partial thromboplastin time (aPTT)

  1. Prolonged interval due to various clotting factor deficiencies or inactivity
  2. Involves fibrinogen, prothrombin and factors V, VII, IX and X
  3. Prolongation due to severe widespread liver necrosis (hepatitis, cirrhosis)

B. SERUM GLOBULIN

C. Urine Urobilinogen levels

D. CBC
• Viral hepatitis may cause a relative or absolute lymphocytosis
• Increased MCV with liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What makes up balanced diet (4)

**source of energy (3)

A

Balanced diet

  1. Energy; Carbohydrate + protein + Fat
  2. Essential and non-essential amino acids
  3. Fatty acids
  4. Vitamins and minerals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Diffentiate primary vs secondary malnutrition

  1. A diet lacking needed components of
    nutrition can cause what type malnutrition?
  2. In contrast, diarrhea resulting in too
    little dietary absorption can cause what malnutrition?
A
  1. Primary malnutrition

2. Secondary or conditional malnutrition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Specify 6 causes of malnutrition

A
  1. Ignorance
    - Infants on artificial milk need iron supplement
    - Iodine deficiency common in areas remote from ocean; risk of goiter
  2. Poverty
  3. Infections
  4. Chronic alcoholism
    - Dietary deficiency, defective GI absorption, abnormal nutrient use and storage
    - Common deficiencies: Thiamine, pyridoxine, folate and Vitamin A
  5. Acute + Chronic illnesses
    - BMR in many illnesses resulting in increased daily requirements for all nutrients
  6. Self imposed dietary restriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q
  1. Chronic alcoholics not uncommonly have
    deficiencies in which of the following
    vitamins? Check all that apply. A. Amino acids B. Carbohydrates C. Folate D. Pyridoxine E. Thiamine F.Vitamin A G. Vitamin C
  2. A baby feed on a diet of only artificial milk is
    susceptible to which deficiency? A. Aluminum B. Copper C. Iodine D. Iron E. Potassium F.Sodium G. Zinc
3. A man living in a remote area of Idaho has
been hunting and trapping his own food
for 25 years.  He also grows potatoes.  He
only uses water from a local stream.  He
does not believe in dietary supplements.
He goes to town only to buy supplies but
no food.  Recently he developed a neck
mass.  What nutritional deficiency is likely
?
A. Aluminum
B. Copper
C. Iodine
D. Iron
E. Potassium
F.Sodium
G. Zinc
A
  1. Chronic alcoholic - deficiency;
    Folate, Pyridoxine, thiamine, Vit A
  2. IRON (baby on artificial milk)
  3. IODINE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Range of clinical syndromes characterized by inadequate dietary intake of protein and calories to meet the body’s need

**Identify ways to evaluate

A

PROTEIN-ENERGY MALNUTRITION (PEM)
** Malnutrition in children: defined as a child whose weight falls to less than 80% of normal weight.

Ways of evaluation mild or moderate PEM:
1. Body weight. Measured by body mass index (BMI). A BMI less than 16kg/m2 is considered malnutrition (normal range 18.5 to 25 kg/m2).
2. Fat stores  skin folds.
3. Muscle mass  circumference of the arm.
4. Serum protein  adequacy of the visceral protein
(albumin and transferrin) reflect visceral protein compartment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q
  1. A Body-Mass Index below what
    number is considered malnutrition?
  2. The two ends of the protein-energy
    malnutrition spectrum are:
  3. PEM is functionally regulated by what two different protein compartments ?
4. 
A. Which protein compartment is most
affected in marasmus? 
B. Which protein component is most
affected in kwashiorkor?
A
  1. 16kg/m2
  2. A. Marasmus
    B. Kwashiorkor
3. 
A. Somatic compartment 
- skeletal muscles 
- affected in MARASMUS**
B. Visceral compartment (organs) 
- affected in KWASHIORKOR** 
  1. A. Somatic - MARASMUS
    B. Visceral - KWASHIORKOR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Identify condition that can result from global starvation

  • diminished subcutaneous fat, decreased body weight
  • growth retardation
  • emanciated extremities, larger head
  • increased risk of infections
  • **NO EDEMA
A

MARASMUS
1. Global starvation
2. Somatic compartment is affected more severely
3. Diminished subcutaneous fat:
Decreased body weight (<60% for expected age)
4. Growth retardation - muscle wasting, wrinkled face.
5. Extremities are emaciated head looks larger than body (shrunken old person)
6. Increased risk of infections
7. Deficiencies of other required nutrients such as iodine and vitamins.
8. Hypoplasia of bone marrow: Anemia
9. Serum electrolytes and protein normal
10. No edema**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q
  1. Marasmus is associated with which of
    the following? Check all that apply A. Anemia B. Increased risk of infection C. Loss of subcutaneous fat D. Severe hypoalbuminemia E. Thrombocytosis
A
  1. Anemia, increased risk of infection, loss of subcutaneous fat - MARASMUS

**NO EDEMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Identify condition of malnutrition

⮚ More common in impoverished African and
southeast Asian children
⮚ Diet relatively high in carbohydrates & deficient in protein
⮚ Protein deprivation is associated with severe
loss of visceral protein compartment - DECREASED serum albumin - generalized edema and ascites.

  • *
  • characteristic skin lesions?
  • hair changes?
A

KWASHIORKOR

Characteristic skin lesions; “FLAKEY POINT”

  • alternating zones of hyper/hypo pigmentations
  • desquamations
Hair changes 
– Overall loss of color or
– Alternating bands of pale and darker hair (“flag sign”) 
– Fine texture. 
– Loss of firm attachment to the scalp.
  • *Edema, ascities, skin changes
  • Pitting edema/ascites characteristic of kwashiorkor;↓plasma oncotic pressure
  • Caused by hypoalbuminemia leading to a loss of plasma oncotic pressure

Micro
- Loss of villi & microvilli Small intestinal Enzyme e.g Disaccharidase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q
  1. A 1 year old arrives to adopting parents from Haiti. He is found to be edematous with a protruding abdomen. He is normal weight. Which of the following nutritional history may explain the findings?

A.Protein deprivation is relatively greater than reduction in
calories
B. Protein deprivation is relatively less than reduction in calories

  1. Histology of kwashiorkor
  2. Which of the following may explain the ascites and edema?
    A. Hypercalcemia B. Hyperkalemia C. Hypernatremia D. Hypoalbuminemia E. Hypocalcemia F. Hyponatremia
  3. Why is the child normal weight
  4. State 4 features
    - 2 indicate increased fluid
    - skin changes?
    - hair changes?
A
      • Protein deprivation is relatively greater than reduction in calories (kwashiorkor)
  1. Kwashiokor
    * *FATTY CHANGES; lipid vacuoles are holes in the cell cytoplasm
  2. HYPOALBUMINEMIA
  3. The edema and ascites adds to the weight.
5. 4 features of kwashiokor 
A. Ascites 
B. Edema 
C. “Flaky paint” skin 
D. Alternating hair color (flag skin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Identify condition of malnutrition

  1. Often develops in chronically ill, elderly, and bedridden patients.
  2. It is estimated that more than 50% of elderly residents in nursing homes in the United States are malnourished.
  3. Weight loss of more than 5% associated with PEM increases the
    risk of mortality in nursing home patients by almost five-fold.

**Identify signs

In patients with AIDS or advanced cancers it is known as???
- controlled by?

A

SECONDARY PEM

Signs of secondary PEM

  1. Depletion of subcutaneous fat in the arms, chest wall, shoulders or metacarpal regions
  2. Wasting of the quadriceps femoris and deltoid muscles
  3. Ankle or sacral edema
  4. Bedridden or hospitalized malnourished patients have an increased risk of infection, sepsis, impaired wound healing and death after surgery

CACHEXIA
Secondary PEM in patients with AIDS or advanced cancers, and in these settings it is known as cachexia: It is controlled by;
- production of metabolic cytokines by the tumor, like TNF, IL-1, IL-6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q
  1. Protein energy malnutrition seen in cancer patient is known as?
  2. The bone marrow in a typical
    malnourished child may be which of
    the following? Select all that apply A.Hypercellular B.Hypocellular
A
  1. CACHEXIA

2. HYPOCELLULAR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Identify the following

  1. Self inflicted starvation - marked weight loss
    * *Clinical features of #1
    - findings related to thyroid levels?
    - bone density ?
  2. Condition where patient binge on food and then induce vomiting
    - medical complications? (3)
A
  1. Anorexia Nervosa
    • Clinical findings are similar to those seen in severe PEM.
    • Amenorrhea: related to DECREASED secretion of
    gonadotropin-releasing hormone (GnRH) - DECREASED LH and FSH.
    • Anemia, lymphopenia, and hypoalbuminemia.
    • Increased susceptibility to cardiac arrhythmia and sudden death (hypokalemia related).

• Finding related to decrease thyroid hormone levels:
– Cold intolerance.
– Bradycardia.
– Constipation.
– Changes in the skin and hair; Fine pale hair (lanugo).
• Bone density is decreased - LOW low estrogen levels & low Ca+ intake.

  1. Bulimia
    ** Occur in previously healthy young women with an
    obsession of being thin!!
    Huge amount of food (mainly carb) is ingested followed by induced vomiting. 1. Amenorrhea occur in 50% of patients. 2. Major medical complications relate to vomiting:
    i. Electrolyte imbalances (hypokalemia) - cardiac arrhythmias.
    ii. Pulmonary aspiration of gastric contents.
    iii. Esophageal and gastric rupture.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q
  1. Which of the following can be seen in typical
    anorexia nervosa? More than one answer A.Amenorrhea B.Constipation C.Dry skin
    D. Heat intolerance E.Hypoalbuminemia F. Hypokalemia G. Osteopenia
    H. Polycythemia I. Tachycardia
  2. Sudden death in bulimia or anorexia
    nervosa can be secondary to which
    of the following A.Hypercalcemia B.Hyperkalemia
    C.Hypernatremia D. Hypocalcemia E. Hypokalemia
    F. Hyponatremia
3. A 23-year-old female patient presents complaining of amenorrhea.  It normally did not bother her but now she wants to have kids. Her BMI is 12 kg/m2.  Her heart rate is 56. Lab tests show an anemia, lymphopenia and hypoalbuminemia.  What is the most likely cause of her amenorrhea?
A.High levels of ADH
B.High levels of Prolactin
C.High levels of TSH
D. Low levels of ACTH
E.Low levels of GnRH
F. Low levels of TSH
  1. A 22-year-old female has had 5 episodes of pneumonia
    over the last year. She is enrolled at WVU and has a
    4.0 grade average. In the past her BMI was 30
    kg/m2 but now she is very proud of how much weight
    she has lost over the last 16 months. She is having
    irregular menses. Her current BMI is 16 kg/m2.
    Physical exam is unremarkable. Laboratory tests are
    all within normal limits. Which of the following is the
    would likely explain her recurrent pneumonia?
    A. Chronic diuretic use
    B. Chronic laxative use
    C. Gastric rupture
    D. Immunodeficiency
    E. IV drug abuse
    F. Pulmonary aspiration
A
  1. ANOREXIA - low thyroid
    - Amenorrhea, constipation, dry skin, hypoalbuminemia, hypokalemia, osteopenia
  2. HYPOKALEMIA
  3. Amenorrhea - Low levels of GnRH
  4. Pulmonary aspiration (Pt has BULIMIA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q
    • how many vitamins necessary for health?
    • endogenous synthesized vitamins?
    • which vitamin cannot be synthesized endogenously
  1. 2 forms/mechanism of absorption
  2. Name the fat soluble vitamin s
A

Vitamins
⮚ Total thirteen vitamins are necessary for health
⮚ Necessary in trace amounts for metabolic functions
⮚ Endogenously synthesized vitamins (e.g. vitamin D and vitamin K and biotin, niacin from tryptophan)
⮚ Vitamin C , can’t be synthesized endogenously
 need to be provided in diet.

2 absorption mechanisms 
⮚ Vitamins A, D, E, and K: fat soluble
⮚ Vitamins C and B: water soluble 
** Fat-soluble vitamins are more
readily stored in the body, but they may be poorly absorbed in fat malabsorption disorders, caused by disturbances of digestive functions
  1. Fat soluble vitamins ; A,D,E,K
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Identify vitamin deficiency

  • Deficiency may occur as consequence of general undernutrition or as a secondary deficiency in individuals with conditions that cause malabsorption of fats
  • Bariatric surgery and, in elderly persons, continuous use of mineral oil as a laxative may lead to deficiency
A

VITAMIN A DEFICIENCY
• In children, stores of vitamin A are depleted by infections, and the absorption of the vitamin is poor in newborn infants.
• Adult patients with malaborption syndromes, such as celiac disease, Crohn’s disease, and colitis, may develop vitamin A deficiency, in conjunction with depletion of other fat-soluble vitamins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q
  1. Which of the following is associated
    with vitamin A deficiency? Check all
    that apply A.Celiac disease B.Chronic use of mineral oil C.Diet high in liver D. Gastric bypass surgery E. Inflammatory bowel disease F. Vegetarian diet
  2. Most of the body’s vitamin A is located in which organ?
A
1. 
A. Celiac disease
B. Chronic use of mineral oil 
D. Gastric bypass surgery 
E. Inflammatory bowel disease 
  1. LIVER
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Identify forms of vitamin A (4)

  • transport form
  • stored in perisinusoidal Ito cells
  • affects growth regulation and differentiation
A

Forms of Vitamin A

  1. Retinol (transport from of vit. A)
  2. Retinol ester (storage form of vit.A 90% stored in liver in perisinusoidal stellate (Ito) cells)
  3. Retinol ester oxidized in vivo to retinal (form used in visual pigment)
  4. Retinoic acid -(affects growth regulation and differentiation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q
  1. What carries retinol from the intestines to the liver?
  2. What binds retinol in the blood?
  3. What receptor on the liver uptakes retinol
  4. Which of the following is a vitamin A
    provitamin? A.β-cadinene B.β-carboline C.β-carboxylic acid D. β-carotene E. β-catinin
A
  1. Chylomicrons
  2. Retinol binding protein
  3. Apolipoprotein E receptor
  4. Beta-carotene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

State 6 functions of Vit A

A
  1. Maintenance of normal vision.
  2. Maintenance of specialized epithelia: Vitamin A and
    retinoids play an important role in the orderly
    differentiation of mucus-secreting epithelium;when a
    deficiency state exists, the epithelium undergoes
    squamous metaplasia, differentiating into a keratinizing
    epithelium
  3. Antioxidant
  4. Enhancement of immunity to infections:Vitamin A
    supplementation can reduce morbidity and mortality from
    some forms of diarrhea, and in preschool children with
    measles
  5. Plays role in Fatty acid metabolism: including fatty acid
    oxidation in fat tissue and muscle, adipogenesis, and
    lipoprotein metabolism
  6. Retinoids are used clinically for the treatment of skin
    disorders such as severe acne and certain forms of
    psoriasis, and also in the treatment of acute promyelocytic
    leukemia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q
  1. What are the major functions of vitamin
    A? Check all that apply A. Carbohydrate metabolism B. Epithelial growth and differentiation C. Fatty acid metabolism D.Maintenance of immune system E. Maintenance of normal vision F. Protein metabolism G.Purine metabolism
A
1. 
B.Epithelial growth and differentiation 
C. Fatty acid metabolism 
D.Maintenance of immune system 
E. Maintenance of normal vision
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Identify consequences. Of Vit A deficiency

**Early vs Late eye lesions

A

Night blindness (earliest manifestation)

  • rhodopsin reduced in rods
  • reduced ability to see in dim light

Early eye lesions
I. Conjunctival xerosis ; conjunctiva becomes dry, thickened, wrinkled, pigmented, loses shiny luster
II. Bitot’s spot (build of keratin debris)
- bilateral, triangular, raised whitish plaques
- plaques appear as fine foam with bubbles

Late Eye lesions
I. Corneal xerosis
- begins with drying; hazy granular surface
- softening of cornea
- ulceration and necrosis
II. Corneal ulcers
- circular punched out
- leads to perforation and prolapse of iris
- keratoma alacia; loss of the eye
- child usually seriously ill with fever (~50% mortality)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q
  1. Identify condition in vit A deficiency patient
    - bilateral, triangular, raised whitish plaques
    - plaques appear as fine foam with bubbles
  2. What are changes can occur in the eye in
    a vitamin A deficiency? Select all that
    apply? A. Bitot spots B. Corneal ulcer C. Excessive tearing (epiphora) D.Keratomalacia E. Myopia F. Night blindness G.Xerophthalmia H.Xerosis conjunctivae
  3. Pathologic histo change with vit A deficiency
  4. What can occur to GU tract in VIT A def pt
    A. Hematuria B. Hydronephrosis C. Nephritic syndrome D.Nephrolithiasis E. Nephrotic syndrome

**Summary of vit A def consequences (3)

A
  1. Bitot’s spot (build of keratin debris)
    - bilateral, triangular, raised whitish plaques
    - plaques appear as fine foam with bubbles
2. 
A. Bitot spots 
B. Corneal ulcer 
D. Keratomalacia 
F. Night blindness
G. Xerophthalmia 
H. Xerosis conjunctivae 
  1. Vit A deficiency - SQUAMOUS METAPLASIA
    **decreased rhodopsin regeneration - night blindness
    A. Conjunctiva - xeropthalmia
    B. Cornea - keratomalacia BLINDNESS
    C. Bronchitis - bronchopneumonia
    D. Pancreatic ducts
    E. Urinary tract - kidney stones
    F. Follicular hyperkeratosis of skin
  2. Genitourinary tract
    A. Hematuria (secondary to nephrolithiasis)
    B. Hydronephrosis (secondary to nephrolithiasis)
    D. Nephrolithiasis

**VIT A DEF consequences
I. Night blindness
II. Xeropthalmia (dry eye)
III. Bitot spot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Identify vit toxicity

**vit deficiency
I. Night blindness
II. Xeropthalmia (dry eye)
III. Bitot spot

A

Vit A Toxicity
1. Acute toxicity; Headache, dizziness, stupor, blurred vision

  1. Chronic toxicity
    a. Weight loss
    b. Anorexia
    c. Nausea and vomiting
    d. Bone and joint pain
    e. Increased risk of fractures
  2. Teratogenic in pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Vitamin B complex

  • water or lipid soluble?
  • which is only gotten from animals?
A

All water soluble – widely availableVitamin B12 (animal
origin): only exception

▪ Vegan diet needs to supplemented with Vitamin B12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Identify vitamin

  • found in fortified breads and cereals fish, lean meats and milk
    ⮚ Cofactor in biochemical reactions that produce ATP
    ⮚ Cofactors for transketolase in pentose phosphate pathway
    ⮚ Maintains neural membranes and normal nerve conduction (chiefly of peripheral nerve)

**causes of vit deficiency

A

THIAMINE (Vit B1) - thiamin pyrophosphate (TPP)

Causes of thiamine deficiency
• Chronic alcoholism (in the United States) is the most common cause.
• Diet of unenriched rice is the most common cause of deficiency in developing countries.

**
Wet beriberi; Dilated cardiomyopathy with biventricular heart failure and dependent pitting edema; cardiac muscle lacks ATP; IV thiamine reverses cardiomyopathy in some cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

40-year-old pedestrian is hit by an automobile and is brought to the
emergency department by ambulance. Laboratory studies completed immediately on arrival include normal complete blood count, serum glucose, and electrolytes. An intravenous line is inserted, and 5% dextrose and normal saline is administered. The patient has the smell of alcohol on his breath. While in the emergency department, he becomes confused and develops eye muscle weakness and horizontal nystagmus. The patient most likely has a deficiency of which of the following vitamins?
A. Folic acid
B. Niacin
C. Thiamine
D. Vitamin B6
E. Vitamin B12

A

THIAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Identify vitamin

  • Water soluble
  • Unstable in sunlight
  • Source: widely distributed, in meat, dairy product and vegetables
  • **Function:Important role in ETC
A

Vitamin B2; RIBOFLAVIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Identify vitamin

  • Can be synthesized endogenously from Tryptophan
  • food source; diary, poultry, fish, lean meat, nuts and eggs

**function? Complication of deficiency

A

NIACIN

Function

  • Essential component of NAD & NADP
  • Used in the treatment of hypercholesterolemia (lowers plasma LDL level by reducing hepatic synthesis of VLDL)

Complication of niacin deficiency
- Patients who have corn-based diets commonly develop niacin deficiency(pellagra) because the niacin in corn is in a bound form that cannot be reabsorbed, and corn is deficient in tryptophan.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q
  1. Why do vitamin supplements during pregnancy typically not include vitamin A?
2. This finding in a patient with a vitamin C deficiency is due to which of the following
A.Anemia
B.Fragile vessels
C.Hypofibrinogenemia
D. Low clotting factors II, VII,
IX and X
E. Thrombocytopenia
A
  1. Vitamin A supplementation can be TERATOGENIC

2. Vitamin C - fragile vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

The deficiency state is scurvy, ⮚ not very common ä Still sometime encountered in:
• Elderly individuals.
• Alcohol addicts.

  • *functions of vitamin?
  • *consequences of deficiency?
A
Vitamin C functions 
- Antioxidant: may retard atherosclerosis (by reducing
oxidation of LDL) 
- Collagen formation: 
- Aids in the absorption of iron

Consequences of Vit C deficiency
1. Impaired wound healing
2. Hemorrhages from fragile vessels due to weak collagen: for example gingival mucosa
3. Characterized by bone disease in children; defective formation
of osteoid matrix (due to impaired synthesis of
hydroxyproline and hydroxylysine)
4. Swelling of the large joints with inflammation and subperiostal
hemorrhages: May results in “pseudo paralysis” with
characteristics frog-legged positioning

    • Skin lesions: perifollicular, hyperkeratotic papular rash
  • purpura and ecchymoses on the skin
    • Note the marked hematomas due to capillary hemorrhages in the legs of the patient with scurvy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Identify vitamin

  • Fat soluble; steroid hormone
  • Major dietary source include fortified milk, liver, fish, butter and eggs.

**origin? 2 forms? Another name

A

VITAMIN D
90% of the vitamin D requirement is endogenously derived from photochemical conversion of 7- dehydrocholesterol present in the skin.

2 forms

1) Vitamin D3 (cholecalciferol, derived from 7-dehydrocholesterol present in skin)
2) Vitamin D2 (ergocalciferol derived from plant ergosterol).

**Vitamin D3 is also known as CHOLECALCIFEROL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Explain the metabolism of Vitamin D

  • *1-OHas
  • activity increased how?
  • how is activity affected through PTH
A
  1. Photochemical synthesis of vitamin D from Vitamin D precursors in the skin and absorption of vitamin D from foods and supplements in the gut
  2. Binding of vitamin D from both of these sources to
    plasmaα1-globulin(D-binding protein or DBP)and
    transport into the liver
  3. Conversion of vitamin D into 25-hydroxycholecalciferol (
    25-OH-D) in the liver, through the effect of 25-Ohases
  4. Conversion of 25-OH-Dinto 1,25-dihydroxyvitamin D,in
    the kidney, the most active form of vitamin D, through
    the activity ofα1-hydroxylase (1-OHase)

1-OHas

  • Activity increased in;
  • hypophosphatemia
  • increases in PTH hormone level
  • Changes in calcium affect activity through PTH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q
1. The role of the liver in vitamin D metabolism
is to 
A. Convert 1,25 (OH)2D to 25(OH)D 
B. Convert D3 to 1,25 (OH)2D 
C. Convert D3 to 25(OH)D 
D. Convert D3 to cholecalciferol
  1. Place the following locations in sequence of
    the formation from Pre-D3 to 1,25(OH)
    2D: _____ to ______ to_______ Choices: 1. Kidney 2. Liver 3. Skin
  2. Which vitamin D is made in the skin from
    photosynthesis A. D1 B. D2 C. D3
  3. Which enzyme converts Vitamin D in the
    kidney to the most active form? A. 1-OHas
    B. 12-OHase C. 21-OHase D. 22-OHase E. 24-Ohase F. 25-OHase
A
  1. C. Convert D3 to 25(OH)D
  2. SKIN to LIVER to KIDNEY
  3. D3
  4. A. 1-OHas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q
  1. Major function of vitamin D active form

2. Identify effects of vitamin D on homeostasis fo 2 othe rminerals (4)

A
  1. Major Function of 1,25-dihydroxyvitamin D ( Vitamin D active form)
    - Maintenance of normal plasma level of calcium/phosphate
  2. Effects of Vitamin D on Calcium and Phosphorus Homeostasis
  3. Stimulation of intestinal calcium absorption.
  4. Stimulation of calcium reabsorption in the kidney.
  5. Interact with parathyroid hormone (PTH) in the regulation
    of blood calcium.
    i. Together, they enhance the expression of RANKL (receptor
    activator of NF-κB ligand) on osteoblasts.
    ii. RANKL binds to its receptor (RANK) located in preosteoclasts
    , inducing the differentiation of these cells into mature osteoclasts
  6. Mineralization of bone
    i. It contributes to the mineralization of osteoid matrix and
    epiphyseal cartilage in the formation of both flat and long bones in the skeleton
    ii. It stimulates osteoblasts to synthesize the calcium-binding
    protein osteocalcin, involved in the deposition of calcium during bone development.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Vitamin D deficiency states (5)

Vit D deficiency in HYPOCALCEMIA (4)

A

Vit D deficiency states

  1. Insufficient vitamin D in diet
  2. Insufficient production of vitamin D in skin due to limited exposure of sunlight (heavily veiled women)
  3. Inadequate absorption (fat malabsorption syndromes)
  4. Abnormal conversion of Vitamin D to its active form (Liver disease and chronic renal failure)
  5. Renal disorders causing decreased synthesis of 1,25-dihydroxyvitamin D

Vit D deficiency in HYPOCALCEMIA (4)

  1. Increase PTH secretion
  2. Increase osteoclast activity
  3. Increase renal phosphate excretion
  4. Decrease renal calcium excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Consequence of vitamin D deficiency

  1. Children vs adults
  2. Milder forms?
A
  1. An excess of unmineralized matrix.
    A. Rickets- Children
    B. Osteomalacia- Adult
  2. Milder forms of vitamin D deficiency leading to an
    increase risk of bone loss and hip fractures are quite common in the elderly in the United States and Europe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Identify condition

  1. Most common during the first year of life
  2. An excess of osteoid producesfrontalbossingand
    asquaredappearancetothehead.
  3. Deformation of the chest results from overgrowth of
    cartilage or osteoid tissue at the costochondral junction, producing the“rachiticrosary.”
  4. The weakened metaphyseal areas of the ribs are
    subject to the pull of the respiratory muscles and thus bend inward, creating anterior protrusion of the sternum(pigeon breastdeformity).
A

RICKETS
** When an ambulating child develops rickets,
deformities are likely to affect the spine, pelvis, and tibia, causinglumbarlordosisandbowingofthelegsshort stature

**BOWING OF LEGS, RACHITIC ROSARY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q
  1. In a child with rickets, what chest deformity
    can occur?
  2. What can occur to the spine in rickets?
  3. In adults, vitamin D deficiency leads to
    which bone disease?
A

In a child with rickets, what chest deformity
can occur? PIGEON BREAST DEFORMITY

What can occur to the spine in rickets? LORDOSIS

In adults, vitamin D deficiency leads to which bone disease? OSTEOMALACIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

IDENTIFY condition
• Newly formed osteoid matrix is inadequately mineralized - excess of persistent osteoid is characteristic.
• Bone is weak and is vulnerable to fractures, usually affecting:
– The vertebral bodies.
– Femoral neck.
• Persistent failure of mineralization - lead to osteopenia (loss of skeletal mass).

A

OSTEOMALACIA - Adult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q
  1. The main function of vitamin D is to regulate
    which of the following? There may be more
    than one answer. A. Bicarbonate homeostasis B. Calcium homeostasis C. Cholesterol homeostasis D. Creatinine homeostasis E. Magnesium homeostasis F. Phosphate homeostasis G. Potassium homeostasis
  2. What directly increases the 1-OHase activity in
    the conversion of 25(OH)D to 1,25 (OH)2D.
    More than one answer. A. High levels of 1,25 (OH)2D B. Hypercalcemia C. Hyperphosphatemia D. Hypophosphatemia E. Increases in parathyroid hormone level F. Renal disease
  3. The main effect of 1,25 (OH)2D on the
    kidney is: ______________ The main effect of 1,25 (OH)2D on the
    intestines is: _____________
  4. The main effect of 1,25 (OH)2D in
    combination with PTH on bone
    metabolism is to do which of the following: A. Increase RANK expression on
    osteoblasts B. Increase RANK expression on osteocytes C. Increase RANKL expression on
    osteoblasts D. Increase RANKL expression on
    osteoclasts E. Increase RANKL expression on
    osteocytes
  5. 1,25 (OH)2D in bone metabolism stimulates
    osteoblasts to make which calcium binding
    protein?
A
  1. Vitamin D regulate
    B. Calcium homeostasis
    F. Phosphate homeostasis
  2. What increase 1-OHase activity
    D. Hypophosphatemia
    E. Increases in PTH hormone level
  3. A. The main effect of 1,25 (OH)2D on the
    kidney is: INCREASED CALCIUM REABSORBTION
    B. The main effect of 1,25 (OH)2D on the intestines is: INCREASED CALCIUM ABSORPTION
  4. Main effect of 1,25 (OH) 2D in combination with PTH on bone metabolism
    C. INCREASE RANKL EXPRESSION ON OSTEOBLASTS
  5. OSTEOCALCIN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

A. What direction do each of the following go
in hypocalcemia with a vitamin D
deficiency.
1. PTH: Increase or decrease
2. Osteoclast activity: Increase or decrease
3. Renal phosphate excretion: Increase or
decrease
4. Renal calcium excretion: Increase or
decrease

B. Patients with ostemalacia are more prone to
fractures because of which of the
following: A. Osteopetrosis B. Paget disease C. Persistent osteoid D. Type 2 collagen defect E. Type 1 collagen defect

A

A. HYPOCALCEMIA and Vitamin D deficiency

  1. PTH: Increase
  2. Osteoclast activity: Increase
  3. Renal phosphate excretion: Increase
  4. Renal calcium excretion: Decrease

B. Osteomalacia patients
***PERSISTENT OSTEOID (NON-CALCIFIED BONE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Identify condition
- Calcifications of soft tissues
– Bone pain
– Hypercalcemia

A

Vitamin D toxicity (Megadoses)

**Cannot get toxic from prolonged sun exposure

** hypervitaminosis D is from the deposit of what material in the soft tissue? Calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Obesity

  1. Histology of adipose tissue
  2. Definition of obesity
  3. Adipocyte numbers
  4. Central obesity
A
  1. Histology of adipose tissue
    - Each clear space corresponds to the fat vacuole in a single adipocyte. When making slides of fat, the tissue is placed through alcohol which dissolves the fat leaving a clear space.
2. Definition of obesity; BMI >30 kg/m2
– Other methods to measure:
• Triceps skinfold thickness 
• Mid-arm circumference 
• Ratio of waist and hip circumferences
– Central (visceral) obesity:  Fat accumulates in
trunk, mesentery and around viscera
  1. Adipocyte numbers
    – Total number established by adolescence
    – In adults, numbers remain constant
  2. Central obesity (or visceral obesity)
    - in addition to fat in subcutaneous tissue, fat is also around the ORGANS
    - fat accumulate around trunk and in abdominal cavity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

State 4 adipocyte hormones
1.
– From ob gene
– Secretion stimulated by abundant fat stores

2.
– Concentration inverse to fat stores (high fat stores
have low concentration; lean have high concentration)
– Increases insulin sensitivity

    • Made in stomach and hypothalamus
      – Increases before meals; falls 1-2 hours after
      meals
      – Postprandial decrease is attenuated in obese
      – Increases food intake
4. 
– Made in ileum and colon
– Low during fasting and increase after food
intake 
– Reduces energy intake
A
1. LEPTIN from fat cells 
– Effects:
• Increase energy expenditure and heat generation 
• Stimulates physical activity 
• Decreases food intake
– If no ob gene, cannot make leptin
• Leads to early onset severe obesity 
– Leptin receptor (OB-R) is from db (diabetes) gene
• If no db gene, also see severe obesity
2. ADIPONECTIN from fat cells 
– Concentration inverse to fat stores (high fat stores
have low concentration; lean have high concentration)
– Fatty acid metabolism
• Directs fatty acids to muscle for use 
• Decreases fatty acid uptake  in liver 
• Decreases glucose production by liver
– Increases insulin sensitivity
  1. GHRELIN
  2. PYY
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q
  1. Identify the leptin gene and the leptin
    receptor gene 1. db 2. erb 3. Her2/neu 4. ob 5. rb
  2. LEPTIN is synthesized by which cells?
  3. Which will have a higher leptin level, a BMI
    of 18 kg/m2 or a BMI of 30 kg/m2?
  4. Increased leptin will do which of the
    following? • Increase or decrease energy expenditure • Increase or decrease heat production • Increase or decrease food intake
  5. Will an animal lacking the ob gene given unlimited food become obese or anorexic?
A
  1. Db - LEPTIN receptor gene
    ob - LEPTIN gene
  2. LEPTIN - synthesized by fat cells
  3. BMI of 30 has higher LEPTIN levels than BMI 18
  4. Increased LEPTIN
    A. INCREASE energy expenditure
    B. INCREASE heat production
    C. DECREASE food intake
  5. OBESE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q
  1. Which of the following are true about Adiponectin.
    There may be more than one answer. A. It decreases sensitivity to insulin. B. It is lower in concentration in an obese person
    as compared to a lean person C. It is mainly secreted by muscle D. It is mainly secreted by the pituitary gland E. It stimulates fatty oxidation in muscle F. It suppresses fatty oxidation in muscle
  2. What happens to ghrelin level after Meal
  3. PYY levels after meal
A
  1. B. It is lower in concentration in an obese person as compared to a lean person
    E. It stimulates fatty oxidation in muscle
  2. GHRELIN DECREASES after meal
  3. PYY INCREASES after meal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

State consequences of obesity (11)

A

• Type 2 diabetes with insulin resistance and hyperinsulinemia

• Metabolic syndrome:
– Includes visceral adiposity, Type 2 diabetes, hypertension, dyslipidemia

• Increased risk of atherosclerosis
• Non-alcoholic fatty liver disease
• Cholelithiasis with high concentration of cholesterol in stones
• Hypersomnolence and Hypoventilation Syndrome (Pickwickian
Syndrome)
– Associated with sleep apnea and polycythemia

  • Osteoarthritis
  • Increased cancer risk for multiple locations
  • Steroid metabolism: Changes in androgen and estrogen balance • Dyslipidemia: Increase triglycerides with decrease HDL
  • Hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q
  1. What arthritis is associated with obesity
  2. What Diabetes is associated with obesity
  3. Type of liver disease associated with obesity
  4. Gallbladder disease associated with obesity?
  5. What happens to HDL in obesity
  6. What may explain polycythemia in a
    severely obese person?
A
  1. Osteoarthritis
  2. Type 2 DM (insulin resistant)
  3. NONALCOHOLIC FATTY LIVER DISEASE
  4. CHOLELITHIASIS (gallstones)
  5. HDL decreases in obesity
  6. Polycythemia in severely obese person
    * *HYPOVENTILATION SYNDROME

Obesity associated with; increased risk of cancer, hypersomnolence, high conc cholesterol (obesity associated gall stones)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Summarize common polyps vs colorectal neoplasia

A

Common polyps

  1. Hyperplastic
  2. Colonic adenomas — > Sporadic Colonic adenocarcinoma
  3. Inflammatory Polyps
  4. Hamartomatous polyps: Sporadic and Syndromic

Colorectal Neoplasia

  1. Sporadic
  2. Familial: (FAP, MYH-associated, Lynch syndrome)
  3. Colitis (Ulcerative Colitis and Crohn Disease); Associated Neoplasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Identify colon condition

• Most common colonic polyp (75 - 90% of colon polyps)
• Most commonly found in the left colon
• Typically <5 mm in diameter
• Singly, frequently multiple (sigmoid colon and rectum)
• Histologically, composed of mature goblet and absorptive
cells (delayed shedding of these cells leads to crowding that
creates the serrated surface architecture)

**what is the CHIEF SIGNIFICANCE?
Microscopic vs gross

A

HYPERPLASTIC POLYPS (Non-neoplastic)

Micro
Serrated surface architecture (morphologic hallmark); typically restricted to the upper third, or less, of the crypt

Gross: Smooth, nodular protrusions of the mucosa, often on the crests of mucosal folds

A) Polyp surface with irregular tufting of epithelial cells
B) Tufting results from epithelial overcrowding
C) Epithelial crowding produces a serrated architecture when
crypts are cut in cross- section

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

Identify colon condition
• Low-grade epithelial dysplasia
• Small, often pedunculated, polyps to large sessile lesions.
• Small male predominance
• Present in ~30% of adults living in the Western world by age 60
• Recommended: all adults in the United States undergo
surveillance by age 50
• Patients at increased risk, including those with a family
history of colorectal adenocarcinoma: typically screened
colonoscopically at least 10 years before the youngest
age at which a relative was diagnosed

  • *
  • do they progress to malignancy?
  • S&S?
  • 4 types
A

COLONIC ADENOMA
• Majority of adenomas do not progress to become adenocarcinomas
• S/S: Most adenomas are clinically silent with
- large polyps that produce occult bleeding and
anemia
- rare villous adenomas that cause hypoproteinemic
hypokalemia by secreting large amounts of protein
and potassium
• Four types: Tubular adenoma, Tubulo-villous adenoma,
Villous adenoma and Serrated adenoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

Describe pathology of colonic adenoma
**Types
A. A smooth surface and rounded glands. Active inflammation occasionally present in adenomas, in this case, crypt dilation and rupture can be seen at the bottom of the field
B. Long, slender projections that are reminiscent of small intestinal villi
C. with an increased nuclear-to- cytoplasmic ratio, hyperchromatic and elongated nuclei, and nuclear pseudostratification. Compare to the nondysplastic epithelium below.
D. lined by goblet cells without cytologic features of dysplasia.

A

A. Tubular adenoma
B. Villus adenoma
C. Dysplastic epithelial cells
D. Sessile serrated adenoma

COLONIC ADENOMA
• Size: 0.3 to 10 cm in diameter
• Pedunculated or sessile
• Having a texture resembling velvety or smooth
• Histologically:
**• Nuclear hyperchromasia (hallmark of epithelial dysplasia) and
elongation, and stratification , changes easily appreciated at the
surface of the adenoma
- Cytologically: prominent nucleoli, eosinophilic cytoplasm, and a reduction in the number of goblet cells
- Pedunculated adenomas have slender fibromuscular stalks
containing prominent blood vessels derived from the submucosa :
usually covered by nonneoplastic epithelium, but dysplastic
epithelium sometimes present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

Identify colon condition
A) The dilated glands, proliferative epithelium, superficial erosions, and inflammatory infiltrate are typical of an inflammatory polyp. However, the
smooth muscle hyperplasia within the lamina propria suggests that mucosal prolapse has also occurred.
B) Epithelial hyperplasia.
C) Granulation tissue-like capillary proliferation within the lamina propria caused by repeated erosion.

A
INFLAMMATORY POLYPS (Non-neoplastic) 
• Mixture of epithelial and stromal components
admixed with inflammatory cells 
• Often related: 
- Inflammatory bowel disease (Crohn's disease or
ulcerative colitis) 
- Anastomosis 
- Ischemic colitis 
- Infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

Identify colon conditions

  1. Composed of tissue elements normally found at that site, but growing in a disorganized manner
    • Sporadically (non-neoplastic)
    • Components of various genetically determined
      or acquired syndromes. Some are neoplastic: - In the polyp, - Some are intestinal and extraintestinal site of malignancy
A
  1. Hamartomatous polyps

2. Colonic Hamartomatous polyps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

Summarize different GI polyposis syndromes

**What are the 2 most important

A
  1. Juvenile polyposis **
  2. Peutz-Jeghers syndrome **
  3. Cowden syndrome, Bannayan-Ruvalcaba-Riley syndrome
  4. Cronkhite- Canada syndrome
  5. Tuberous sclerosis
  6. Familial adenomatous polyposis (FAP)
    * *classic FAP, attenuated FAP, Gardner syndrome , Turcot syndorme, MYH-associated polyposis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

Identify colon condition

• Focal malformations of the epithelium and lamina
propria
• Sporadic or syndromic; histologically same
• Mostly <5 years, may at older ages ; Most in the rectum:
• S/S: typically rectal bleeding; some cases :
intussusception, intestinal obstruction, or polyp prolapse

A

JUVENILE POLYPS
A. Sporadic juvenile polyps (retention polyp): Usually
solitary lesions
B. Juvenile polyposis syndrome (Autosomal Dominant): - (3 -100) hamartomatous polyps - Require colectomy to limit the chronic and sometimes
severe hemorrhage associated with polyp ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

Identify condition, genetic mutations?

Gross; Pedunculated, smooth-surfaced, reddish lesions with characteristic cystic spaces apparent after sectioning • Microscopic examination:
- Cysts to be dilated glands filled with mucin and inflammatory debris
- Remainder of the polyp is composed of lamina propria
expanded by mixed inflammatory infiltrates
- Muscularis mucosae may be normal or attenuated

**
A. Surface erosion and cystically dilated crypts
B. Inspissated mucous, neutrophils, and inflammatory debris can accumulate within dilated crypts.

A

JUVENILE POLYPS
- Dysplasia is extremely rare in sporadic juvenile polyps**
- Dysplasia associated with Juvenile polyposis syndrome,
both within the juvenile polyps and in separate
adenomas - 30% to 50% of pts with juvenile polyposis develop colonic adenocarcinoma by age 45

AUTOSOMAL DOMINANT
• A minority cases: polyps in stomach and small bowel
that undergo malignant transformation
• Pulmonary arteriovenous malformations and other
congenital malformations
• Mutation identified: <50% cases
- Most common: SMAD4, which encodes a cytoplasmic intermediate in the TGF-β signaling pathway
- Others: BMPR1A, a kinase that is a member of the
TGF-β superfamily, may be mutated in other cases
- Other responsible genes: remain to be discovered!!!!!! (MAY BE YOU ARE ONE OF THEM TO DISCOVER☺ )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

Identify colon condition

A. surface (top) overlies stroma composed of smooth muscle bundles cutting through the lamina propria
B. Complex glandular architecture and the
presence of smooth muscle are features that distinguish it from another

**pathogenesis

A

Peutz-Jeghers polyps
**differentiate from juvenile polyps

Pathogenesis
• Germline heterozygous loss-of-function mutations in the
gene STK11: ~50% familial Peutz-Jeghers syndrome and a subset of sporadic Peutz-Jeghers syndrome
• STK11 is a tumor suppressor gene that encodes a kinase
that regulates cell polarization and acts as a brake on growth and anabolic metabolism
• Loss of fu

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

Identify condition
• Median age of 11 years with multiple GI hamartomatous polyps and mucocutaneous hyperpigmentation
• Mucocutaneous hyperpigmentation: - Dark blue to brown macules on the lips, nostrils, buccal mucosa, palmar surfaces of the hands, genitalia, and perianal region - Similar to freckles, but presence in the buccal mucosa.
• Polyps– > intussusception, occasionally fatal
• Markedly increased risk of malignancies:
Lifetime risk: ~ 40%
• Regular surveillance at beginning of birth:
- beginning at birth for sex cord tumors of the testes
- late childhood for gastric and small intestinal cancers
- second and third decades of life for colon, pancreatic,
breast, lung, ovarian, and uterine cancers

**Identify clinical features

A

Peutz-Jeghers Syndrome: Clinical Features
• Most common in SMALL INTESTINE> stomach and colon >bladder and lungs
• Morphology of Peutz-Jeghers polyps overlap with that of
sporadic hamartomatous polyps

• Diagnosis:
- Multiple polyps in the small intestine
+ mucocutaneous hyperpigmentation
+ a positive family history
• Detection of STK11 mutations can be helpful, particularly
diagnostically in patients with polyps who lack
mucocutaneous hyperpigmentation.
• Absence of STK11 mutations does not exclude the
diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Identify 3 FAMILIAL colorectal neoplasia

A
  1. Familial Adenomatous Polyposis (FAP)
  2. MYH-associated Polyposis Syndrome
  3. Hereditary Nonpolyposis Colorectal Cancer (HNPCC) (Lynch syndrome )
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

Identify colorectal condition

  • AUTOSOMAL DOMINANT
  • develops numerous colorectal adenomas as teenagers
  • 100% of untreated patients develop COLORECTAL ADENOCARCINOMA often before age 30 and nearly always by age 50
  • standard therapy; prophylactic colectomy
  • *how many needed for diagnosis?
  • *morphology similar to what?
  • *micro?
  • what prevent colorectal cancer?
  • manifestations?
A

Familial adenomatous polyposis (FAP)
• At least 100 polyps are necessary for a diagnosis of
classic FAP, but as many as several thousand may be
present
• Morphologically indistinguishable from sporadic adenomas; flat or depressed adenomas are also prevalent in FAP
• Microscopic adenomas, consisting of only one or two dysplastic crypts, are frequently observed in otherwise normal-appearing mucosa

• Colectomy prevents colorectal cancer, but patient remain at risk for neoplasia at other sites:
- Adenomas elsewhere in GI tract, particularly adjacent to the ampulla of Vater and in the stomach
• Associated with a variety of extraintestinal manifestations :
- Congenital hypertrophy of the retinal pigment
epithelium, which can generally be detected at birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

Identify pathogenesis of colorectal condition

**Therapy - COLECTOMY
• Colectomy prevents colorectal cancer, but patient remain at risk for neoplasia at other sites:
- Adenomas elsewhere in GI tract, particularly adjacent to the ampulla of Vater and in the stomach
• Associated with a variety of extraintestinal manifestations :
- Congenital hypertrophy of the retinal pigment
epithelium, which can generally be detected at birth

A

Familial adenomatous polyposis (FAP)

Pathogenesis

  • Mutations of the adenomatous polyposis coli, or APC, gene, a key negative regulator of the Wnt signaling pathway
  • Approximately 75% of cases are inherited, remaining appear to be caused by de novo mutations
  • Specific APC mutations associated with the development of other extraintestinal manifestations of FAP and partly explain variants such as Gardner syndrome and Turcot syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

Identify colorectal condition

  • Autosomal recessive disorder
  • Colonic phenotype is similar to attenuated FAP
  • Polyp development at later ages
  • Polyps: fewer than 100 adenomas
  • Delayed appearance of colon cancer, often at ages of 50 or older.
A

MYH-associated Polyposis Syndrome

• Bi-allelic mutations of the base-excision repair
gene MYH ( MUTYH)
• Serrated polyps, often with KRAS mutations, are frequently present in MUTYH-associated polyposis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

Identify colorectal condition
Originally described based on familial clustering of cancers at several sites including - Colorectum - Endometrium - Stomach - Ovary - Ureters - Brain - Small bowel - Hepatobiliary tract - Pancreas - Skin

  • what percent of colorectal cancers?
  • what part of colon?
  • what age?
  • Inherited mutations
  • what 5 repair genes
A

(HNPCC)= Lynch syndrome
• Account for 2% to 4% of all colorectal cancers, most
common hereditary colorectal carcinoma syndrome
• Colon cancers in HNPCC patients occur at younger ages
than sporadic colon cancers
• Often located in the right colon
• Inherited mutations in mismatch repair (MMR ) genes (encode proteins responsible for the detection, excision, and repair of errors that occur during DNA replication, particulary seen in microsatellite regions)
- At least five mismatch repair genes:
Majority of patients: mutations in MSH2 or MLH1; less commonly MSH6 or PMS2; others: PMS1, EPCAM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

Identify colon condition
**Presentation? Screening? Markers?

Epidemiology
• Most common malignancy of the GI tract
• Major cause of morbidity and mortality worldwide
• Approximately 1.2 million new cases, and 600,000 associated
deaths, occur each year worldwide
• Responsible for nearly 10% of all cancer deaths • Incidence : highest in North America: - In US: ~10% of worldwide cases ; 15% of all cancer-related deaths in the US , second only to lung cancer. • Other counties with high incidence: Australia, New Zealand,
Europe, and, with changes in lifestyle and diet, Japan,
• Lower Incidence: South America, India, Africa, and South
Central Asia
• Peaks at 60 to 70 years of age, with fewer than 20% of cases
occurring before age 50

A

COLONIC ADENOCARCINOMA
• Per rectal bleeding
• Screening: at age 50 years (colonoscopy and occult blood testing)

• Presentation:

  • Proximal colon: Polypoid and exophytic; rarely obstruct lumen; Iron deficiency anemia (fatigue and weakness)
  • Distal colon: Annular lesions that produce “napkin ring” constructions and luminal narrowing - obstruction;
  • Presentation; occult bleeding, changes in bowel habits, or cramping and left lower quadrant discomfort
  • *Associated with STREPTOCOCCUS BOVIS ENDOCARDITIS
  • *Serum tumor marker; CEA for treatment response and follow up; NOT FOR SCREENING
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

• Associated with Streptococcus bovis endocarditis • Serum Tumor Marker: CEA for treatment response
and follow-up; not for screening

  • *IDENTIFY
  • dietary factors? Theories?
A

COLONIC ADENOCARCINOMA
• Dietary factors: most closely associated with colorectal cancer;
- Low intake of unabsorbable vegetable fiber and high
intake of refined carbohydrates and fat
- Theorized:
a. Reduced fiber content leads to decreased stool bulk and altered composition of the intestinal microbiota - increase synthesis of potentially toxic oxidative by products of bacterial metabolism, remain in contact with the colonic mucosa for longer periods
b. High fat intake also enhances hepatic synthesis of cholesterol and bile acids, which can be converted into carcinogens by intestinal bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

Colon condition
High expression enzyme cyclooxygenase-2 (COX-2):
~90% of colorectal carcinomas and 40% to 90% of adenomas

**Pharmacologic chemoprevention???

A

COLONIC ADENOCARCINOMA

** Pharmacologic chemoprevention:
a) Some NSAIDs cause polyp regression in FAP patients in
whom the rectum was left in place after colectomy. It is
suspected that this effect is mediated by inhibition of
the enzyme cyclooxygenase-2 (COX-2)
b) COX-2 is necessary for production of prostaglandin E2,
which promotes epithelial proliferation, particularly
after injury
c) COX-2 expression is regulated by TLR4, which recognizes
lipopolysaccharide and is also overexpressed in
adenomas and carcinomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

2 genetic pathways of colonic adenocarcinoma

A
  • Molecular events: heterogeneous and includes genetic and epigenetic abnormalities
  • Involved at least two genetic pathways:

1) APC/β-catenin pathway, which is activated in the classic
adenoma-carcinoma sequence (80% of sporadic ) and
2) Microsatellite instability pathway, which is associated with
defects in DNA mismatch repair and accumulation of
mutations in microsatellite repeat regions of the genome

  • Both pathways involve the stepwise accumulation of
    multiple mutations, but differ in the genes involved and the mechanisms by which mutations accumulate
  • EPIGENETIC EVENTS (methylation-induced gene silencing)
    – > enhance progression along either pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

SUMMARIZE 4 PATHOGENESIS OF COLORECTAL CARCINOMA

A
  1. CLASSIC ADENOMA - CARCINOMA Sequence
  2. DNA mismatch repair deficiency, mutations accumulate in microsatellite repeats, a condition referred to as microsatellite instability
  3. A subset of MICROSATELLITE UNSTABLE colon cancers without mutations in DNA mismatch repair enzymes demonstrate the CpG island hypermethylation phenotype (CIMP):
    - MLH1 promoter region is typically hypermethylated, thereby reducing MLH1 expression and repair function
    - BRAF mutation
    - No KRAS and TP53 mutation
  4. A small group of colon cancers display increased CpG island methylation in ABSENCE OF MICROSATELLITE instability.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

DESCRIBE Pathogenesis (main one)

A, Circumferential, ulcerated rectal cancer. Note the anal mucosa at the bottom of the image.
B, Cancer of the sigmoid colon that has invaded through the muscularis propria and is present within subserosal adipose tissue (left). Areas of chalky necrosis are present within the colon wall (arrow).

A

COLORECTAL CARCINOMA - PATHOGENESIS

  1. CLASSIC ADENOMA - CARCINOMA SEQUENCE
    • Typically includes mutation of APC early in the neoplastic
    process
    • Normally APC protein binds to and promotes — > degradatio
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

Histology types
A. Note the elongated, hyperchromatic nuclei. Necrotic debris, present in the gland lumen, is typical.
B. forms a few glands but is largely composed of infiltrating nests of tumor cells.
C. with signet-ring cells and extracellular mucin pools.

**Metastasis?

A

Colorectal carcinoma
A. Well-differentiated adenocarcinoma
B. Poorly differentiated adenocarcinoma
C. Mucinous adenocarcinoma

Metastatic colorectal carcinoma.
A, Lymph node metastasis. Note the glandular structures within the subcapsular sinus.
B, Solitary subpleural nodule of colorectal carcinoma metastatic to the lung.
C, Liver containing two large and many smaller metastases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

Identify colon condition

A, Dysplasia with extensive nuclear stratification and marked nuclear hyperchromasia.
B, Cribriform glandular arrangement in high- grade dysplasia.
C, Colectomy specimen with high-grade dysplasia on the surface and underlying invasive adenocarcinoma. A large cystic, neutrophil- filled space lined by invasive adenocarcinoma is apparent (arrow) beneath the muscularis mucosae. Also seen are small invasive glands (arrowhead).

**Risk factors? (3)

A

COLITIS ASSOCIATED DYSPLASIA

Colitis associated Neoplasia
• Incidence of CRC in patients with IBD: Six times higher
>general population

RISK OF DYSPLASIA related to several factors;

  1. Duration of the disease; risk increases sharply 8-10yrs after disease onset
  2. Extent of the disease; pancolitis are at greater risk than those with only left-sided disease
  3. Nature of the inflammatory response; Greater frequency and severity of active inflammation (characterized by the presence of neutrophils) confers increased risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

Surveillance programs in colitis associated dysplasia/neoplasia

A

• Typically enrolled in surveillance programs :
- screening starts ~8-10 years after diagnosis of IBD
and surveillance colonoscopy recommended every 1 to 2 years thereafter

• IBD and primary sclerosing cholangitis:

  • generally enrolled for surveillance at the time of
    diagnosis.

• Surveillance requires regular and extensive
mucosal biopsies:
- Low-grade dysplasia
- High-grade dysplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

Summary causes of gastroenteritis (stomach flu)

  • transmission (how is it spread?)
  • incubation period?
  • how do you get disease symptoms (diarrhea?)
A

Gastroenteritis (stomach flu) is caused by a number of bacteria and viruses. Viral gastroenteritis is especially widespread worldwide in infants and children with the most severe disease seen in underdeveloped countries where nutritional deprivation is a primary factor. The spectrum and severity of disease depends of the virus itself as well as the underlying health of the individual. Most virus- caused gastroenteritis (GE) have symptoms of diarrhea, nausea, vomiting, fever and abdominal pain and resolves without clinical intervention after several days.

Recovery requires bed rest and supportive therapy, especially administration of fluids. In more severe cases of GE, especially those caused by rotavirus infection of infants, aggressive rehydration therapy may be required.

The viruses are spread by the fecal-oral route via contaminated water and food and by personal contact. The incubation period for GE is usually 2-4 days. Recall discussions about Enteroviruses within Picornaviridae.

In order to produce disease symptoms, the virus merely infects the cells lining the lumen of the GI tract. Lysis of these cells leads to disruption of the salt and ion flow and an electrolyte imbalance ensues. This process leads to diarrhea, which in severe cases, can lead to dehydration, especially in children who are malnourished. See Jan. 11 lecture for the specifics of Adenoviruses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

Viruses that cause gastroenteritis (stomach flu) - 7

**virueses - family - polarity - DNA or RNA

A
  1. Rotavirus ; reoviridae ; double stranded RNA genome, segmented genome
  2. Calicivirus ; caliciviridae ; + polarity RNA
  3. Norovirus (genotypes 1,2) ; caliciviridae; + polarity RNA
  4. Coronavirus ; cornaviridae; + polarity RNA
  5. Astrovirus ; astroviridae ; + polarity RNA
  6. Adenovirus types 40,41 ; adenoviridae ; double stranded DNA genome
  7. Picornaviruses (enteroviruses - Coxsackie A) ; picornaviridae ; + polarity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

IDENTIFY virus causing stomach flu

    • An orphan virus was originally isolated before corresponding disease was determined, Recall ECHO virus
  • characteristics?
A

REOVIRIDAE (reo =respiratory enteric orphan)

Characteristics of reovirus particles

a. 60-80 nm
b. Usually naked virion (for our purposes it is non-enveloped)
c. stable to acid and in the environment
d. Structural features of the virus particle: Two concentric icosahedral capsids –
* External capsid + internal capsid, the latter is commonly designated “core”
* Tubular structures originates from the vertices of the core (internal capsid) and extend through the vertices of the external capsid
e. RNA dependent RNA polymerase + capping enzymes are located inside of core (internal capsid)
f. Double stranded RNA genome in 10-12 segments (depending on the reovirus), genome segments classified based on length of genome segment: L = large, M = medium, S = small
g. mRNA and (+) strand of DS RNA are capped at 5’ end

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

REOVIRIDAE

  • replication location?
  • steps
  • *what occur within the core structure of the virus (2)
A

Replication in CYTOPLASM

Viral replication and transcription of the genome to form viral mRNAs are unusual. Both of these events occur WITHIN THE CORE STRUCTURE of the virus.

First step of the reovirus infection of target cells is the attachment of virus to specific receptors on the surface of the cell. After entry of the virus particle into the cell, the outermost capsid is removed (partial uncoating). Unlike the case of most other viruses the genome of the virus is not released from the inner capsid (core).

The core associated viral enzymes are activated in the sense that the viral RNA polymerase becomes active inside the core and RNA synthesis ensues. Two types of RNA are synthesized inside the core: 1) new genomic RNA segments and 2) viral mRNAs.

The tubular projections that originate at the vertices of the core structure serve as transport channels for viral mRNAs out of the core and into the cytoplasm. Remember each of the 10 segments of genome RNA are transcribed and the transcription products exit the core via the tubular projections

Following translation of the viral mRNAs in the cytoplasm of the cell, new structural (capsid) proteins are synthesized, newly synthesized viral genome segments are encapsidated and the progeny virus is produced.

118
Q

IDENTIFY VIRUS

Host: Vertebrates serve as host, do not multiply in invertebrates
A. Three types distinguished by neutralization and hemagglutination inhibition B. All 3 types of OrthoReoviruses have been found in healthy children C. Antibody against reovirus is prevalent in populations worldwide D. Precise syndromes caused by these viruses have not been identified E. Were isolated during outbreaks of : 1) minor febrile illness, 2) diarrhea or enteritis in children; cause and effect not proven

A

Genus: OrthoReovirus

119
Q

IDENTIFY VIRUS

  1. Host: All members replicate in insects, several replicate in vertebrates
    A. Serious animal pathogens - eg. bluetongue virus of sheep, African horse sickness virus
  2. Colorado tick fever of human (virus of one antigenic type), mild febrile disease without rash which is transmitted by ticks (Dermacentor andersoni), Myalgia, chills, ocular pain, severe muscle and joint pain, nausea, vomiting , DIPHASIC FEVER –> complete recovery - habitat of tick determines location of disease
A
  1. Genus: Orbovirus, Arbovirus
  2. Genus: Coltivirus, Arbovirus
    * *saddle back or diphasic fever (similar to poxvirus and yellow fever)
120
Q

IDENTIFY VIRUS

A. Genome consists of 11 segments of double stranded RNA
B. Not grown in cell culture
C. Cause human infantile diarrhea (endemic), ubiquitous, fecal-oral route; highly infectious
D. Isolated from 40 to 50% of nonbacterial gastroenteritis in young patients hospitalized in the winter
responsible for 1/3 of hospitalization for diarrhea in children under 5 years
E. Infects the cells at the tips of the villi lining the small intestine, cells lyse which interferes with the absorption of sugar, salts and water; water accumulates in the lumen giving rise to diarrhea; incubation period for infection is about 2-4 days
Severe diarrhea seen in malnourished children, Leading cause of death of children under 2 year in developing countries

**Symptoms? Treatment? Diagnosis?

A

Genus: Rotavirus, Two primary human serotypes

Symptoms:
- Diarrhea, fever, abdominal pain, vomiting, dehydration –> fatal unless treated, death

Treatment:
- AGGRESSIVE use of oral rehydration therapy

Diagnosis: Elisa (Rotazyme),
virus seen in stools by electron microscopy,
PCR (RT-PCR) methods for viral RNA

121
Q

Rotavirus vaccine

First gen vs new gen

**approved for what age group?

A
  1. First Generation Of Rotavirus vaccine (RotaShield)
    -Rise and fall of the Rotavirus vaccine, intussusceptions linked to the vaccine,
    In-folding of the intestine led to bowel obstruction
  2. New Generation Vaccines:
    Rotarix – Oral, live-attenuated vaccine containing ONE strain of rotovirus, two doses- first dose after 6 weeks of age and second dose at least 4 weeks later

“RotaTeq” Vaccine (Merck), oral, live attenuated vaccine
- A pentavelent vaccine; Vaccine consists of 5 rotavirus types that were created by molecular biology techniques
- Each of the five types were produced by genome reassortment (recall Influenza virus lecture)
- The five types correspond to 5 different antigenic forms of rotavirus
Minimum age of vaccination = 6 weeks
Start vaccination series prior to 12 weeks
- 3 doses of RotaTeq, administered at 2,4, and 6 months of age

** Vaccines are not FDA approved for older children and adults.

122
Q

Icosahedral capsid; + Polarity RNA genome, single stranded, and non-segmented

5 genera, two genera have members that cause human disease, eg. Norovirus and Sapovirus genera

In general Norviruses infect older children and adults where as Sapoviruses cause GE in infants

A

Caliciviridae:
Members of Caliciviridae are not well characterized because of their inability to grow well in tissue culture (Monkey calicivirus grows to limited extent in culture, model system)

123
Q

Identify virus ? Aka?

Characteristics that facilitate disease process

1) only a small number of virus particles produce disease (< 100 virus particles),
2) prolonged shedding of virus (2 weeks)after recovery, 3) resists inactivation by alcohols and detergents, 4)stability in environment,
5) long lasting immunity is not developed as a result of infection; short lived IgA is the primary protective antibody

**Infection ? Kids? All ages? Symptoms?

A

Norovirus genus

  • Also designated Norwalk virus
  • Noroviruses are divided into 6 genotypes, Members of 3 genotypes G1, G2, and G4 infect humans

Norovirus infection
- Specificity of Infection: Some individuals appear to be resistant to infection by certain strains of norovirus

Blood group (ABO) Glycolipids/ Glycoproteins act as cell surface receptors for norovirus. Certain individuals having a specific blood group (types B and AB) will bind norovirus poorly or not at all thereby preventing the initial stages of the infection and imparting resistance.

Infects individuals of all ages

Disease symptoms:
- Nausea, abdominal pain, vomiting, diarrhea, chills, headache, myalgia, and fever

124
Q

divided into 6 genotypes, Members of 3 genotypes G1, G2, and G4 infect humans

Disease symptoms:
Nausea, abdominal pain, vomiting, diarrhea, chills, headache, myalgia, and fever

  • *Epidemiology
  • *diagnostic methods
A

NOROVIRUS GENUS; aka NORWALK VIRUS

  • A major cause of nonbacterial/non-parasitic gastroenteritis in U.S and world-wide
  • Spread by fecal oral route- contaminated food and water, person to person spread and aerosols (created as a result of violent vomiting)
  • Peak incidence of disease during winter months, referred to as “winter vomiting disease”
  1. Cause gastroenteritis in both adults and children where people work and live in closed quarters or communities
  2. Long-term care facilities, dormitories, cruise ships, hospitals, military encampment and prisons

** Diagnostic methods: ELISA, electron microscopy, and RT-PCR (state of the art)

125
Q

Identify virus

A. Virus particle structure is unusual for an RNA virus with a + polarity RNA genome. It has a
helical nucleocapsid, whereas the other + polarity RNA viruses have icoshedral capsids
B. Helical nucleocapsid is surrounded by viral envelop
C. Two viral glycoproteins located in envelope form a structure called a peplomers
E. Replicate in cytoplasm
F. Virus mature by budding to acquire envelop

**replication?

A

CORONAVIRIDAE

In the discussion of respiratory viruses it was indicated that a type of coronavirus causes severe acute respiratory syndrome (SARS). In addition to respiratory infections, coronaviruses can cause infections of the gastrointestinal tract. SARS, for example, can cause both a respiratory infection and a GI tract infection, which suggests that the receptor for the virus is on the surface of several cell types. The prevalence of Coronavirus has not been determined.

REPLICATION
A. Cytoplasmic, replication cycle has been characterized, but it will not be discussed in any detail.
B. Replicative intermediate formed (+ RNA)
C. Nucleocapsids “bud” at plasma membrane and cytoplasmic vesicles including those of the endoplasmic reticulum (ER)
D. Limited or no CPE in tissue culture

126
Q

Identify virus
Host: Humans, rodents
Strains determine severity of illness, range from mild infections to severe disease

A.  Infectious bronchitis virus of humans (IBH), found  primarily in adults
B. Possibly causes gastroenteritis in infants. Necrotizing enterocolitis in newborns
C.    Severe  Acute  Respiratory  Syndrome  (SARS),  Lower  respiratory  tract  infections,  spread world wide, spread by droplets  and contact
D. Vaccine in development
A

Genus: Coronavirus

127
Q

Identify virus

**2 genera? Cause? Are there antivirals or vaccines? Infectious process?
Virus structure
- Non-enveloped, icosahedral capsid that are observed as having a “Star” appearance using an electron microscope
- Genome is + polarity RNA, single stranded and non-segmented

Most severe diarrhea seen in malnourished and immunocompromised children and older adults with impaired immune systems

Diagnosis: ELISA, electron microscopy, and PCR techniques
Immunity is long term and childhood infections can produce protect immunity that last throughout adulthood

A

Astroviridae
Family of viruses that infect birds and mammals that is separated into two genera; 1) Mamastroviruses and 2) Avastroviruses

World wide Astroviruses (certain types within the Mamastrovirus genus) cause high levels of gastroenteritis is both children and adults. No antiviral drugs or vaccines are available to treat or prevent infections

Infectious process:

  • Spread by the fecal oral route and person to person contact
  • Based on the presence of anti-astrovirus antibodies in young children, the virus infection is very common in young children. Most infections are asymptomatic. Overt infections are usually mild and symptoms include nausea, vomiting, fever, diarrhea and abdominal pain. Dehydration is rare as is hospitalization.
128
Q
Herbs 
1. Government regulation 
- what are they considered as? 
- do you need to prove if safe or effective? 
2. FDA supplemental facts 
3. Marketing claims 
A. Can’t be marketed as? 
B. Labeling 
C. Are herbs natural?
A

I. Government Regulation
A. Herbal products are not classified as drugs
B. Herbal products considered dietary supplements C. Do not have to prove safe or effective

II. FDA Supplemental Facts
A.  Similar to Nutrition Facts on Foods 
B.  Contain common name 
C.  Botanical name and plant part 
D.  Serving size 
E.  Recommended daily amount 
F.  Total wt of proprietary blend

III. Marketing claims for herbs
A. Herbal products cannot be marketed for prevention or treatment of a disease

B. Labelling

  1. Standardized, certain concentration is consistent between batches
  2. NF (national formulary) meets standards for level of marker compound and labeling

C. Herbs are natural

  1. Not uniform in active ingredients; multiple active ingredients may act in synergy
  2. Active ingredient varies with climate, soil and fertilization
  3. Herbs contain a multiple active ingredients
  4. Herb product activity dependent on family of compounds
129
Q

Identify herb

Actions

  • lower cholesterol
  • inhibit platelet aggregation
  • *marketed uses
  • *differences in preps
  • *action on platelets
  • *drug interaction and cautions
A

GARLIC
Marketed Uses
1. Lower cholesterol
2. “Heart health” Reduce risk myocardial infarct or thrombotic stroke

Differences between garlic preps

  1. Allin converted to allicin (garlic odor) by allinase in plant and GI tract
  2. Heat evaporates diallyl sulfides

Action on platelets

  1. Inhibit platelet aggregation
  2. Ajoene (Allicin metabolite) and Diallyl trisulfide inhibit platelet thromboxane generation

Drug Interaction and Cautions

  1. Caution use of high doses 4 cloves/day with antiplatelet drugs
  2. Chopped Garlic in oil, need to store in refrigerator
    - Clostridium infection has been reported if stored at room temperature
130
Q

Identify herb

Actions

  1. Decreases leg pain, pruritis, fatigue and edema
  2. Active ingredients are escin and aesculin
  3. Escin, lowers leg edema
    - Escin decreases vascular permeability of venous capillaries

Adverse Effects

  1. Aesculin, component that increases risk of bleeding
  2. Similar to hydroxycoumarin

***CONTRAINDICATIONS

A

HORSE CHESTNUT

Marketed Claims

  1. Improve vasculature
  2. Reduce problems associated with varicose veins
  3. Product Venostat

CONTRAINDICATIONS

  1. ANTICOAGULANTS, ASPIRIN OR NSAIDS
  2. CATEGORY X FOR PREGNANCY AND BREAST FEEDING
131
Q

Identify herbs

Actions;

  • Improve perfusion of capillaries, cerebral blood flow
  • Inhibits platelet aggregation by action on platelet activating factor

Neural effects

a. Kaempferol, antioxidant, reduce free radical damage in brain
b. Kaempferol and apigenin ,MAO-A and MAO-B inhibitors

**adverse effects? Cautions? Drug interactions?

A

GINKO BILOBA
Adverse Effects and Cautions
1. Major adverse effect is bleeding
2. Ingestion of ginko seeds (contain ginkotoxin) toxic, cause seizures

Drug Interactions

  1. Antiplatelet drugs (aspirin, NSAIDs)
  2. Enhanced bleeding with heparin and warfarin
  3. Enhanced bleeding with IIb/IIa receptor antagonists (clopidogrel)
132
Q

Identify herbs
**marketed uses? Effect on anxiety? Mood?

Possible MoA

  1. Serotonin re-uptake inhibitor
  2. MAO inhibition
  3. Activation of GABA
  4. Cumulative effect mediated by more than one mechanism of action

Active Ingredients

  1. Dianthrones, Hyperforin and Hypericin
  2. Considered to possess majority of anti-depressant action in alcohol extract
  3. Preparations standardized to contain minimum of 3% hyperforin 3. Effective for mild depression
A
ST. JOHN’S WORT 
MARKETED USES
1.  Improve MOOD
2.  Improve sleep quality
3.  Reduce anxiety 

ANTI-ANXIETY ACTION

  1. GABA mediated effect
    - Affinity for GABA receptors
    - Action inhibited by flumazenil

Effect on MAO to Enhance Mood
1. MAO inhibition is mediated by Hypericin

Effect on Serotonin Re-Uptake to Enhance Mood

  1. Directly Inhibits 5-HT uptake in selected regions of brain
  2. Occurs at levels attained with dosing of St John’s Wort extract
133
Q

identify side effects and drug interactions of the herb

Marketed uses

  1. Improve MOOD
  2. Improve sleep quality
  3. Reduce anxiety
A

ST. JOHN’S WORT

SIDE EFFECTS

  1. Generally well tolerated
  2. Minor effects of
    - Headache
    - Loss of appetite

DRUG INTERACTIONS
1. Should not be taken with
– MAO inhibitors
– Selective serotonin re-uptake inhibitors
2. Induces P450 isozyme Cyp 3A4
– May need to increase dose of oral contraceptives, theophylline, warfarin

134
Q

Identify herbs? **adverse effects

Marketed use

  1. INSOMNIA
  2. Anxiety

Neural Effects

  1. Sedation mediated by an effect on GABA
  2. Extracts have effect similar to benzodiazepines
  3. Binds to GABA A receptor chloride channel compels
A

VALERIAN
**active ingredient; valerenic acid, valtrate, glutamine

Adverse effects

  1. Drowsiness
  2. Increased sedation when mixed with alcohol
  3. Caution use with benzodiazepines, barbiturates or MAO inhibitors
135
Q

Identify herb

MARKET Claims and forms

  1. CAPSULES, TABLETS, LOZENGES, TEA and ALCOHOL TINCTURES
  2. STIMULATE IMMUNE SYSTEM may be multiple agents

Stimulate immune system by

  1. Stimulates phagocytosis and chemotaxis
    - heteroxylan stimulate phagocytosis
    - arabinogalactan promotes release of TNF and IL-1 from macrophages***
  2. ALCOHOL EXTRACT BETTER THAN WATER EXTRACT

**effect on colds? Side effects?

A

ECHINACEA
Stimulate immune system; arabinogalactan promotes release of TNF and IL-1 from macrophages***

Effect on Colds
1. ORAL TREATMENT WITH AN ORAL EXTRACT FOR 12 WEEKS
302 INDIVIDUALS
2. Not effective in preventing colds
3. Less severe symptoms for a cold 
**Not effective in kids <12yrs 

Side effects

  1. ALLERGIC REACTIONS**
  2. Avoid chronic use due to potential to suppress immune system (< 8 weeks)
136
Q

IDENTIFY HERB

MARKETED USES

  1. Improve health of prostate
  2. Diuretic effect

**list actions

A

SAW PALMETTO

ACTIONS OF SAW PALMETTO

  1. May block the translocation of the cytosol androgen receptor to the nucleus
  2. Inhibitor of 5α-reductase enyzme converts testosterone to dihydrotestosterone
  3. Some studies show Comparable or less effective than Finasteride (5α-reductase inhibitor) if taken for 6 Months. Other studies show saw palmetto combined with stinging nettle are Comparable to finasteride. All studies show better tolerated than finasteride. Saw palmetto reduces urination difficulty.
137
Q

Identify herb

Marketed Uses

  • Anti-oxidant
  • Anti-aging
  • Anticancer
  • asian type is excitability, American type more relaxing
  • *Active ingredients?
  • action? (4)
  • adverse effects
A

GINSENG
ACTIVE INGREDIENTS
1. Ginsenosides, most studies conducted on this chemical group
2. Over 20 different ginsenosides in ginseng
3. Amount different between species

Action
1. Memory and stress
- decrease levels of neurotransmitters elevated during stress
2. CV effects
• Red ginseng may increase HDLs
• Panax ginseng inhibits platelet aggregation
3. Effect on immune system
- Stimulate chemotaxis more than placebo of polymorphonuclear cells
-Antiviral activity may be mediated by stimulation of interferon production
4. ENDOCRINE EFFECTS
-Increases glycogen storage -Helps reduce fasting blood glucose

Adverse effects

  • Nervouseness
  • Avoid taking with caffeine
  • Ginseng abuse syndrome; Hypertension, excitability, sleeplessness, nervousness and morning diarrhea
138
Q

Identify herb
**adverse effect

A. Marketed Use

  1. Sedation and relaxation
  2. Alternative to alcohol

B. Mechanism
-interacts with GABA receptor

A

KAVA

Adverse effects

  • sedation, impairment of motor skills
  • yellow skin and nails
  • HEPATIC TOXICITY FDA warning issued in 2002 regarding hepatic damage
139
Q

Identify herb

A.  Marketed Use
      -migraines
      -arthritis pain
B.  Mechanism
      -inhibits phospholipase A2
      -inhibits platelet serotonin release

**adverse effects (5)

A

FEVERFEW

Adverse effects

  1. drowsiness, dizziness
  2. postfeverfew syndrome of insomnia, joint pain, muscle aches when stopping feverfew
  3. Women, reports of menstrual irregularities, heavier menstrual flow***
  4. Mouth ulceration, lips swell
  5. Potential interaction to increase bleeding with aspirin and anticoagulants
140
Q
  1. Herbs to avoid prior to surgery
    Pharmacodynamic (5) vs pharmacokinetic (1)
  2. Herbs to avoid mixing with alcohol (2)
  3. Herbs to avoid mixing with MAOI or SSRI (2)
A
1. Herbs to avoid prior to surgery 
A. Pharmacodynamic (5); 
- Feverfew, 
- Garlic, 
- Ginko Biloba, 
- Ginseng, 
- Horse Chestnut (AESCULIN - risk of bleeding) 
B. pharmacokinetic (1) 
- ST JOHN’s WORT
  1. Herbs to avoid mixing with alcohol (2)
    - Valerian
    - Kava
  2. Herbs to avoid mixing with MAOI or SSRI (2)
    - ST JOHN’s WORT
    - Valerian
141
Q
1. Which of the following herbal agents could increase the clearance of indinavir, an HIV protease inhibitor 
 A. Echinacea
 B. Feverfew
 C. Garlic
 D. St. John’s Wort
 E. Saw Palmetto
2. Which ingredient in horse chestnut is responsible for reducing leg pain 
 A. Ajoene
 B. Aesculin
 C. Escin
 D. Heteroxylan
 E.  Parthenolide
A
  1. D. St. John
  2. C. ESCIN induce leg pain ***
     A. Ajoene (antiplatelet agent in garlic)
     B. Aesculin (coumarin like agent in horse chestnut)
     C. Escin
     D. Heteroxylan (stimulates phagocytosis-echinacea)
     E. Parthenolide (feverfew inhibitor of platelet serotonin
    release)
142
Q

A 42-year-old woman has heartburn after meals and a sour taste in her mouth. For the past 4 to 6 months she has had symptoms several times per week. Symptoms are worse when she lies down or bends over. Antacids help somewhat. The patient has no dysphagia, vomiting, abdominal pain, exertional symptoms, melena, or weight loss. Past medical history and family history are noncontributory. The patient drinks alcohol occasionally and does not smoke.

On physical exam, height is 5 feet 4 inches, weight 170 pounds, and BP 140/88 mmHg. The remainder of the exam is unremarkable.

What is the next step in management of this patient? •A. Abdominal Ultrasound
•B. Ambulatory esophageal pH monitoring
•C. Esophageal manometry
•D. Trial of a proton pump inhibitor

A

GERD - trial of PPI

This patient has classic symptoms of gastroesophageal reflux disease (GERD).
• Symptoms of heartburn and regurgitation are strong predictors for the clinical diagnosis of GERD.
• GERD is due to inappropriate relaxation of the Lower Esophageal Sphincter (LES).
• The most appropriate next step in a patient without alarm symptoms (dysphagia, unintentional weight loss, hematemesis, or melena) is an empiric trial of a PPI.

143
Q

A 52-year-old man presents with a 6-month history of heartburn and atypical chest pain, both unrelated to food. He also described “gurgling” sounds in his chest. A month before presentation he developed intermittent dysphagia to both solids and liquids, regurgitation, and weight loss of 3 kg.

Labs were normal and upper endoscopy reveals no luminal mass.
What is the next step in management of this patient?
• A. Abdominal Ultrasound • B. Ambulatory esophageal pH monitoring • C. Barium Swallow • D. Trial of a proton pump inhibitor

**what is required to confirm diagnosis?

A

BARIUM SWALLOW show BIRD BEAK - ACHALASIA; loss of peristalsis and incomplete lower esophageal sphincter relaxation

  • Inflammatory destruction of inhibitory neurons in the esophageal myenteric (Auerbach) plexus results in loss of peristalsis and incomplete lower esophageal sphincter relaxation.
  • Barium radiography shows a dilated esophagus with narrowing at the lower esophageal sphincter, described as a “bird’s beak.”
  • **MANOMETRY is required to confirm the diagnosis of achalasia.
  • Treatment includes pharmacologic, endoscopic, and surgical modalities.
144
Q

• A 48-year-old man presents to the ER after several episodes of vomiting blood following periods of forceful retching and vomiting. He had been binge drinking alcohol over the preceding 2 days.
• On physical examination, temperature is 37.0 °C (98.6 °F), blood
pressure is 103/62 mm Hg supine and 78/50 mm Hg standing, pulse rate is 101/min supine and 125/min standing, and respiration rate is 14/min. There is no jaundice, spider angiomata, or palmar erythema. Abdominal examination reveals no tenderness, guarding, or rebound. Rectal examination is positive for blood.

What is the most important next step in this patients care?
• A. Assuring patient abstains from further alcohol use. • B. Hemodynamic stability. • C. Perform upper endoscopy. • D. Arrange for AA meeting.

** WHAT IS PROCEDURE OF CHOICE FOR DIAGNOSIS

A

Check first for HEMODYNAMIC STABILITY
**Stabilize the patient first - give him fluids

Next differential to tackle - MALLORY WEISS TEAR; sudden rise in abdominal pressure or transmural pressure gradient across the gastroesophageal junction
**EGD for diagnosis

  • The pathogenesis of MWT is not completely understood.
  • Most cases seem to occur as a result of a sudden rise in abdominal pressure or transmural pressure gradient across the gastroesophageal junction.
  • When these forces are high enough to cause distention in this poorly distended area, an acute gastroesophageal tear or laceration may occur.
    • Surgery should be reserved for situations where endoscopic hemostasis of bleeding has failed or transmural esophageal perforation is a problem.
145
Q

• A 55-year-old man presents with severe dysphagia to solids and worsening dysphagia to liquids. His social history is significant for 40 pack-year cigarette
smoking and a 6-pack of beer per day. He has lost over 10% of his body weight and currently is nourished only by milkshake supplements. He complains of some mild odynophagia (painful swallowing) and is constantly coughing up mucus secretions.

  1. What is the next step in evaluating this patient?
    • A. Abdominal Ultrasound • B. Upper Endoscopy • C. Esophageal manometry • D. Trial of a proton pump inhibitor
  2. Pathophysiologic mechanism (3)
    * * what is critical to treatment decisions
A
  1. UPPER ENDOSCOPY shows Esophageal Adenocarcinoma
    - arise in mucosa of the esophagus; can invade submucosa and muscular layer

Pathophys Mechanism

  • alcohol
  • tobacco
  • GERD and Barrett esophagus

Critical to treatment decisions are the stage of the disease and the patient’s overall physiologic status.

146
Q

A 35-year-old man is evaluated for a 2-month history of upper abdominal discomfort after eating. He has recently returned from working in a rural area of a developing country. He takes no medications. There is no family history of esophageal or gastric cancer.

On physical examination, vital signs are normal. BMI is 40. Centripetal obesity is noted, but abdominal examination findings are otherwise normal.

Laboratory studies reveal a hemoglobin level of 15 g/dL (150 g/L).
1. Most appropriate management
• A. Barium esophagram • B. Empiric Helicobacter pylori eradication therapy • C. H. pylori testing • D. Upper endoscopy

**MOST ACCURATE TESTS (2)

A
  1. H.pylori testing; check for infection
    A. Serologic testing; limitation - doesnt test for active H pylori infection and has poor predictive value
    B. FECAL ANTIGEN test and UREA BREATH test offer a more accurate means of noninvasive testing for H. pylori, as both of these test modalities assess for the presence of active infection.

Fecal antigen and urea breath tests are equivalent in terms of their accuracy.

The choice of fecal antigen testing versus urea breath testing will typically depend on test availability and patient preference.

147
Q

• A 40-year-old man presents to his primary care physician with a 2- month history of intermittent upper abdominal pain. He describes thE pain as a dull, gnawing ache. The pain sometimes wakes him at night,
is relieved by food and drinking milk, and is helped partially by
ranitidine. He had a similar but milder episode about 5 years ago,
which was treated with omeprazole.
• Physical examination reveals a fit, apparently healthy man in no
distress. The only abnormal finding on PE is mild epigastric
tenderness on palpation of the abdomen. CBC showed Hgb of 9.9.
1. NEXT STEP in management
• A. Barium esophagogram • B. Empiric Helicobacter pylori eradication therapy • C. H. pylori testing • D. Upper endoscopy

**Cardinal symptoms?

A
  1. UPPER ENDOSCOPY (EGD) - shows PEPTIC ULCER DISEASE (PUD)
    * *Cardinal symptom in uncomplicated PUD is epigastric pain or discomfort
    - accompanying symptoms; nocturnal pain, relief of pain with eating, early satiety, nausea, bloating or abdominal fullness
    * *A complication is ACTIVE BLEEDING

Peptic ulcers are diagnosed not by symptoms but instead by the presence of a mucosal break 5 mm or larger in the stomach or duodenum.

Upper endoscopy is considered the gold standard in the diagnosis of PUD.

The goal of therapy is to treat complications (e.g., active bleeding), eliminate the underlying cause whenever possible, relieve symptoms, and heal ulcers.

148
Q

A 77-year-old man presents to his primary care physician with weight loss of 15 pounds and a 3-month history of dysphagia and abdominal pain. The only abnormal finding on physical examination is stools
positive for occult blood. He is referred for an upper endoscopy,
which shows an exophytic, ulcerated mass in the cardia of the
stomach. Biopsy reveals moderately differentiated adenocarcinoma.
1. Next step in management
• A. Palliative gastrectomy • B. Endoscopic mucosal resection (EMR). • C. Multidisciplinary evaluation for staging • D. Surgery followed by postoperative chemoradiation

A
  1. MULTIDISCIPLINARY STAGING OF CANCER; staging based on imaging is required

Cancer that develops in any portion of the stomach and may spread to other organs.
Presents with weight loss and abdominal pain, although patients with proximal or gastroesophageal junction tumors may present with dysphagia.
Upper GI endoscopy with biopsy demonstrating carcinoma is required to confirm the diagnosis. Staging based on imaging is required.
Early-stage disease is treated with surgery alone.
Locally advanced disease should undergo surgery followed by postoperative chemoradiation, or chemotherapy before and after surgery.
Metastatic disease is treated with chemotherapy or chemoradiation and supportive care measures.

149
Q

A 43-year-old woman with a PRIOR HISTORY of open CHOLECYSTECTOMY presents with gradual onset of nausea, vomiting, and abdominal distention. Physical exam does not demonstrate peritonitis (NO REBOUND TENDERNESS). Pt appears to be in moderate distress, vitals are within normal limits
along with labs.
• What is the next step in management? - xray show dilated bowel?
**Diagnosis?
**nonoperative vs operative treatment?

A

Abdominal xray - Dilated bowels - SMALL BOWEL OBSTRUCTION

  • *Nonoperative treatment; fluid resuscitation, bowel decompression, analgesia
  • *Operative treatment; EXPLORATORY LAPAROTOMY performed in patients with; Complete SBO, all cases with documented peritonitis, evidence of strangulation, patients who don/t respond to nonoperatve tx

Common causes of SBO in adults include:
•Previous surgery with the formation of intra-abdominal adhesions, including colorectal/gynecologic surgery, resection of intra-abdominal tumors, laparotomy for trauma
•Inguinal hernia with incarceration; ventral, incisional, umbilical, and parastomal hernias
•Crohn disease
•Intestinal malignancy
•Appendicitis

150
Q

• A 46-year-old woman presents with fatigue and is found to have iron deficiency with anemia. She has experienced intermittent episodes of mild diarrhea for many years, previously diagnosed as irritable bowel
syndrome and lactose intolerance. She has no current significant
gastrointestinal symptoms.
• Examination reveals 2 oral aphthous ulcers and pallor. Abdominal
examination is normal and results of fecal testing for occult blood are negative.
1. Next step in treatment
• A. Colonoscopy • B. Upper Endoscopy • C. Serology testing for immunoglobulin A-tissue transglutaminase
(IgA-tTG) • D. Iron replacement

A
  1. Serology testing for IgA-tTG (immunoglobulin A -tissue transglutaminase)
    * **CELIAC DISEASE
    - another sensitive and specific serologic marker is Endomysial antibodies (EMA)

Celiac disease is a systemic autoimmune disorder triggered by gluten peptides from grains including wheat, rye, and barley.
These peptides are resistant to human proteases, allowing them to persist intact in the small intestinal lumen.
The diagnosis of celiac disease requires positive serologic markers and a compatible small- bowel biopsy.
IgA tissue transglutaminase (tTG) antibodies and endomysial antibodies (EMA) are sensitive and specific serologic markers; testing for these should be done while the patient is consuming gluten.

151
Q

A 22-year-old male presents to the emergency room with abdominal pain, anorexia, nausea, and low-grade fever. Pain started in the midabdominal region 6 hours ago and is now in the right lower quadrant of the abdomen. The pain was steady in nature and aggravated by coughing.
• Physical examination reveals a low-grade fever (100.5°F; 38°C), pain on palpation at right lower quadrant, and leukocytosis
(12,000/microliter) with 85% neutrophils.

What would be the best next step in treating this patient.
• A. Observation • B. Laparoscopic intervention • C. Start oral antibiotics and monitor response • D. Upper GI series

A
  1. APPENDICITIS; acute inflammation of the vermiform appendix
    * *Laparoscopic intervention - take it out ( surgical appendectomy)

Acute inflammation of the vermiform appendix.
Typically presents as acute abdominal pain starting in the midabdomen and later localizing to the right lower quadrant.
Associated with fever, anorexia, nausea, vomiting, and elevation of the neutrophil count.
Diagnosis is usually made clinically. If investigation is required, CT scan and ultrasonography may show dilatation of the appendix outer diameter to more than 6 mm.
Definitive treatment is surgical appendectomy.

152
Q

• A 34-year-old mother of 3 presents to her family physician with a 3-week history of abdominal cramping pain in both lower quadrants. She has been
having frequent small, soft stools accompanied by some mucus but no blood. Her symptoms are improved with bowel movement or passage of flatus. She has had these symptoms almost monthly since she was in college, but they have been worse recently. Past history is negative except for 3 normal pregnancies. Family history is negative for colon cancer.
A sister has similar symptoms but has not seen a physician. Personal/social history reveals that she is an accountant working long hours. Her firm is about to merge with another, and she fears her job situation is tenuous.
Review of systems is otherwise negative. She has not lost any weight or had any other constitutional symptoms. On physical exam, the only finding is some mild tenderness in the RLQ. No mass is felt.

**female, stressed, bouts of depression, constipation and diarrhea
1. What is the disease and the characteristics
• A. The pain or discomfort may be relieved by defecation. • B. Symptoms often improve during periods of stress. • C. Patients with IBS often do not have symptoms of depression and
anxiety. • D. Patients with very typical symptoms who have no red flag
symptoms stil require extensive workup.

A
  1. (IBS - Irritable bowel syndrome) - The pain or discomfort MAY be relieved by defecation

Irritable bowel syndrome is a chronic condition characterized by abdominal pain associated with bowel dysfunction.
The pain or discomfort may be relieved by defecation.
It is important to determine whether there are any dietary associations such as lactose- containing foods or fructose-containing foods.
Exam of the abdomen is usually unremarkable. There may be mild and poorly localized tenderness in the RLQ and/or LLQ.
The diagnosis is based on the patient’s history, and there are no specific diagnostic tests. If the patient has worrying symptoms or findings such as anemia, weight loss, or fever, then these require more thorough investigation.
Treatment should be individualized and is dependent on the patient’s predominant symptoms.

153
Q

• A 25-year-old white man presents to his primary care physician with cramping abdominal pain for 2 days. He reports having loose stools and losing 15 lb (6.8 kg) over a 3-month duration. He also reports
increased fatigue. On physical exam, his temperature is 99.6°F
(37.6°C). Other vital signs are within normal limits. Abdomen is soft with normal bowel sounds and moderate tenderness in the right lower quadrant, without guarding or rigidity. Rectal exam is normal and the stool is guaiac positive. The rest of the examination is unremarkable.
• CT scan of abdomen and pelvis performed demonstrating thickening of the terminal ileum.

  • What is the definitive test for diagnosis of this disease?
  • A. Abdominal US • B. Barium Enema • C. Colonoscopy • D. Gastric Emptying Study
A
  1. COLONOSCOPY
    **IBD (Inflammatory Bowel Disease) ; Crohn’s disease (SIGNIFICANT WEIGHT LOSS AND DIARRHEA)
    Diagnosis confirmed by colonoscopy with ileoscopy and tissue biopsy.
    The overall treatment goals are to induce and maintain remission plus prevent relapse or recurrence.
    Complications include extraintestinal involvement, intestinal obstruction, abscess formation, sinuses, and fistulae.

vs
ulcerative colitis
- TOXIC MEGACOLON can occur with associated risk of perforation
- BOWEL ADENOCARCINOMA is a complication in 3-5% of pts
• Form of inflammatory bowel disease that affects the rectum and extends proximally. • Patients commonly experience bloody diarrhea, chronic diarrhea (or both) • Diagnosis requires endoscopy with biopsy and negative stool culture. • Relapses are often associated with pathogens; therefore, stool should be
obtained for culture in all cases of disease flare-up. • Treatment aims to induce and maintain remission. Drug choice and
formulation depends on the severity and extent of disease.

154
Q

• A 70-year-old white male presents to his primary care physician with a complaint of rectal bleeding. He describes blood mixed in with the stool, which is associated with a change in his normal bowel habit
such that he is going more frequently than normal. He has also
experienced some crampy left-sided abdominal pain and weight loss.
He has previously been fit and well and there was no family history of GI disease. Examination of his abdomen and digital rectal examination are normal.
• Barium enema showed the following: APPLE CORD appearance

  1. What is next step of management
    • A. Colonoscopy • B. Testing for CEA • C. Iron Studies to identify anemia • D. Stool softener
A
  1. COLONOSCOPY; determine stage of cancer and do biopsy
    * *COLON CANCER; third leading cause of death

Third leading cause of cancer deaths in the US in men and women.
Rare below 40 years of age.
Symptoms are not specific and occur frequently in benign colorectal conditions.
Surgical resection is the main curative treatment.
Combined modality treatment (chemotherapy, radiation therapy, resection of metastases) has increased survival in selected cases.
Overall 5-year survival is 59% in the US.

155
Q

• A 57-year-old woman with history of hypertension and hypercholesterolemia presents to the emergency department with a 24- hour history of gradually worsening left-lower quadrant abdominal pain associated with nausea and vomiting. Prior to this episode, the patient did
not have any significant GI problems, except slight constipation and occasional dyspepsia after heavy meals. She felt feverish but did not take her temperature. Her family history is negative for GI disorders.
• Vitals were within normal limits.
• Laboratory studies are significant for a hemoglobin level of 12.8 g/dL (128 g/L) and a leukocyte count of 10,400/µL (10.4 × 109/L). Serum electrolyte levels and kidney function studies are normal.
• Abdominal CT scan shows INFLAMMATION of the SIGMOID COLON and MESENTERY; no bowel obstruction or abscess is noted.

  1. Next step in management
    • A. Laparoscopic sigmoid resection • B. Discharge home with antibiotic therapy and close follow-up • C. Urgent colonoscopy • D. Percutaneous drainage
A

**Patient has DIVERTICULAR DISEASE
1. Discharge home with ABX therapy and close follow up
**Patient is stable, no fever so can send them home
- patient with acute diverticulitis present with fever, leukocytosis and left lower quadrant pain
Tx: bowel rest, antibiotics, surgical intervention

Usually asymptomatic; may have constipation or nonspecific abdominal symptoms.
Symptomatic acute diverticulitis presents with fever, leukocytosis, and left lower quadrant pain.
CT scan is the imaging modality of choice for acute diverticulitis.
Treatment includes bowel rest, antibiotics, and surgical intervention.
Complications include bleeding, segmental colitis, perforation, abscess, fistulas, and obstruction.

156
Q

• A 42-year-old man is referred to the liver clinic with mild elevation in alkaline phosphatase and aminotransferases for several years. He has a medical history significant for obesity,
hypertension, and hypercholesterolemia. He does not smoke
or drink alcohol and there is no high-risk behavior. He has a
family history of premature cardiac disease. He is taking a
diuretic and discontinued a statin several months ago. Other
than complaints of mild fatigue, the patient feels well. Exam is
notable for a BMI of 37 kg/m^2, truncal obesity, and mild
hepatomegaly.
• Liver biopsy demonstrates a mildly active steatohepatitis
without fibrosis. An iron stain is negative.
1. Initial management
• A. Bariatric surgery • B. Phlebotomy • C. Surveillance for hepatocellular carcinoma • D. Weight loss with diet and exercise

A
  1. Weight loss, diet and exercise
    * *NON ALCOHOLIC FATTY LIVER (STEATOSIS)

Nonalcoholic hepatic steatosis, or nonalcoholic fatty liver disease, is the most common cause of chronic liver disease in the Western world.
It is projected to become a leading indication for liver transplantation, superseding hepatitis C.
The diagnosis of hepatic steatosis is based on exclusion of other etiologies, such as alcohol use, along with histology.
Associated with obesity and features of the metabolic syndrome in most cases. May progress to steatohepatitis and end-stage liver disease.
There are no currently recommended drug treatments. Lifestyle modification remains the first-line therapy.

157
Q

• A 56-year-old male with a remote history of intravenous drug use presents to an initial visit complaining of increased abdominal girth but denies jaundice. He drinks about 2 to 4 glasses of wine with dinner and
recalls having had abnormal liver enzymes in the past.
Physical exam reveals a palpable firm liver, mild
splenomegaly, and shifting dullness consistent with the
presence of ascites. Liver function is found to be
deranged.
Labs showed the following:
Antibody to HCV - POSITIVE
HCV RNA - 1.2?
Hepatitis B surface antibody - POSITIVE
Hepatitis B surface antigen - NEGATIVE

  1. Most appropriate management
    • A. Hepatitis B vaccination • B. Treatment for hepatitis C virus infection • C. Serial monitoring of ALT levels • D. Hepatitis A vaccination
A
  • *HEPATIC CIRRHOSIS
    1. Treatment for Hep C infection
  • *Patient has active Hepatitis infection; treatment of underlying causative condition to slow or halt the progression of cirrhosis

Cirrhosis is the pathologic end-stage of any chronic liver disease
It is essential to treat the underlying causative condition such as:
 Hepatitis B and C  Alcoholic liver disease  Hemochromatosis  Wilson disease  Alpha-1 antitrypsin deficiency  Primary biliary cholangitis  Primary sclerosing cholangitis  Autoimmune hepatitis  Budd-Chiari syndrome

158
Q

• A 46-year-old obese woman presents with a 6-hour history of moderate steady pain in the RUQ that began after eating dinner and radiates through
to her back. This pain gradually increased before becoming constant over the last few hours. She has had previous episodes of similar pain for which she has not sought medical advice. Her vital signs are normal. The pertinent findings on physical exam are tenderness to palpation in the right upper quadrant without guarding or rebound.
• She is admitted to the hospital, and fluid resuscitation is started. • Abdominal ultrasound shows cholelithiasis with no gallbladder wall thickening or pericholecystic fluid. The common bile duct is not dilated. There is no choledocholithiasis (specific stone in the common bile duct)

  1. Next step in management
    • A. Cholecystectomy prior to hospital discharge • B. Cholecystokinin hepatobiliary (CCK-HIDA) scintigraphy • C. Endoscopic retrograde cholangiopancreatography with biliary
    sphincterotomy • D. Intravenous Imipenem
A
  • *CHOLELITHIASIS
    1. Cholecystectomy prior to hospital discharge ; **definitive treatment for symptomatic patients
  • Common risk factors include older age, female gender and pregnancy, obesity, rapid weight loss, and a family history.
  • Abdominal ultrasound provides effective diagnostic imaging.
  • Laparoscopic cholecystectomy represents definitive treatment for symptomatic patients.
  • Complications such as cholecystitis, cholangitis, and pancreatitis develop commonly.
159
Q

• A 53-year-old man presents to the emergency room complaining of severe mid-epigastric abdominal pain that radiates to the back (aneurysm?). The pain improves when the patient leans forward or assumes the fetal
position and worsens with deep inspiration and movement. He also
complains of nausea, vomiting, and anorexia, and gives a history of heavy alcoholic intake this past week. He is tachycardic, tachypneic, and febrile with hypotension. He is slightly agitated and confused. He is diaphoretic with decreased breath sounds over the base of the left lung.
• Laboratory studies reveal a leukocyte count of 14,000/μL (14 × 109/L), a blood urea nitrogen level of 25 mg/dL (8.9 mmol/L), and a serum lipase level of 952 U/L. Lipid panel was within normal limits.

  1. What is mechanism of patient disease
    • A. Direct toxic insult to the acinar cell, causing inflammation and
    membrane destruction. • B. Intracellular Trypsin inactivates Zymogen cascade • C. Hypertriglyceridemia • D. Aortic elastic medial degeneration and mild cystic medial necrosis
    resulting in aortic dilation and aneurysm formation.
A
  1. Direct toxic insult
    * *PANCREATITIS; steady, sudden onset abdominal pain radiating to the back

Cardinal symptom is usually steady, sudden-onset abdominal pain radiating to the back.
Associated with nausea and vomiting. A history of cholelithiasis or alcohol intake is often present.
Typical signs include epigastric tenderness, fever, and tachycardia.
Elevated serum amylase and lipase concentration supports but is not pathognomonic for the diagnosis of acute pancreatitis.
Initial treatment includes resuscitation with intravenous fluids and correction of electrolyte abnormalities, analgesia, and tight glucose control.
Treatment of severe acute pancreatitis includes support of end organ failure, most commonly of respiratory, renal, and circulatory systems.

160
Q

A 70-year-old man who smokes heavily presents with a 6-month history of intermittent abdominal pain and nausea. He has lost 10 kg of weight in the past 2 months, which he thinks is due to a decreased
appetite, and he complains of pruritus. On physical exam there is
icterus in the conjunctival sclerae and epigastric tenderness but no abdominal mass or lymphadenopathy.
• Blood tests demonstrate elevated bilirubin and alkaline phosphatase; the rest of the blood tests are within the normal range
CT show mass

A

PANCREATIC CANCER

Fourth most common cause of cancer-related death in the US.
Most common presentation is at 65 to 75 years of age with painless obstructive jaundice and weight loss. Generally presents late with advanced disease.
Surgical resection offers the only hope for cure. Chemotherapy and radiation therapy, as primary treatment modalities, produce a small but statistically significant benefit. Adjuvant chemotherapy prolongs survival.
Only a minority (5% to 10%) of patients can undergo potentially curative surgery: these patients have a 5-year survival of up to 22%, which decreases to <2% in the presence of distant metastasis.
Patients with metastatic disease (50% to 55%) have a limited survival of only 3 to 6 months.

161
Q

A 51-year-old man with moderate obesity (BMI of 34 kg/m^2) is seen in consultation for heartburn and regurgitation. He has a diagnosis of GERD and has been treated with proton-pump inhibitors. His
heartburn is less severe with the medication, but he still is bothered by regurgitation. His physical examination is unremarkable.

  • What would be the next step in management of this patient.
  • A. Increase Proton Pump inhibitor to BID • B. Add H2 Blocker • C. Lifestyle modifications such as losing weight • D. Upper GI series
A
  1. Upper GI series
    * *TYPE I (SLIDING) HIATAL HERNIA, with about one third of the upper stomach in the chest
    * *Patient will benefit from - NISSEN FUNDOPLICATION
162
Q

Identify types of genetic variants and single gene inheritance (5)

**what is the common disease common variant hypothesis

A
  1. Variant: general term for any change regardless of frequency
  2. Single nucleotide variants/polymorphisms (SNV/SNP), one base is changed
  3. Insertions and deletions (grouped together under the term “indel”)
  4. Structural variants (e.g. translocations, rearrangements)
  5. Simple tandem repeats (STR)
    - Dinucleotide, trinucleotide repeats

** Common Disease Common Variant Hypothesis: Role of common variants in disease: The common disease-common variant (CDCV) hypothesis predicts that common variants in human populations will confer risk to a given disease. Examples: APOE ε4 in Alzheimer’s disease, IL23R in Crohn’s disease.

163
Q
  1. variant allele (or any variant DNA sequence) that is present in greater than one percent of the allelic population.
    - term used incorrectly when?
    - what has a higher form?
A
  1. POLYMORPHISM
    - Some individuals incorrectly use the term polymorphism to connote a benign mutation.)
    - A locus which has many (>100) alleles is said to be highly polymorphic.
164
Q

Identify
**Expression of the genes encoding cell surface antigens, dystrophin, phenylalanine hydroxylase and many others is not influenced by the action of other genes

A

MONOGENIC INHERITANCE

  • Because the trait/disease phenotype in these cases is dictated by one gene, this is known as single gene (or monogenic) inheritance.
  • In terms of molecular basis, treatment and risk of recurrence to family members, we know the most about single gene disorders.
  • The simplest case of inheritance involves a single gene having two different alleles in a population. The presence of one allele gives a particular phenotype, while the other allele results in a second phenotype which may be very similar or strikingly different. Some genes have alleles that are deleterious such as deletion mutations in the DMD gene. Other genes have alleles that are relatively innocuous or beneficial.
  • For example, the HLA antigens and blood group antigens represent genes where many different alleles may be present in a population, although an individual can have only two different alleles at a given locus.
165
Q
  1. WHAT refers to the configuration of alleles at a given locus?
    - genetic locus with 2 different alleys is said to be?
    - what term is used if 2 defective alleles are present
A

Allelic constitution refers to the configuration of alleles at a given locus.

  • A genetic locus that has two different alleles is said to be heterozygous.
  • Heterozygosity can mean either the presence of a wild type and a mutant allele, or the presence of two different mutant alleles.
  • The term heteroallelic is used if two defective alleles are present.
166
Q

Genetic Heterogeneity

  • Differentiate Allelic vs Locus heterogeneity
  • give example of allelic heterogeneity (DISEASE)
A
  1. For monogenic traits/diseases, variations in phenotype can result from the presence of differing defective alleles at a given locus or from the presence of differing alleles at different loci.
  2. Allelic heterogeneity describes different alleles at the same locus which gives rise to the same or similar disease. Example: in the case of cystic fibrosis,
    - we have noted that there are several different alleles that give rise to CF.
    - Individuals who are homoallelic for the delta F508 allele have the PI (pancreatic insufficiency) form of CF, while those who have a “milder” allele (e.g 455 Ala - Glu) and the delta F508 allele will have the less severe PS form of teh disease
    - Disease severity and clinical management is dependent on the types of mutant alleles present.

**ALLELIC HETEROGENEITY EXAMPLE 1: CYSTIC FIBROSIS
I. F508/+ (heterozygous) - normal carrier
II. F508/F508 (homoallelic) - severe PI form
II. F508/455 (heteroallelic) - less severe PS form

167
Q

**Identify genetic condition

describes genes at different loci that cause the same or similar disease. Example???

Type (3), gene, location, phenotype (Diet/meds)

A

LOCUS HETEROGENEITY

E,g PKU - results from failure to convert phenylalanine to tyrosine
- 97% of all PKU have defects in phenylalanine hydroxylase (see pathways). 3% have defects in other loci.

Type I
Gene; phenylalanine hydroxylase
Location; chromosome 12
Phenotype; restrict phenylalanine + provide tyrosine

Type II
Gene; BH4 reductase
Location; chromosome 4
Phenotype; restrict phe+ L-DOPA + 5HT

Type III
Gene; biopterin synthesis
Location; several loci
Phenotype; restrict phe+ L-DOPA + 5HT

168
Q

Solve genetic problem
1. Will their progeny be at risk?
◼ Assume Mom = Type I = PAH homozygous mutant and BH4 synthesis homozygous normal
◼ e.g. no defect in any BH4 biosynth pathway
◼ Assume Dad = Type III = PAH homozygous normal and BH4 synthesis homozygous mutant
◼ Work in groups to set up Punnett Square
(3 minutes)

A
  • *All kids will be heterozygous

- 100% offspring will be phenotypically normal

169
Q

Explain Mitochondrial inheritance

A

Mitochondrial inheritance
 Mt genome= 37 genes involved in ox-phosphorylation, rRNAs and tRNAs
 Disruption of energy production is pleiotropic (many sequellae)
 >100 known point mutations + >100 known rearrangements
 Mitochondrial = maternal only inheritance
- Mom to all offspring
- Dad to no offspring

170
Q

Mendelian summary

Allelic heterogeneity vs locus heterogeneity vs monogenic inheritance vs mitochondrial vs complex modes of inheritance

A
  1. Allelic Heterogeneity: one gene with multiple alleles that give rise to same/similar disease
  2. Locus Heterogeneity: one of several genes (with or without multiple alleles) that give rise to the same/similar disease.
  3. Mendelian = monogenic inheritance Mitochondrial: passed from mom to all offspring (rare exceptions)
  4. Complex mode of inheritance
    A. Polygenic
    B. Multifactorial
171
Q

Identify couples (non Mendelian) forms of inheritance

  1. Environmental and genetic factors combine to produce a phenotype: height, intelligence, weight, obesity, cardiovascular disease, cancer, Alzheimer’s disease. Most human traits/disorders fall into this category.
  2. For many traits, a number of genes (gene products) interact to render the actual phenotype.
A
  1. Multifactorial inheritance
  2. Polygenic inheritance
    - Genetic background refers to all other genes that influence the action of the gene in question. Genetic phenomena like sex influence, incomplete penetrance and variable expressivity are often explained by invoking genetic interactions. However, for most cases of polygenic inheritance, the identity of the interacting genes is not known.
    * * Polygenic inheritance includes forms of penetrance and variable expressivity. Although some traits/disorders are most probably the consequence of the interaction of two or more genes, in most cases the actual participating genes have not been identified.

** In a few cases, allelic heterogeneity (caused by genomic instability), not genetic interactions or gene-environment, provides a better explanation for observed variation (example: Fragile X syndrome).

172
Q
  1. defined as the probability of manifesting a trait given the presence of an allele or set of alleles. This is an “either or” phenomenon. Given the presence of the defective allele, you either exhibit the trait or you don’t.
  2. believed to determine the outcome.
A
  1. Penetrance
  2. A modifier gene
    - Incomplete penetrance is a characteristic of dominant inheritance; no cases of incomplete penetrance are known for recessive traits.
    - The generalized pedigree to the right illustrates incomplete penetrance. It looks like the disease has “skipped a generation”.
173
Q

Examples of penetrance

  1. If CF genotype is homozygous mutant, then child has 100% chance of developing CF disease. CF is said to be
  2. For Huntington’s disease (Huntington’s chorea; autosomal dominant), if you receive the disease allele, you develop the disease at some point (usually after childbearing years).
  3. Polydactyly (autosomal dominant), extra digits on hands and feet. Not all persons with disease allele get extra digit, therefore disease or gene is said
    * *formular of % penetrance
  4. Retinitis pigmentosa (RP)

**Polygenic summary and exception

A
  1. Complete penetrance; CF
  2. Complete penetrance with variable age of onset; HD
  3. Incomplete penetrance; polydactyl (AD)
    - also in brachydactyly and in fragile X syndrome
    * *Formular of penetrance = # cases with phenotype / # cases with genotype
  4. Retinitis Pigmentosa (RP): An example of true polygenic inheritance (GIM text pp 299-301)
    - Two unlinked genes (peripherin and ROM1) encode photoreceptor proteins.
    - In a few families, patients heterozygous for either (but not both) loci do not develop retinal degeneration. Patients heterozygous at both peripherin and ROM1 develop the disease.

Polygenic summary and exception
- For polygenic modes (like incomplete penetrance), two or more genes determine the phenotypic outcome. In a few cases, monogenic allelic heterogeneity (caused by genomic instability) provides a better explanation for observed variations in phenotype.

174
Q

Identify condition

  • Carrier females are rarely physically dysmorphic and show variable learning ability. Some carriers are affected in that they tend to be shy and show some learning disorders. (Since carriers have an affected phenotype, most authors classify the condition as dominant trait)
  • phenotypic variation in females can be due to ?
  • because affected males rarely mate, homozygous females of the condition are very rare
  • *Cytology?
  • *Phenotypes??
A

FRAGILE X SYNDROME and UNSTABLE REPEATS

    • Fragile X syndrome is the second most common cause of mental retardation (Trisomy 21 is the most common) and most common hereditary form of intellectual disability.
  • Cytology: Cells cultured from Fragile X patients have a novel secondary constriction on the X chromosome, called a fragile site, which is the site of frequent breakage. This site fails to condense during metaphase like other chromosomes.
  • Phenotypes: Frequency of affected males is 1 in 3600. Affected males are moderately retarded, have large testes (macroorchidism), large heads, large protruding ears, prominent jaw and stubby hands. Speech development is delayed. As adults, they are usually nonassertive, but friendly. Some males have symptoms of autism.
175
Q

second most common cause of mental retardation (Trisomy 21 is the most common) and most common hereditary form of intellectual disability.

  • mode of transmission/ pedigree studies
  • what type of penetrance?
  • what type of heterogeneity?
  • explain SHERMAN PARADOX ?
A

FRAGILE X SYNDROME
Fragile X syndrome segregates as an X-
linked dominant trait with incomplete penetrance. It is considered to be X-linked dominant because a single defective allele in the X-linked FMR1 gene causes some mental deficiency in females.

Fragile X exhibits incomplete penetrance because not all carriers of a “defective” allele are affected; % penetrance is sex dependent. Incomplete penetrance of Fragile X syndrome is not a consequence of polygenic interactions; it is best explained by allelic heterogeneity.

In a standard fragile X pedigree, a phenotypically normal man who passes the disease allele to his daughters and his grandsons is called a nonpenetrant transmitting male (NTM; square with a bullet).

While the brothers of this NTM have a 9% risk of being affected, the grandsons and greatgrandsons have a higher chance of being affected (37% and 50% respectively). The risk of the granddaughters and great-granddaughters being affected also increases from 5% (sister affected) to 17% and 20% respectively (see pedigrees). Therefore, position in the pedigree in part determines the risk of developing the syndrome. This is known as the SHERMAN PARADOX.

176
Q

EXPLAIN molecular basis of Sherman paradox

  • what condition?
  • permutation alleles?
  • functional FMR1 gene product?

**Why are NTMs said to be nonpenetrant?

A

SHERMAN PARADOX

  • The paradox has been partly resolved by the discovery of the nature of the Fragile X mutation. Multiple CGG trinucleotide repeats are present in the 5’ noncoding region of fragile X gene (FMR1). Phenotypically normal males and females have less than 50 repeats.
  • NTMs and carrier females have variant alleles with between 50 and 200 repeats called premutation alleles.
  • Normal and premutation alleles allow for normal levels of functional FMR1 gene product and normal mental development ensues.
  • However, during female meiosis, the premutation allele can expand to 200-3000 CGG repeats, so that a fraction of gametes carry the fully expanded (and defective) FMR1 allele.
  • Normal alleles can also expand to full mutations, but at a much lower frequency than premutation alleles; therefore, normal females only rarely make gametes with full mutations.
  • The highest range of repeats correlates well with the absence of the FMR1 mRNA and the presence of clinical disease.

** NTMs are said to be nonpenetrant because they have a “defective” allele but do not express the phenotype. This is a slight twist on accepted meaning of penetrance, because premutation allele is not truly defective since it allows for normal levels of FMR1; but it does confer increased risk of expansion to the “full” mutation.

177
Q

Molecular diagnosis of fragile X syndrome

  • *what 2 tests
  • *In class exercise - what are the phenotypes? (Look at notes)
A

Diagnosis of fragile X syndrome is based on molecular genetic analysis which has replaced
karyotype visualization of the fragile X chromosomes following cell culture in folate deficient media. Most labs now use either
(1) Southern blot analysis to measure methylation and the size of expansions in large pre-mutation or full mutation alleles or
(2) PCR to identify normal alleles and discriminate small differences in the intermediate and premutation sizes.

178
Q

State other diseases caused by triplet repeats (5)

A

Expanding triplets have also been implicated in myotonic dystrophy, Kennedy syndrome (androgen receptor gene) and Huntington’s disease.

  1. Fragile X CGG
  2. Huntington CAG
  3. Myotonic dystrophy GCT
  4. X linked spinal and bulbar muscular atrophy CAG
  5. Spinocerebellar ataxia type I CAG
  6. Fragile site FRAXE GCC
179
Q

Identify phenomenon

    • refers to the apparent worsening of a disease over several generations. Worsening may mean increase in disease severity, increase in penetrance or decrease in the age of onset.
  • example? (2)
A

ANTICIPATION
- Anticipation may also stem from ascertainment bias, that is, mildly affected individuals may escape detection in prior generations perhaps because of archaic detection methods. This would erroneously reduce penetrance in that generation and give the appearance of increasing penetrance over generations.

E.g
1. Huntington disease is a variable age of onset autosomal dominant disorder characterized by personality changes, motor abnormalities (choreiform movements), gradual loss of cognition and premature death. Variable age of onset. Disease stems from expansion of CAG repeat in the huntingtin gene; extent of repeat correlates inversely with age of onset.

  1. Myotonic dystrophy is an autosomal dominant disorder characterized by myotonia, ptosis, cataracts, hypogonadism, frontal balding, ECG changes. Defect in one form of this disorder is an amplified trinucleotide repeat in the 3’ untranslated region of a protein kinase gene on chromosome 19. Repeat expansion accounts for the phenotypic worsening over generations.
    Diagnostic probes for measuring repeats and predicting disease status are available.
180
Q

Summary - monogenic traits definitions

A

 Monogenic traits: Allelic and Locus heterogeneity  Penetrance, sex influence, some RP can be explained by polygenic inheritance
 ANTICIPATION in Fragile X and others is based on ALLELIC INSTABILITY (TRIPLET EXPANSION), not gene- gene interactions.

181
Q

Identify phenomenon

applies to the range of phenotypic manifestations of the same genetic disorder (or of the same genotype).
*Give example

*differentiate from penetrance ?

A

VARIABLE EXPRESSIVITY
** While penetrance refers to the presence or absence of any effect of a gene, expressivity refers to the type or degree of manifestation of a gene that is a penetrant. Examples:

  • Neurofibromatosis (NF1) is an autosomal dominant neurocutaneous disorder.
  • Mild cases involve presence of café au lait spots (light brown in color) and benign skin tumors, neurofibromas. In more severe cases, thousands of disfiguring neurofibromas and malignant tumors (eye, brain, and spinal cord), mental retardation and/or speech impediment can be present. A wide variety of NF1 mutations have been found in NF patients.
  • ***Most studies have not found an obvious relation between particular NF1 mutations and the resulting clinical manifestations. The variability of the NF1 phenotype, even in individuals with the same NF1 gene mutation, suggests that other factors are involved in determining the clinical manifestations, but the nature of these factors has not yet been determined.
  • *CASE FOR POLYGENIC INHERITANCE IN EXPRESSIVITY - VARIABLE PHENOTYPE EVEN IN THOSE WITH SAME NF1 MUTATION
182
Q

The features of neurofibromatosis fit the strict definition of expressivity precisely, because many phenotypes can be observed in individuals who have the same defective NF allele in common. The multiplicity of phenotypes observed must therefore stem from differences at other genetic loci, i.e. differences in the genetic background.

*Give 2 other examples of variable EXPRESSIVITY conditions

A
  1. Osteogenesis imperfecta. Principal features: blue sclerae, very fragile bones and deafness, skeletal deformities. Overall incidence 1/10,000. Autosomal dominant with nearly 100% penetrance. Expressivity varies greatly from patient to patient within same family.
  2. Muscular dystrophies: Duchenne, Becker forms both involve the mutations in the same gene. These do not fit the definition of expressivity, because the variations in phenotype are not based on the interaction of a single gene with other genetic loci, but rather on the presence of the several defective alleles at one genetic locus. Allelic heterogeneity is more applicable term in this case. III. Uniparental Disomy/Genomic Imprinting
183
Q

Uniparental disomy vs genomic imprinting

**give 2 disease examples

A

In rare cases, a gamete disomic for a given chromosome will fertilize one which is nullisomic for the same chromosome. The resulting zygote will have a euploid chromosome number but (at least) two chromosomes (e.g. two maternal chromosome 15s) were inherited from the same parent (UNIPARENTAL DISOMY).

Some genes are activated or inactivated in a sex-specific manner, a phenomenon called GENOMIC IMPRINTING. It follows that uniparental disomy could lead to a gene being present in either two active or inactive doses. Several human diseases result from this functional imbalance and the phenotype depends on the “parent of origin”.

** Prader-Willi (PWS) and Angelman Syndromes (AS) are parent of origin diseases and stem from genomic imprinting of several genes in critical region on chromosome 15. Genomic imprinting can inactivate expression of some genes in a sex-specific manner.

184
Q

Normal genotype = one set of maternally expressed genes by one set of paternally expressed genes.

*describe mechanisms of diseases (2) with uniparental disomy / genomic imprinting

A

PW and AS can stem from several mechanisms:
(1) Physical deletion of the active PWS gene(s) in a sperm + fertilization of an egg where the genes are not expressed results in a zygote where no critical region genes are expressed. Conversely, physical deletion of the active AS genes in an egg + fertilization by a sperm where the AS genes are not expressed results in a zygote where no critical region genes are expressed. Deletion explains 70% of PWS and AS cases.

(2) Uniparental disomy can form zygotes where both c15’s are maternal OR paternal in origin. If both C15s are maternal in origin, no active paternal genes are present and PWS follows. There is no consensus on the number of genes in the PWS and AS critical regions. PWS can result from inheritance of pair of maternal chromosome 15’s and no paternal 15’s (30% of all cases). AS results from the inheritance of pair of paternal chromosome 15s and no maternal 15s (5% of cases).

185
Q

Explain

** complex traits) are those that have both a genetic and an environmental basis.

A

MULTIFACTROIAL TRAITS (sometimes called complex traits) are those that have both a genetic and an environmental basis. Note that for many physical and behavioral traits, there is a continuous spectrum of phenotypes (measured in meters, grams, test scores, etc.). These are referred to as quantitative traits because measuring methods (biometry) are used to describe the trait and the measurements vary across individuals in a population. Many quantitative traits can be explained by multifactorial inheritance.

Consider height as an example of a trait with continuous distribution. Four models can be proposed to explain the population frequencies: one gene, two genes, three genes, three or more genes + environment. Note that as more features are added to the model, the number of possible genotypes increases and the appearance of the bell curve approaches the actual distribution.

Examples of normal human traits affected by a number of genes and environmental factors: skin and hair color, height, weight, blood pressure, intelligence.

186
Q

EXPLAIN

  • threshold (dichotomous) vs quantitative trains
  • examples (5)
A

Threshold (Dichotomous) vs Quantitative traits: A number of complex human diseases do not occur in a bell-shaped distribution, instead they are either fully present or absent in an individual. One explanation is that the liability (genes + environment) for a given disorder follows the bell curve and that only when a certain threshold is reached will the disease phenotype manifest itself.

  • *Examples of threshold human diseases:
    1. Pyloric stenosis is 5X more common in males than females (threshold is higher in women)
    2. Neural tube defects
    3. Cleft Lip/Palate
    4. Cardiovascular disease: Genotype of individual (family history of heart attack) + environmental factors (cigarette smoking, stress, and diet)
    5. lung disease in patients with α1-antitrypsin deficiency is determined by mutations in the alpha1anti-trypsin gene and environment factors (smoking).
187
Q

Example of monogenic and multifactorial disease

Description
Incidence
Pathology

A

Alzheimer’s disease (Examples of Monogenic and Multifactorial Disease)

Description: Slow progression that results in memory loss and alteration of intellectual function and cognitive abilities (e.g. loss of executive function). AD is the most common form of dementia occurring after age 40.

Incidence: 1 in 9 age 65 or older; 1 in 3 age 85 or older. Early onset forms occur before age 60 and are likely to be inherited as autosomal dominant traits. Late onset forms are more common than early onset and in some cases appear to be multifactorial.

Pathology: Neurofibrillary tangles are found in neurons of cerebral cortex and hippocampus. Amyloid deposits within senile plaques are caused by the accumulation of amyloid precursor protein (APP). Presenilin 1 and presenilin 2 are required for processing of APP. Mutations in these genes and APP itself lead to early onset forms of the disease. Abnormal APP cleavage leads to amyloid deposits (see figures)

188
Q
  1. Locus heterogeniety in Alzheimer’s disease
  2. What is Alzheimer’s susceptibility gene
  3. Clinical use of ApoE4 testing
A

Locus heterogeneity in Alzheimer disease: Early onset forms are caused by mutations in either APP, PSEN1 or PSEN2. But these three genes only explain a small percentage of all affected persons. See table.

ApoE, an Alzheimer’s disease susceptibility gene. The apoE gene has a number of missense polymorphisms. Two common sets of linked polymorphisms result in amino acid substitutions at 112 and 158 as shown below.

  • chromosome 1; presenilin II - early
  • chromosome 14; presenilin I - early
  • chromosome 19; APOE - BOTH (MOST COMON)
  • chromosome 21; APP - early
  • *unknown for late

ApoE alleles were found to confer risk in a dose dependent fashion. ApoEe4 allele results in increased risk of development and decrease in age of onset. ApoE4 homozygotes have a 90% chance of developing by age 75, while apoEe4/apoEeX have a 45% chance and apoEeX/apoEeX have only a 20% chance (where EX is any allele except E4). ApoEe4 binds to APP more rapidly and may affect its processing.

  1. Clinical Utility of ApoEe4 testing (See p492 in Genetics in Medicine. 7th edition) Population screening vs Diagnostic testing Population PPV for e4/e4 = 23% vs Diagnostic PPV for e4/e4 = 98%
    So, ApoE testing may be helpful in confirming a diagnosis of dementia in a patient with dementia. However even in this case, testing has limited practical value because of the absence of suitable treatments.
189
Q

Alzheimer’s disease summary

Progression? 
Pathology 
Early vs late onset 
Gene variants 
Multifactorial
A

A. SLOW PROGRESSIVE LOSS OF MEMORY AND COGNITIVE FUNCTION
B. 0.1% AGE 60-69; 2.2% ABOVE AGE 80
C. PATHOLOGY: NEUROFIBRILLARY TANGLES, APP in AMYLOID DEPOSITS, ROLE OF PRESENILINS
D. EARLY ONSET (AGE 40-50) ONLY ACCOUNT FOR A FEW % OF TOTAL CASES
- LARGELY AUTOSOMAL DOMINANT
- LOCUS HETEROGENEITY
- PRESENILIN AND APP GENES
E. LATE ONSET (AGE 60 AND UP) 50% OF ALL CASES
- MULTIFACTORIAL (?)
- GENES UNKNOWN
F. APOE VARIANTS LEAD TO BOTH EARLY AND LATE FORMS
- E4/E4; 90% by age 75
- E4/EX; 45% by age 75
- EX/EX; 20% by age 75
G. MULTIFACTORIAL: ONE COPY E4 + (Age, head trauma, ???)

190
Q

Identify condition

Chronic, relapsing, multifactorial, neurobehavioral disease wherein an increase in body fat promote adipose tissue dysfunction and abnormal fat mass physical forces resulting in adverse metabolic, biomechanisma and psychosocial health consequences

Is this a silent killer?

A

OBESITY
- Unlike the other chronic diseases, however, it is not a silent killer, but one whose external manifestations are evident to afflicted individuals from its outset as weight gain and increased girth.

**WEST VIRGINIA now leads the nation in obesity

191
Q
  1. 3 medical conditions associated with weight gain
  2. Obesity physiopathology
    A. Afferent (7) vs efferent signals (3)
A
  1. A. Cortisol excess (Cushing syndrome)
    B. Hypothyroidism
    C. Growth hormone deficiency
  2. Obesity physiopathology
    A. Afferent signals; GHRELIN, PYY, Insulin, amylin, IL6, LEPTIN, ADIPONECTIN, others
    B. Efferent signals; sympathetic, parasympathetic, thyroid hormones
192
Q

Summarize 5 classes of medications associated with weight gain **

A
  1. Anticonvulsant/mood stabilizers; carbamazepine, gabapentin, pregabalin, valproic acid, lithium
  2. Antidepressants
    A. MAOI; Phenelzine
    B. SSRI; Citalopram, escitalopram, fluvoxamine
    C. Presynaptic alpha 2 antagonist; mirtazapine
    D. SNRI; duloxetine
    E. Tricyclics; amitryptyline, imipramine
  3. Antidiabetics; insulin, meglintinides, sulfonylureas
  4. Antipsychotics; atypical and conventional
  5. Others; antihistamines, corticosteroids, hormonal contraceptives - depolarizing injections
193
Q

Obesity diagnosis

Overweight vs class 1 vs class 2 vs class 3 
**recommendations per class
A

➢ Overweight: BMI 25–29.9 kg/m2
➢ Class 1 obesity: BMI 30–34.9 kg/m2
➢ Class 2 obesity: BMI 35–39.9 kg/m2
➢ Class 3 obesity: BMI ≥

194
Q

5A approach for obesity

Dietary strategies used in lifestyle modification (4)

Behaviors associated with weight loss maintenance (5)

A

❑ Assess (assess weight and risk factors)
❑ Advise (advise weight loss, personalize the
recommendation to the patient)
❑ Agree (agree on a target for behavior change)
❑ Assist (assist with a referral)
❑ Arrange (arrange follow-up)

Dietary strategies

  1. Calorie restriction
  2. Physical activity
  3. Any calorie reduction diet leads to weight loss
  4. Calorie deficit diet following federal dietary guidelines

Behaviors associated with weight loss maintenance
❑ Participation in structured weight management program
❑ Physical activity >60 mins/day most days of the week

195
Q

FDA approved anti-obesity medication indications

A
1. FDA approved indications 
A. Patient with obesity (BMI >30) 
B. Patient overweight (BMI >27) with presence of increased adiposity complications 
- Type 2 DM 
- Hypertension 
- Dyslipidemia 
  1. Other principles
    - Anti obesity medications promote variable weight loss over variable duration in patient whom are overweight or obese
    - Some patients have an average of 5-10% weight loss with variations
196
Q

Identify medication

Mechanism of Action: sympathomimetic amine with pharmacologic properties
MOA in reducing appetite appears secondary to CNS effects, including stimulation of hypothalamus to release norepinephrine
• Approved in 1960s for short-term use (3 months)
similar to amphetamines;

  • *mean weight loss?
  • *common side effects? Contraindications?
A

Phentermine (Adipex-P)
- mean weight loss; 3.6kg (7.9lbs)

Common side effects
• Headache • Elevated blood pressure • Palpitations • Insomnia • Dry mouth • Constipation • Anxiety

Contraindications
• Anxiety disorders (agitated states) • History of heart disease • Uncontrolled hypertension • MAO inhibitors • Pregnancy and breastfeeding • History of drug abuse

197
Q

Agent approved for chronic weight management

Mechanism of Action: Reversible inhibitor of pancreatic and gastric lipase; decreases absorption of fat by 30%

  • *common side effects?
  • *contraindications?
  • *drug interactions ; AMIODARONE? Cyclosporine? Levothyroxine? Anticonvulsant? Warfarin?
A

Orlistat (Alli, Xenical)

Common side effects
• Decreased absorption of fat-soluble vitamins • Oily spotting
• Flatulence with discharge • Fecal urgency • Increased defecation

Contraindications
• Chronic malabsorption syndrome
• Pregnancy and breast feeding (Category X)
• Cholestasis • Warfarin • Antiepileptic drugs

Orlistat Drug Interactions
A. Amiodarone: decrease serum concentration
B. Cyclosporine: decrease serum concentration
• Administer orlistat at least 3 hours before or after cyclosporine
C. Levothyroxine: decrease serum concentration
• Separate administration by at least 4 hours
• Monitor for signs and symptoms of hypothyroidism
D. Anticonvulsants: decrease serum concentration
E. Warfarin: enhance the anticoagulant effect of vitamin K
antagonist

198
Q

Agent approved for chronic weight management

FDA approved in 2012 for chronic weight management
MoA; Selective serotonin (5-HT2c) receptor agonist

  • *common side effects?
  • contraindications/use with caution
A

Locaserin (Belviq)

Common side effects
• Headache • Nausea
• Dry mouth • Dizziness
• Fatigue • Constipation

Contraindications/use with caution
• Pregnancy and breastfeeding
• SSRI • SNRI/MAOI
• St

199
Q

FDA approved medication for chronic weight management

Mechanism of Action:
• Phentermine: Reduces appetite appears to be secondary to CNS effects, including stimulation of the hypothalamus to release
norepinephrine • Topiramate: Effects appetite suppression and satiety enhancement and based on a combination of potential mechanisms; block
neuronal voltage-dependent sodium channels, enhances GABA(A) activity, antagonizes AMPA/kainite glutamate receptors, and
weakly inhibits carbonic anhydrase

**side effects? Contraindications?

A

Phentermine/Topiramate (Qsymia)

Common side effects 
• Insomnia • Dry mouth 
• Constipation • Paresthesia 
• Dizziness • Dysgeusia 
• Increased heart rate

contraindications
• Pregnancy and breastfeeding
• Hyperthyroidism • Glaucoma
• MAO inhibitor • Sympathomimetic amines

Qsymia REMS program
A. To inform prescribers and females of reproductive age the
potential of:
• Increased risk of congenital malformation, specifically orofacial clefts, in infants exposed to Qsymia during the first trimester of pregnancy
• Important of pregnancy prevention for females of reproductive
potential receiving Qsymia
• Need to discontinue Qsymia if pregnancy occurs
B. Pregnancy test should be taken BEFORE starting treatment and
every mouth after while on treatment

200
Q

FDA Approve in 2014 for chronic weight management

MoA

  1. Reuptake inhibitor of dopamine and NE
  2. Opioid antagonist

**side effects? Contraindications?

A

Naltrexone/Buproprion (Contrave)

Common side effects 
• Nausea • Constipation 
• Headache • Vomiting 
• Dizziness • Increased thirst 
• Insomnia

Contraindications
• Uncontrolled hypertension • Seizure disorders
• Anorexia nervosa or bulimia • Drug or alcohol withdrawal
• MAO inhibitors

201
Q

Identify FDA approved chronic weight management drug

Mechanism of Action: Slows gastric emptying and decreases food intake

Side effects?
Contraindications?

A

Liraglutide (Saxenda)

Common side effects
• Headache • Diarrhea
• Constipation • Vomiting
• Abdominal pain • Gastroenteritis

Contraindications
• History of or family history of medullary thyroid cancer history
• Patients with multiple endocrine neoplasia syndrome type 2
• Pregnancy

202
Q

Obesity SUMMARY ***

  1. Screening and prevention
  2. Diagnosis
  3. Treatment (3)
    - which is most effective? Advantage?
A
  1. Screening and prevention
    ❖ Screen for obesity
    ❖ Refer for intensive treatment interventions
    ❖ Review medication lists: could changes reduce weight gain?
    ❖ Encourage behaviors that can prevent weight gain
  2. Diagnosis
    ❖ Use BMI to diagnose obesity Diagnose obesity
    ❖ Combine with other patient characteristics to assess risk
    ❖ Measure waist circumference if BMI 25-34.9 kg/m^2
    A. Abdominal obesity increases health risk
    B. Focus history and physical exam on
    ▪ Weight-related conditions
    ▪ Weight trajectory
    ▪ Previous weight loss attempts
    C. Screen for diabetes, nonalcoholic fatty liver disease, thyroid
    dysfunction, dyslipidemia
203
Q

Explain the Hardy-Weinberg equation

A

The Hardy-Weinberg equation allows one to determine the frequency of a given genotype from the frequencies of the alleles of locus in question. Allele frequencies are determined by counting the number of alleles of one type and dividing by the total number of all the different alleles.
P+q = 1

(p+q)^2 = p^2 + 2pq + q^2 = 1. Where; 
P^2 = the frequency of BB genotype 
2pq = the frequency of Bb genotype 
Q^2 = the frequency of bb genotype
204
Q

INCIDENCE AND GENE FREQUENCY OF SELECTED DISORDERS

** probability of a match between two DNA samples is dependent on??

A

Allele frequencies have clinical and forensic significance. Because these values can vary from population to population, the risk of carrier status varies (sometimes dramatically) and influences the risk of having an affected offspring. These population-specific allele frequencies allow us to calculate the probability of carrier status (examples will follow).

In forensic science, the probability of a match between two DNA samples is dependent on the frequencies of the alleles in a given population; in modern applications, allele frequencies have been determined for many population subgroups (race, ethnicity, etc.).

205
Q

Hardy Weinberg Conditions

**STATE hardy Weinberg law
Condition in which this law holds ? (5)

A

The Hardy-Weinberg law states that genotypes will be distributed in a population BASED ON the ALLELE FREQUENCIES and the GENOTYPE FREQUENCIES will REMAIN CONSTANT from generation to generation. This law only holds as long as all of the following conditions are met:

  1. The population exhibits random mating with little stratification, assortative mating or inbreeding.
  2. The trait is present in a LARGE POPULATION.
  3. There is a NEGLIGIBLE NET MUTATION RATE between the B and b alleles.
  4. There is a NEGLIGIBLE AMOUNT OF MIGRATION into or out of the population.
  5. There is a NEGLIGIBLE AMOUNT OF SELECTION, that is, all genotypes are equally viable and equally fertile.
206
Q

3 CLASSES OF RANDOM MATING

The Hardy-Weinberg law states that genotypes will be distributed in a population based on the allele frequencies and the genotype frequencies will remain constant from generation to generation. This law only holds as long as all of the following conditions are met:
1. Population exhibit random mating

A
  1. The population exhibits random mating with little stratification, assortative mating or inbreeding. For example, if one genotype (bb) rarely mates, then the b allele frequency will decline over time. There are three classes of nonrandom matings:

(A) Consanguineous matings result in an increase in homozygous genotypes and a decrease in heterozygotes.
(B) A stratified population is one having subgroups that do not intermarry. Basis can be culture, economic status, race, religion etc.
C) Assortative mating is the choice of mate based on phenotype (intelligence, stature, skin color, musical talent etc.); as in consanguineous matings, heterozygous types are also underrepresented in assortative matings or stratified populations. Here’s why: In random mating population where; p = 0.5 and q = 0.5
AA = p^2 = 0.25,
Aa = 2pq = 0.50
aa = q^2 = 0.25
In population where nonrandom matings predominate, i.e. mostly BB X BB and bb X bb, the frequency of heterozygotes will decline so that AA = 0.50, Aa = 0, aa = 0.50

207
Q

The Hardy-Weinberg law states that genotypes will be distributed in a population based on the allele frequencies and the genotype frequencies will remain constant from generation to generation. This law only holds as long as all of the following conditions are met:

  1. Trait is present in large population
    * *Explain
    - genetic drift?
A
  • The trait is present in a large population. In a small population one genotype may be transmitted exclusively to a subsequent generation by chance.
  • ***The net effect would be a reduction in the frequency of one or more alleles not present in this genotype.
  • This exclusive transmission can happen in any population, but is much less likely to happen in large populations.
  • GENETIC DRIFT applies to the establishment of new alleles or allele frequencies in a population and to the formation of subpopulations isolated from larger population.
208
Q

The Hardy-Weinberg law states that genotypes will be distributed in a population based on the allele frequencies and the genotype frequencies will remain constant from generation to generation. This law only holds as long as all of the following conditions are met:
3. Negligible net mutation rate between the B and b alleles

A

There is a negligible net mutation rate between the B and b alleles. For example, two alleles may differ by a single site (point mutation). Their frequencies can change under the following conditions. (A) A high mutation rate in favor of forming the b allele will tend to raise its frequency. (B) Alleles are lost when individuals have no offspring. This can be significant if the trait reduces the fitness of the carrier.

For autosomal dominant disorders, the mutation rate at a given locus must account for the proportion of alleles lost by selection. Genetic fitness is the probability of transmitting one’s genes to the next generation. For example, fitness (f) for achondroplasia is 20%. This means that 80% of the defective alleles are lost every generation.

For X-linked recessive disorders that have zero fitness, one third of all recessive alleles are lost every generation. If this population is in HW equilibrium, then the proportion of mutant alleles that result from spontaneous mutations is one third.

Mutation rates can be relatively high for some genetic loci and may depend on the size and DNA sequence of the gene. New mutations may account for many of the clinical cases of a given disorder.

209
Q

The Hardy-Weinberg law states that genotypes will be distributed in a population based on the allele frequencies and the genotype frequencies will remain constant from generation to generation. This law only holds as long as all of the following conditions are met:

  1. negligible amount of migration into or out of the population.
    - founder effect?
A

There is a negligible amount of migration into or out of the population. Founder effect occurs when a group of colonists do not have the same allele frequencies as their original population or the population they move into.

For example, Lake Maracaibo Venezuelans have high frequency of Huntington’s disease because one or a few individuals (possibly European colonists) had many offspring there and thereby introduced the disease. So the allele frequency in Venezuela is higher than in Europe. Other examples: Ellis van Creveld syndrome in the Amish, tyrosinemia in French Canadians.

210
Q

The Hardy-Weinberg law states that genotypes will be distributed in a population based on the allele frequencies and the genotype frequencies will remain constant from generation to generation. This law only holds as long as all of the following conditions are met:
5. negligible amount of selection, that is, all genotypes are equally viable and equally fertile.

A

There is a negligible amount of selection, that is, all genotypes are equally viable and equally fertile. If there is complete selection against aa individuals, only AA and Aa will contribute to the gene pool of the next generation. This will reduce q (freq (a)) over time, but will not completely eliminate it.

211
Q

Applications of hardy Weinberg law (4)

Example:
The frequency of males with Factor VIII hemophilia is 1 in 10,000. What is the frequency of carrier females in this population?

**LOOK AT YOUR NOTES

A

Application
A. MN blood groups. Determine the frequency of M and N alleles from the information on the genotypes. Use equations (1) and (2) below. Genotype frequencies: MM = 36; MN = 48; NN = 16. Total sample = 100

B. Albinism, autosomal recessive disorder:
Given the frequency of albinos = 1/20,000 in the general population, please determine the frequency of AA and Aa in the population. 1/20,000 is the genotype frequency.

C. Tay Sachs Disease
Given the frequency of affected individual with Tay Sachs disease determine the carrier frequency in each of these populations

D. Hardy-Weinberg statement for X - linked genes: For female populations: p2 + 2pq + q2 = 1 (the standard form of HW)
For male populations, there are only two possible genotypes:
H/(Y) whose genotype frequency = p, and
h/(Y) whose genotype frequency is q

Example:
The frequency of males with Factor VIII hemophilia is 1 in 10,000. What is the frequency of carrier females in this population?
freq q = 1/10,000
2 pq = 2 (9999/10,000) (1/10,000) = 0.000199 = 0.0002 = 0.02%

212
Q

Estimation of recurrence risk

**how is carrier status determined (2)

A

Determination of risk to an individual is an essential part of genetic counseling. For single gene disorders, assessing the probability of recurrence of a given disorder can be fairly straightforward.

For example, if the parents are known to be carriers of an autosomal recessive disorder, the probability of having an affected child is 1/4.

Carrier status for some disorders is readily determined by (1) direct detection of the wild type and mutant alleles (by PCR, for example) or (2) detection of closely linked genetic markers, such as RFLPs or HLA markers.

However, for the majority of diseases the carrier status cannot be directly determined.

213
Q

Risk calculation for Mendelian traits

**for complex traits?

A

A) if carrier status is known, Punnett square is sufficient.
B) if carrier status is not known, use the population-based frequency (and/or Bayes’ theorem) + Punnett square calculation.

VB. Risk calculation for Complex traits
Empiric (observed) risk is used as the probability of recurrence. Empiric risk is based on the observed numbers of affected individuals divided by the number of offspring.

214
Q

General Guide to Population Genetics/Recurrence Risk Problems

A
  1. Build a pedigree based on family data
  2. Determine the genotype and probability of genotype for the prospective couple
  3. Determine the probability of having an affected offspring given genotype (probable) of the parents.
  4. Combine the three probabilities (for autosomal). P(carrier or affected) x P (carrier or affected) x Punnett probability = P (having an affected)
  5. Always round p to 1 for this course.
215
Q

Physiology of gastric acid secretions

  1. Gastric acid secretion by what cells?
  2. What 3 regulate acid secretion? How?
  3. Indirect effect on acid secretion? How?
  4. Gastrin action
  5. Histamine action
  6. What activates H+, K+ ATPase (proton pump)? Result?
  7. Somatostatin action
A

i. Gastric acid secretion - a complex, continuous process in which multiple central and peripheral factors contribute to a common endpoint - the secretion of H+ by parietal cells.
ii. Neuronal (acetylcholine), paracrine (histamine) and endocrine (gastrin) factors all regulate acid secretion by acting on their specific receptors (M3, H2 and CCK2, respectively) present on the basolateral membrane of parietal cells in the body and fundus of the stomach.

iii. Ach and gastrin signal through GPCRs that couple to the Gq-PLC-IP3-Ca2+ pathway in parietal cells. Ach also indirectly affects by increasing the release of histamine from the enterochromaffin-like (ECL) cells in the fundus of the
stomach and gastrin from the G cells of the gastric antrum.

iv. Gastrin stimulates acid secretion indirectly by inducing the release of histamine by ECL cells
v. Histamine acts as a paracrine mediator, diffusing from its site of release to nearby parietal cells, where it activates H2 receptors. The H2 receptor is a GPCR that activates Gs-adenylyl cyclase-cAMP-PKA pathway.
vi. In parietal cells, the cAMP and the Ca2+-dependent pathways activate H+,K+ ATPase (the proton pump), which exchanges hydrogen and potassium ion across the parietal cell membrane.
vii. Somatostatin (SST) is a small peptide, produced by antral D cells. SST inhibits gastric acid secretion (NEGATIVE FEEDBACK LOOP - activated by acidification of grastic luminal pH <3)

216
Q

The extremely high concentration of H+ in the gastric lumen requires defense mechanisms to protect the esophagus and the stomach.

  • how does gastric defense occur?
    • WHAT 2 THINGS DO THIS
A

GASTRIC DEFENSE

  • *PGE2 and PGI2
    i. The primary esophageal defense is the LOWER ESOPHAGEAL SPHINCTER, which prevents reflux of acidic gastric contents into the esophagus.
    ii. The stomach protects itself from acid damage by a number of mechanisms that require ADEQUATE MUCOSAL BLOOD FLOW.
    iii. First key defense is the SECRETION OF A MUCUS LAYER that protects gastric epithelial cells. MUCUS PRODUCTION is stimulated by PGE2 and PGI2, which also DIRECTLY INHIBIT GASTRIC ACID SECRETION by parietal cells.
    iv. Second important defense is the secretion of bicarbonate ions by superficial gastric epithelial cells.
217
Q

PEPTIC ULCER DISEASE

General

  • causes of disease?
  • therapy aim?

Therapy
- 2 categories

Properties of therapy

A

A. General Comments

i. Disease can result from an increase in gastric acid secretion, pepsin activity, NSAIDs, H. pylori and/or a decrease in mucus, HCO3- or PGs.
ii. Therapy is aimed at decreasing acid or promoting mucosal protection.

B. Antacids

  1. *Two general antacid categories
    a. Systemic antacids – NaHCO3 (baking soda, Alka Seltzer)
    b. Non-systemic antacids – CaCO3 (Tums), Al(OH)3, Mg(OH)2 (milk of magnesia, Mylanta, Gelusil)

Pharmacologic Properties of Antacids

a. Antacids react with gastric acid (HCl).
b. *The basic group in the antacid neutralizes the acid to form water, carbon dioxide and chloride salts.
c. Added simethicone decreases foaming and esophageal reflux.

218
Q

Peptic ulcer medication

Adverse effects (5) 
- what cause constipation? Vs diarrhea? 
Drug interactions (3)
A

Antacid Adverse Effects

a. NaHCO3 & CaCO3: Formation of CO2 causes gastric distention and belching; Transient metabolic alkalosis – NaHCO3 & CaCO3
b. Consider sodium levels in CHF
c. *GI Effects Al(OH)3 can cause constipation Mg(OH)2 can cause diarrhea Net effect of combination agents (e.g. Gelusil, Maalox, etc.) depends on the relative amounts of the two agents.
d. Excessive use of Al and Mg antacids can lead to hypophoshatemia due to formation of insoluble metal phosphate salts.
e. *In DECREASED renal function, absorbed Al3+ and Mg2+ can lead to systemic toxicity.

Antacid Drug Interactions

a. *Altered gastric or urinary pH may affect rate of absorption or excretion and the bioavailability of some drugs.
b. Altered GI motility by Al3+ or Mg 2+ or complex formation (Al) can alter absorption of some drugs.
c. *Significant DECREASED bioavailability – many factors: iron, theophylline, quinolone antibiotics, isoniazid, tetracycline and ketaconazole.

219
Q

Acid secretion inhibitors
**Identify medication
Therapeutic Uses
1. *Gastric and Duodenal Ulcers – If H. pylori is present, then
eradication of the infection should be instituted to reduce ulcer recurrence. For ulcers caused by aspirin or NSAIDs, the NSAIDs should be discontinued.
2. *Gastroesophageal Reflux Disease – H2RA used for chronic
management of heartburn. A major use for these drugs.
3. Zollinger-Ellison syndrome – Rare syndrome where gastrin-
producing tumor INCREASE HCl secretion
4. Acute Stress Ulcers – associated with significant physical trauma in high-risk patients in ICUs. (Continuous iv H2 antagonists)

**exmaples of drugs? MoA

A

Histamine H2 Receptor Antagonists (H2RA)
a. Include: cimetidine (Tagamet), ranitidine (Zantac), nizatidine (axid) and famotidine (Pepcid).
b. *Mechanism of Action:
- Competitive antagonists of histamine at H2 receptors
- DECREASED volume of gastric juice and [H+] content
- DECREASED pepsin secretion
c. Cimetidine was the initial agent in this class. Other agents are
generally more potent than cimetidine and are longer acting.
d. *Cimetidine, ranitidine and famotidine are biotransformed by the liver in varying amounts, while nizatidine is eliminated primarily by the kidney.
e. All H2RA’s inhibit 60-70% of total 24hr acid secretion
f. Especially effective at inhibiting nocturnal acid secretion (Histamine dependent acid secretion), but modest impact on meal-stimulated acid secretion (stimulated by gastrin, Ach and histamine)

220
Q

cimetidine (Tagamet), ranitidine (Zantac), nizatidine (axid) and famotidine (Pepcid).

Class of drugs?
Adverse effects?
Drug interactions?

A

Histamine H2 Receptor Antagonists (H2RA)

Adverse effects
1. The incidences of adverse effects are low and generally minor. 2. Most common adverse effects (1-3%) are headache, itching,
rashes, lethargy and confusion. The last two are seen most in
elderly patients or patients with renal impairment.
3. Cimetidine inhibits binding of dihydrotestosterone to androgen
receptors, inhibits E2. At high doses and long-term use may
case impotence in men.

Drug interactions
1. Similar interactions to antacids due to altered gastric acid
secretion.
2. Cimetidine – inhibits CYP450 and alters the biotransformation
rate of many drugs. May increase toxicity of second drug, if
dose adjustments are not made. Other H2RAs have no effect
on hepatic biotransformation of other drugs.

221
Q

Include : omeprazole (Prilosec), esomeprazole (nexium) and lansoprazole
(prevacid).

Class of drugs?
MoA?

A

Proton Pump Inhibitors
Mechanism of action: PPIs irreversibly inhibit the H+/K+ - ATPase in parietal cells to DECREASED basal and stimulated gastric acid secretion (>90%).

[PPIs are administered as inactive prodrugs (acid –resistant, enteric-coated capsules or tablets). After passing through the stomach into the intestinal lumen, the enteric coatings dissolve and the prodrug is absorbed (the parietal cell canaliculus). The prodrug rapidly becomes protonated within the canaliculus and rapidly undergoes a molecular conversion to the active form, a reactive thiophilic sulfenamide cation, which forms a covalent disulfide bond with the H+/K+ - ATPase, irreversibly inactivating the enzyme.]

PPIs inhibit both fasting and meal-stimulated secretion because they block the final common pathway of acid secretion, i.e. the proton pump. The drug is administered one hour before meal so that the peak serum concentration coincides with the maximal activity of proton pump secretion. Though the serum half life of the drug is only 1.5 hours, the acid inhibition lasts up to 24 hrs owing to the irreversible inactivation of the proton pump.

222
Q

Specify therapeutic uses of proton pump inhibitors (4)

A
  1. *Peptic ulcers – Compared to H2RA, PPIs afford more rapid symptom
    relief and faster ulcer healing for duodenal ulcers and to a lesser extent, gastric ulcers. Note: eradicate H. pylori infection if present, to reduce recurrence of ulcer formation (see below for H. pylori treatment regimen).
  2. GERD: PPIs are the most effective agents for the treatment of
    nonerosive and erosive reflux disease, esophageal complications of reflux disease and extraesophageal manisfestations of reflux disease. Empiric treatment with PPI provides sustained symptomatic relief in 70- 80% of GERD patients compared with 50-60% with H2RA.
  3. Zollinger-Ellison syndrome
  4. NSAID associated ulcers: For patients with ulcers caused by aspirin or NSAIDs, either H2RA or PPI provide healing so long as NSAIDs are discontinued. If patients require continued NSAID therapy, treatment with once or twice daily PPIs are more reliable to promote ulcer healing.
223
Q

Identify class of medications

Used for; peptic ulcer, GERD, zollinger Ellison syndrome, NSAID associated ulcers

  • *Adverse effects?
  • *Drug interactions
A

Proton Pump Inhibitors
a. Include : omeprazole (Prilosec), esomeprazole (nexium) and lansoprazole (prevacid).

ADVERSE EFFECT
1. Generally well tolerated
2. Effects at 1.5-3% incidence include mainly GI effects (nausea,
diarrhea, flatulence) and some CNS effects (headache, dizziness).
3. Long term use-warning about increased risk to fractures (reduced gastric acidity might interfere with calcium absorption)
4. QT interval prolongation and torsades de pontes (TdP) associated with severe PPI-induced hypomagnesia has been reported. Hypomagnesia is usually accompanied by hypocalemia and hypocalcemia,
5. Prolonged use of prescription strength PPI could lead to CKD and end-stage renal disease
6. Gastric cancers have been observed in animals. Human

224
Q

Identify medication

Adeverse effect
- CKD and ESRD
- QT prolongation
- risk of fractures
MoA ; irreversibly inhibit the H+/K+ - ATPase in
parietal cells to DECREASE basal and stimulated gastric acid secretion (>90%).

**drug interactions (4)

A

Proton Pump Inhibitors
a. Include : omeprazole (Prilosec), esomeprazole (nexium) and lansoprazole (prevacid).

Drug interactions

  1. Interactions due to altered gastric acid secretion similar to antacids and H2RA.
  2. Omeprazole and esomeprazole– inhibits CYP450s (Cyp2c19). 3. Can increase serum levels of drugs metabolized by Cypc19 such as diazepam (Valium)
  3. Omeprazole and esomeprazole can inhibit conversion of antiplatelet drug clopidogrel (plavix and generics) to its active form. (patients taking clopidogrel use other PPIs such a lansoprazole etc).
225
Q

Drug that promote mucosal protection

Adverse effect

  1. GI effects – cramping, diarrhea, and nausea are the most common side effects.
  2. Promotes uterine contractions.
  3. *Contraindicated in pregnancy.

**effect and use

A

MISOPROSTOL (cytotec)
a. A stable methyl analog of PGE1

b. Biological effects include; DECREASED acid secretion, INCREASED mucous and HCO3- secretion

Therapeutic uses; prevention of peptic ulcer disease related to NSAID administration in high risk patients. Less effective than H2RA for other types of peptic ulcer disease.

226
Q

Drug that promote mucosal protection

Adverse effects; released Al3+ may cause constipation
**antagonized by agents that INCREASE gastric pH

MoA?

A

SUCRALFATE (carapace)

a. A sulfated sucrose and polyaluminum hydroxide complex.
b. *Mechanism of action: At pH < 4, sucralfate forms polymers/cross-links to form a sticky gel that adheres to GI cells and ulcer craters. A protective barrier against acid.

227
Q

Drug that promote mucosal protection

Mechanism of action: coats ulcer craters, INCREASE mucus and HCO3- secretion, inhibits pepsin activity and is antibacterial toward H. pylori. Healing rate of ulcers better with H2RA.

**adverse effect?

A

Bismuth Compounds
a. Colloidal bismuth subcitrate (GI ulcers) and bismuth subsalicylate (Pepto-Bismol) (ulcers and heartburn).

Adverse effects
- Can darken oral cavity and stool (bismuth sulfide from reaction with bacterial H2S).

228
Q

a gram-negative rod that grows on the luminal side of the gastric epithelium.

  • peptic ulcer patients have what in GI tract?
  • impaired production of what?
  • is single agent therapy effective?
  • treatment requirement
A

Helicobacter pylori

*** Impaired production of somatostatin by Δ cells, inhibition of gastrin production

229
Q

Identify disease

  • Also known as heartburn affects 10% of the US population.
  • most effective treatment?
A

GERD (Gastroesophageal Reflux Disease)

  1. Also known as heartburn affects 10% of the US population.
  2. Antacids (neutralize gastric acid, INCREASED lower esophageal sphincter tone and clearance).
  3. H2RA and PPIs inhibit acid secretion and are preferred if problems persist with the use of OTC antacids.
  4. PPIs are the most effective agents for the treatment of nonerosive and erosive reflux disease, esophageal complications of reflux disease and extraesophageal manisfestations of reflux disease.
  5. Empiric treatment with PPI provides sustained symptomatic relief in 70-80% of GERD patients compared with 50-60% with H2RA.
230
Q

Identify medication

  • *Therapeutic Use: Tx of symptomatic GERD but are not effective in patients with erosive esophagitis. (it is also used in patients with diabetic gastroparesis)
  • *Adverse effects: hyperprolactinemia, CNS effects, Tardive dyskinesia

MoA?

A

Metoclopramide (Regalan)
*Metoclopramide has combined cholinergic agonist and dopamine (D2) antagonist activity. A prokinetic agent.

MoA;

  • INCREASE esophageal clearance
  • INCREASE LES pressure and INCREASE gastric emptying
  • NET effect is to DECREASE REFLUX
231
Q

The following agents cause what condition?
Agents
Analgesics (inhibitors of prostaglandin synthesis) Antacids (containing calcium carbonate or aluminum hydroxide) Anticholinergic agents Antidiarrheal agents Antihistamines (H1 blockers; anticholinergic effect) Antiparkinsonian drugs (anticholinergic effect) Barium sulfate Corticosteroids Clonidine Diuretics that cause hypokalemia Ganglionic blocking agents Heavy metals (especially lead) Iron Laxatives (used chronically) Lithium Monoamine oxidase inhibitors Muscle relaxants
Octreotide Opioids Phenothiazines (anticholinergic effect) Polystyrene resins Propranolol Tricyclic antidepressants (anticholinergic effect) Verapamil

A

CONSTIPATION

  • Constipation is characterized by dry stools that are often voided with excessive straining. Frequency of defecation is also reduced.
  • Can be caused by a wide range of causes, including drugs, stress, diet, and disease of the GI tract.
232
Q

Constipation meds

  1. A. bulk-forming agents that include bran, whole grains, psyllium
    preparations, methylcellulose and calcium polycarbophil.
    B. *They absorb water to soften the stool and increase bulk.
    C. *Generally well tolerated, but intestinal obstruction and impaction can occur.
  2. A. include magnesium salts (hydroxide, sulfate, citrate) and
    phosphate salts (oral or rectal).
    B. *Act via their osmotic pressure to retain water in the colon, which stimulates peristalsis
3. 
include lactulose (synthetic disaccharide of galactose and
fructose), sorbitol, and mannitol. These non-absorbable sugars are hydrolyzed in the colon to short-chain fatty acids
A
  1. Bulk-forming laxatives (Dietary Fibers (DFs))
  2. Saline Laxatives
  3. Osmotic laxatives
    - Osmotic effects retain water in the colon and soften stools**
233
Q

Constipation meds

    • include bisacodyl and phenolphthalein (withdrawn)
    • *Act directly on enterocytes, enteric neurons & GI smooth muscle by stimulating mucosal water and electrolyte secretion. Mechanisms include activation of prostaglandin-cAMP and NO-cAMP pathways, PAF production.
    • OTC preparations are popular
    • include the docusates and castor oil, which are
      anionic surfactant that lowers the surface tension of the stool to allow mixing of aqueous and fatty substances.
  1. non-absorbed oil lubricant that softens the stool.
A
  1. Stimulant laxatives
  2. Surfactant laxatives
    - *Docusates are mainly wetting and emulsifying agents that help soften the stool.
    - Castor oil - The oil of the castor bean contains a triglyceride ester of ricinoleic acid.
    - *Castor oil is cleaved to ricinoleic acid in the small intestine and can produce a purging effect with semi-fluid stools in 1-6 hours. Can be days before a normal defecation again.
    - *Ricinoleic acid is an anionic surfactant that DECREASED net absorption of fluid/electrolytes and stimulates peristalsis.
  3. Mineral oil
    - *Can decrease the absorption of fat-soluble vitamins.
    - If aspirated, lipid pneumonitis can occur.
234
Q

Identify new FDA approved drug for constipation

• A metabolite of prostaglandin E1
• Opens chloride channels on the luminal surface of the GI epithelium thus stimulating intestinal secretion of fluid and electrolytes and accelerating stool transit time
**adverse effects?

A

Lubiprostone (Amitiza ) (2012):

  • Adverse effects: nausea, abdominal pain diarrhea, some patients-dyspnea
  • Modestly effective also in treating opioid-induced constipation (exogenous opioids decrease peristalsis and secretion of fluid and electrolytes into the intestinal lumen).
235
Q

Identify new FDA approved drug for constipation
- Guanylate cyclase-C receptor agonist (Lunaclotide-14-amino acid synthetic
peptide and Plecanatide-synthetic analog of uroguanylin-endogenous guanylase cyclase C receptor agonist)
- Activates Guanylate cyclase C receptors on the luminal surface of the intestinal epithelium, increasing cAMP within intestinal epithelial cells resulting in activation of CFTR (cystic fibrosis transmembrane conductance regulator) ion channel, increasing the secretion of chloride and bicarbonate ions into the intestinal lumen
**Adverse effects

A

Linaclotide (Linzess) (2013) (Plecanatide-Trulance-2017)

  • Increases intraluminal fluid and accelerates intestinal transit
  • Adverse effects: diarrhea, abdominal pain, flatulence; (black box warning against use in patients <18 years due to deaths in young mice.
236
Q

Identify new FDA approved drug for constipation

• A pegylated derivative of the opioid antagonist naloxone
• Only oral opioid antagonist approved by FDA in 2014
• Mechanism: Opioids exert their analgesic effect by stimulating mu receptors in the CNS, but also stimulate peripheral mu receptors in the GI tract leading to decreased muscle contractility, inhibition of water and electrolyte secretion and
increased rectal sphincter tone.
**Adverse effects

A

Naloxegol (Movantik), (2014)
• Naloxegel is a peripheral mu-opioid receptor antagonist. Pegylation reduces ability to cross BBB and makes it a substrate of the efflux transporter P- glycoprotein.
• Adverse effects- dose related: abdominal pain, diarrhea, nausea, flatulence and vomiting

237
Q
  • *Uses and abuses of laxatives
  • use?
  • contraindications?
A
  1. Used to: maintain soft feces, prevent straining during defecation and evacuation of the bowel before surgery or diagnostic procedures.
  2. Contraindicated in patients with cramps, colic, nausea, vomiting, undiagnosed pain, or symptoms of appendicitis.
  3. The laxative habit.
238
Q

Identify treatment

  • Caused by E.coli, drugs or toxicants
  • Excessive water and electrolyte loss can lead to dehydration and
    electrolyte imbalance.
A
DIARRHEA; Characterized by watery stools and can be associated with an INCREASED frequency
of defecation (> 3x/day). 

Treatment

  1. Nonspecific antidiarrheals – aim is to prevent dehydration and electrolyte imbalances.
  2. If diarrhea is drug induced, change the dose of the drug or change to a new drug. Infectious diarrhea may require antibiotics.
239
Q

How do opioids work on the GI?

  • *used with?
  • *adeverse effects?
  • *what is used to treat moderate to severe travelers diarrhea
A

Mechanism of action: Opioids stimulate the mu opiod receptors in the GI tract to:

  • DECREASE GI motility Which INCREASE transit time and absorption of water and salt
  • DECREASE secretion of water and salt

Agents include;

  • DIPHENOXYLATE + atropine
  • DIPHENOXIN (active metabolite of diphenoxylate) + atropine
  • LOPERAMIDE*Atropine affects GI motility and secretion, but side effects discourage abuse of the opioid preparation.

Loperamide has poor CNS penetration.

*For moderate-to-severe traveler’s diarrhea; LOPERAMIDE + an appropriate ANTIMICROBIAL drug are preferred

    • Adverse Effects
      a. Constipation
      b. With high doses of diphenoxylate + atropine, CNS effects can occur due to activation of central mu opiod receptors (opiod) and antimuscarinic effects (atropine)
240
Q
  1. What is used to treat mild to moderate travelers diarrhea
  2. What is Used to treat diarrhea caused by disease (e.g. chemotherapy, AIDS, refractory, diabetes), tumors and other disorders.
A
  1. Bismuth Subsalicylate
    A. *Pepto-Bismol - Used to treat mild-to-moderate traveler’s (infectious) diarrhea.
    B. Salicylate provides anti-inflammatory effects.
    C. Bismuth is antibacterial.
  2. Octreotide
    A. A synthetic analog of somatostatin
    B. *Numerous effects on the GI tract including DECREASE in GI endocrine secretions, intestinal fluid and HCO3- secretion and smooth muscle contractility.
    C. Used to treat diarrhea caused by disease (e.g. chemotherapy, AIDS, refractory, diabetes), tumors and other disorders.
241
Q

IBD

2 types
Causes
Pharmacology

A

Inflammatory bowel disease (IBD)
• Causes unknown; autoimmune disease?
• Crohn’s Disease; inflammation anywhere in GI tract
• Ulcerative colitis: inflammation predominately in colon and rectum

Pharmacology
• Involves drugs that belong to different therapeutic classes and have different non- specific mechanisms of anti-inflammatory action
• Drugs chosen on the basis of disease severity, responsiveness and drug toxicity

242
Q

Treatment of IBD

Mild (3) vs moderate (3) vs Moderate who fail/severe (5)

A

**Treatment choice is predicted on both the severity of illness and responsiveness to therapy.

MILD: 5-aminosalicylic acid (5-ASA) (UC or Crohn’s colitis)
A. Topical corticosteroids (UC)
B. Antibiotics (Crohn’s colitis or Crohn’s perianal disease)
C. Budesonide (synthetic analog of prednisolone) (Crohn’s ileitis)

MODERATE (pt that fail initial therapy of mild disease)
A. Oral corticosteroid (promote disease remission)
B. Immunomodulators (azathioprine, mercaptopurine, methotrexate) to promote or maintain disease remission Anti-TNF antibodies)

MODERATE (who fail above therapy) Or SEVERE
A. IV corticosteroid
B. Anti-TNF antibodies
C. Surgery
D. Natalizumab (ab-alpha 4 intergrin) or Ustekunumab (stellar IL12 and IL23) antagonist (those who have failed Immunomodulators or TNF antagonists)
E. Cyclosporine (those with severe UC who have failed IV corticosteroids)

243
Q

Differentiate jaundice vs cholestasis

*common causes of jaundice (3)

A

Jaundice; yellow discoloration of the skin due to retention of bilirubin

Cholestasis; systemic retention of bilirubin and other solutes normally eliminated by bile

Common causes of jaundice

  1. Overproduction of bilirubin
  2. Hepatitis
  3. Bile flow obstruction
244
Q

Functions/chemical composition of BILE

A

a. Dietary fat emulsification in the gut lumen via detergent action of bile salts
b. Elimination of bilirubin, excess cholesterol and other waste products
c. Consists mostly of bile salts (conjugation of bile acids with taurine or glycine)

245
Q
  1. What is formed primarily from heme degradation of senescent RBCs?
    - different forms?
    **What is excreted in feces
    • What is the major catabolic product of CHOLESTEROL
A
  1. BILIRUBIN
    (a) In blood, heme oxidized to biliverdin (by mononuclear phagocytic cells)
    (b) Biliverdin reduced to indirect (unconjugated) bilirubin which is bound to albumin and taken up by hepatocytes
    (c) In hepatocytes, indirect bilirubin is conjugated with
    glucuronic acid by bilirubin uridine diphosphate- glucuronyltransferase (UDPGT1A1)
    (d) Direct (conjugated) bilirubin is formed, transported into the bile canaliculi and secreted into the intestine
    (e) Intestinal bacteria deconjugate the direct bilirubin and
    eventually degrades it to urobilinogen
    ***Urobilinogen primarily excreted in the feces (small amount
    reabsorbed and excreted in urine)
  2. BILE ACIDS
    (1) Major catabolic products of cholesterol
    (2) Primary human bile acids are cholic acid and chenodeoxycholic acid
    (3) Conjugated with taurine or glycine to form bile salts
    (4) Detergents that solubilize water-insoluble lipids in bile
    (5) Lipid carriers that remain soluble in water
    (6) Most are reabsorbed from the gut and returned to the liver by
    enterohepatic circulation
246
Q

Pathophysiology of JAUNDICE

2 types of bilirubin

  1. Water insoluble vs
  2. Water soluble
  • *when is it clinically evident?
  • **when does it occur?
A
  1. INDIRECT (unconjugated)
    (a) Virtually water insoluble at physiologic pH
    (b) Tightly complexed with serum albumin
    (c) CANNOT be excreted in urine (why not?)
    (d) Very small amount exists as albumin-free anion in blood
    (d) Elevated in severe hemolytic anemias, with certain protein-
    binding drugs and physiologic jaundice of the newborn
    (e) Can cause kernicterus in newborns (severe neurologic
    damage)
  2. DIRECT (conjugated)
    (a) Water soluble at physiologic pH
    (b) Nontoxic
    (c) Loosely bound to albumin
    (d) CAN be excreted in urine
    (e) Elevated in deficiency of canalicular membrane transporters and impaired bile flow

**CLINICALLY evident when bilirubin levels >2.0 to 2.5 mg/dL

** Occurs when the balance between bilirubin production and clearance is
disturbed by:
(1) Excessive extrahepatic bilirubin production (unconjugated)
(2) Reduced hepatocyte uptake (unconjugated)
(3) Impaired conjugation (unconjugated)
(4) Decreased hepatocellular excretion (conjugated)
(5) Impaired bile flow (conjugated)

247
Q

Identify condition of liver

a. Due to the immaturity of the liver at birth, resolves within 2 wks
b. Causes elevated indirect (unconjugated) bilirubin
* *aggravated by?

A

NEONATAL JAUNDICE (physiologic jaundice of the newborn)

**May be aggravated by breastfeeding (Beta-glucuronidases in milk)

248
Q

Hereditary Hyperbilirubinemias
**Identify type

(1) Autosomal recessive
(2) Complete lack of bilirubin UDPGT1A1 activity
(4) Fatal within 18 months due to kernicterus
(5) Liver morphologically normal
* *bilirubin type and levels?

A

Crigler - Najjar Syndrome TYPE 1

    • Elevated serum indirect (unconjugated) bilirubin
  • *RARE
249
Q

Hereditary Hyperbilirubinemias
**Identify type

(1) Autosomal dominant with variable penetrance
(2) Partial reduction of bilirubin UDPGT1A1 activity ((4) Less severe than type I
* *bilirubin type and levels? Treatment?

A

Crigler-Najjar Syndrome Type II

  • *Elevated indirect (unconjugated) bilirubin
  • *Treatment: Phenobarbital reduces indirect bilirubin levels
250
Q

Hereditary Hyperbilirubinemias
**Identify type

(1) Two patterns of inheritance depending on mutation (2) Decrease in bilirubin UDPGT1A1 activity to about 30% of normal (3) (4) Usually detected after illness, strenuous exercise or fasting (5) No clinical significance except for jaundice
* *bilirubin type and levels

A

Gilbert Syndrome

** Elevated indirect (unconjugated) bilirubin

251
Q

Hereditary Hyperbilirubinemias
**Identify type

(1) Autosomal recessive
(2) Defective excretion of bilirubin glucuronides across the canalicular membrane
(4) Darkly pigmented liver but otherwise normal
(5) No clinical significance except for jaundice
* *bilirubin type and levels

A

Dubin-Johnson Syndrome

** Increased direct (conjugated) bilirubin

252
Q

Hereditary Hyperbilirubinemias
**Identify type

(1) Autosomal recessive
(2) Due to multiple defects in hepatocellular uptake and excretion of direct (conjugated) bilirubin
(3) bilirubin type and levels???
(4) Liver NOT pigmented
(5) No clinical significance except for jaundice

A

Rotor syndrome

** Increased direct (conjugated) bilirubin

253
Q

Identify condition

Signs and symptoms

(1) Jaundice and pruritis (deposition of bile acids in the skin)
(2) Xanthomas (focal accumulation of cholesterol due to hyperlipidemia and impaired cholesterol excretion)
(3) Intestinal malabsorption including deficiencies of fat-soluble vitamins (due to decreased bile flow)
(4) Increased alkaline phosphatase (ALP) and gamma-glutamyl transpeptidase (GGT)

**define? Cause (2)? Morphology?

A

Cholestasis
a. Impaired bile formation and bile flow LEAD TO accumulation of bile pigment in liver

Causes

  1. Due to Intrahepatic or extrahepatic biliary obstruction OR
  2. Defects in hepatocyte bile excretion

Morphology
• Accumulation of bile pigment within hepatocytes give
a fine, feathery appearance (feathery degeneration)
• Green-brown bile plugs in dilated canaliculi

254
Q

Identify condition
**Most common causes; gallstones, malignancies of biliary tree or head of pancreas

-condition in kids?

**how can condition promote this condition - Influx of periductular neutrophils into bile duct epithelium and lumen

A

LARGE BILE DUCT OBSTRUCTION

** Obstructive conditions in children: biliary atresia, cystic fibrosis, choledochal cysts, insufficient intrahepatic bile ducts

May promote ascending cholangitis

(1) Secondary bacterial infection of intrahepatic biliary radicles ducts due to obstruction most often caused by enteric organisms (coliforms, enterococci)
(2) Fever, chills, abdominal pain and jaundice
(3) Acute inflammation of the bile duct wall and into the lumen

255
Q

Condition that can promote ascending cholangitis

  • *morphology?
  • *What is the hallmark of ascending cholangitis?

**which type can be fixed with surgery? Which can’t?

A

LARGE BILE DUCT OBSTRUCTION

Morphology

(1) Bile duct distention and proliferation
(2) Portal tract edema and periductular acute inflammation
(3) Unrelieved obstruction may lead to portal tract fibrosis and possible biliary cirrhosis
(4) Hallmark of ascending cholangitis: Influx of periductular neutrophils into bile duct epithelium and lumen

*** Extrahepatic obstruction is amenable to surgery while intrahepatic is NOT

256
Q

Identify liver condition

a. Direct effects of intrahepatic bacterial infection
b. Ischemia from hypotension (cirrhotic liver is most susceptible)
c. Response to circulating microbial products

** What is the most common cause?

A

Cholestasis of sepsis - liver affected in 3 ways

a. Direct effects of intrahepatic bacterial infection
b. Ischemia from hypotension (cirrhotic liver is most susceptible) c. Response to circulating microbial products- ***Most common cause of Cholestasis of sepsis

257
Q

Identify condition of liver
**Due To? Major causes (5)?
Morphology
a. Architectural distortion and focal necrosis and apoptosis
b. Giant cell transformation of hepatocytes (non-specific)
c. Prominent cholestasis
d. Mild mononuclear portal inflammation
e. Bile duct proliferation and portal tract fibrosis
f. Extramedullary hematopoiesis

  • *Clinical
    a. See jaundice, dark urine, acholic stools (light or clay color) and hepatomegaly
    b. Must differentiate between extrahepatic biliary atresia (treated surgically) and other causes (clinically possible in 90% cases)
    c. Liver bx is crucial in differentiating neonatal hepatitis from cholangiopathy
A

NEONATAL CHOLESTASIS
** Due to prolonged increase in conjugated bilirubin levels

Major causes - aka neonatal hepatitis

  1. Extrahepatic biliary atresia or bile duct obstruction
  2. Infections and toxins
  3. Genetic disorders; alpha 1 AT deficiency and lots more
  4. Miscellaneous
  5. Idiopathic (10-15%)
258
Q

Identify condition of liver

(1) Complete or partial obstruction of the lumen of the extrahepatic biliary tree within the first 3 months of life
(2) Most frequent cause of death in early childhood from liver disease
(3) Accounts for 50-60% of children referred for liver transplant

**identify pathogenesis of 2 forms

A

BILIARY ATRESIA

Pathogenesis of 2 forms
(1) Fetal form (20%)
(a) Associated with other anomalies (malrotation of abdominal
organs, polysplenia, congenital heart disease)
(b) Due to aberrant intrauterine development of extrahepatic tree

(2) Perinatal form (most common)
(a) Destruction of the normally developed biliary tree after birth (b) Possible etiologies include viral infection and autoimmunity

259
Q

Identify condition

Clinical

(1) Usually normal birth weight baby w/neonatal cholestasis & jaundice
(2) Normal stools become acholic
3. Labs; bilirubin 6-12 mg/dL, moderately increased transaminases and alkaline phosphatase levels
4. Death in 2 years without surgery or transplant

**Morphology??
Type I - III

A

BILIARY ATRESIA

Morphology

(1) Inflammation and fibrosing stricture of the extrahepatic or CBD
(2) Periductal inflammation and destruction of intrahepatic biliary tree
(3) Cirrhosis develops in uncorrected cases in 3-6 months
(4) Type I- disease limited to common bile duct; surgically corrected
(5) Type II- disease limited to hepatic bile ducts; surgically corrected
(6) Type III (90% of cases) - disease at or above the porta hepatis; NOT surgically correctable; may need a liver transplant

260
Q

Identify condition

Clinical

a. Begins as a febrile illness (flu or chicken pox) in children < 4 years
b. Vomiting, irritability, lethargy, hepatomegaly
c. Labs: most patients with NORMAL liver function tests
d. 25% with ABNORMAL LFTs progress to coma and death

Morphology?
- liver vs brain vs skeletal muscle

A

REYE SYNDROME

  • Acute hepatic failure and encephalopathy
  • Possible correlation between a febrile illness and aspirin therapy
  • Secondary to mitochondrial dysfunction in the liver and brain

Morphology

a. Liver- microvesicular steatosis without necrosis or inflammation b. Brain- edema without inflammation
c. Skeletal muscle, kidney & heart with fatty change

261
Q

Viral Hepatitis

**systemic viral infections causing hepatitis include ?
What types of viral hepatitis?

A

Viral Hepatitis

a. Systemic viral infections causing hepatitis include:
(1) Infectious mononucleosis (Epstein-Barr virus)
(2) Cytomegalovirus (CMV)
(3) Rubella, adenovirus, enterovirus and herpes virus

b. Term “Viral Hepatitis” reserved for specific hepatotropic viruses; A, B, C, D, E

262
Q

Identify hepatitis

(a) Usually benign self-limited disease
(b) Spread mostly by ingestion of contaminated water and foods (raw or steamed shellfish, food workers [fecal-oral route])
(c) Short incubation period - 2-6 weeks
(d) Viruses shed in stool for 2-3 weeks before and 1 week after the onset of jaundice
(e) Vaccine available

  • *serology
  • what indicate acute infection?
  • what indicate recovery and lifelong immunity?

**clinical?

A

Hepatitis A virus (HAV)

Serology

(a) IgM HAV Ab indicates acute infection
(b) IgG HAV Ab appears after IgM HAV Ab indicating recovery and lifelong immunity

Clinical

(a) Asymptomatic to mild symptoms (fever, fatigue, anorexia, nausea, vomiting and jaundice)
(b) Usually a sporadic illness in developed countries
(c) Does NOT cause chronic hepatitis or a carrier state

263
Q

Identify hepatitis type

May cause
i) Acute hepatitis with recovery ii) Chronic nonprogressive hepatitis iii) Chronic progressive disease with cirrhosis iv) Acute hepatic failure with massive necrosis v) Asymptomatic carrier state

  • *precursor for what condition?
  • Transmission by?
A

Hepatitis B virus (HBV)

*can be a precursor to HEPATOCELLULAR CARCINOMA

Transmission by;

i) Perinatal transmission in high prevalence areas (Asia, Africa)
ii) Sexual transmission and IV drug abuse in low prevalence areas (North America, Western Europe, Australia)

264
Q

Identify hepatitis type
- can be a precursor to HEPATOCELLULAR CARCINOMA
- Longer incubation period: 4-26 weeks
- Virus present in the blood during active episodes of
acute and chronic infection

**structure? Core proteins? Envelope glycoproteins? Protein for viral replication?

A
Hepatitis B (HBV) 
Enveloped partially dsDNA Hepadnaviridiae virus
which is a spherical double layered “Dane particle” 

I. Nucleocapsid “core” proteins HBcAg and HBeAg
II. Polymerase (Pol) with DNA polymerase and reverse transcriptase activity
III. Envelope glycoproteins; large, middle and small HBsAg
IV. HBx protein for viral replication and associated with the pathogenesis of Hepatocellular carcinoma

265
Q

Serology of Hep B in acute infection with resolution

  1. i) Appears before symptoms
    ii) Peaks during overt disease
    iii) Declines to undetectable levels in 3-6 months
  2. I. Appears soon after #1
    II. Signify active viral replication
    III. Persistent levels denotes continued viral replication and progression to chronic hepatitis
  3. I. Appears just before symptoms
    II. Appears with initial rise in aminotransferase levels
  4. I. Replace #3 over a period of months
  5. I. Appears after end of acute disease as HBsAg disappears
    ii. Occasionally not detected for weeks to months after disapperance of HBsAg
    III. May persist for life conferring immunity
  6. I. Appears as acute infection has peaked and is waning
A
  1. HBsAg
  2. HBeAg, HBV-DNA and DNA polymerase
  3. IgM HBcAb
  4. IgG HBcAb
    - eventually replaces IgM HBcAb over period of months
  5. HBsAb
  6. HBeAb
266
Q

Serology in chronic infection of hep B

**what 2 may you not see?

A

(a) Continued production of HBsAg and possibly
HBeAg, HBV-DNA and DNA polymerase
(b) WILL not see production of HBsAb** or HBeAb
NO HBsAb in CHRONIC HEPATITIS B

**progression to chronic infections occur in ~5-10% of acute infections

267
Q

Hep B clinical

  1. How many with no jaundice
  2. Are most caused bad or self limited
  3. How many develop chronic hepatitis
  4. Vaccine induced mutants
  5. What is main determinant regarding disease outcome
  6. What is best predictor for Chronicity
  7. Does HBV directly injury hepatocyte?
  8. Asymptomatic carrier state?
A
  1. About 70% with mild or no symptoms without jaundice
  2. Most cases are self-limited and resolve without treatment
  3. About 5-10% develop chronic hepatitis (20-30% cirrhosis)
  4. Vaccine-induced mutants which alter recognition of HBsAg
    by HBsAb can also occur
  5. Host immune response is the main determinant
    regarding disease outcome (strong response by virus- specific CD4+ and CD8+ cells associated with resolution of acute infection)
  6. Age at time of infection best predictor for chronicity – younger, more likely to develop chronic infection
  7. HBV does not directly injure hepatocyte, CD8+ cytotoxic T cells attack infected hepatocytes
  8. Asymptomatic carrier state (>= 30% of chronic hepatitis)
    i) HBsAg in serum > 6 months
    ii) HBeAg negative
    iii) HBV DNA at < 100,000 copies
    iv) Persistent normal ALT and AST levels
268
Q

Identify hepatitis type

Most common risk factors
i) IV drug abuse, multiple sex partners, surgery in past 6 months, needle stick injury, medical and dental employees and multiple contacts with infected persons
II. About 1/3 of patients with unknown etiology

**major route of infection?

A

HEPATITIS C Virus (HCV)
(a) Most common chronic blood-borne infection in the US
(B) majority (~80-90%) of patients develop chronic disease (20-30% develop cirrhosis)

(d) Major route of infection in children: perinatal transmission
(e) Enveloped ssRNA Flaviviridae virus
i) Unstable virus with multiple genotypes
ii) Envelope has variable regions which cause emergent strains to escape neutralizing antibodies
(F) incubation period of 4-26 weeks (mean -9 weeks)

269
Q

**Most common chronic blood borne infections in the US

Serology

  1. Detected in blood with increased serum transaminases
  2. Detected in only 50-70% of patients with symptomatic acute infection
A

HEPATITIS C VIRUS (HCV)

Serology
1. HCV RNA
i) Detected in the blood with INCREASED serum transaminases
II) Persist in chronic infection despite the presence of HCV antibodies

  1. HCV Ab
    I) Detected in only 50-70% of patients with symptomatic acute infection
    II) In rest of patients, detected about 3-6 weeks after start of infection
    III) IgG HCV Ab does NOT confer lifelong immunity
270
Q

Most common chronic blood borne infections in the US

  • Clinical
  • symptoms?
  • immune response?
  • complication of acute infection?
  • liver?
  • what 2 conditions may develop
  • treatment?
A

(a) Most patients with asymptomatic acute illness (85%, less severe than acute hepatitis B)
(b) Symptoms may include fatigue, anorexia, nausea, vomiting, muscle and joint pain
(c) Strong immune response with CD4+ and CD8+ cells associated with the few self-limited infections
(d) HCV infection usually produces persistent infection and chronic hepatitis (80-90% of cases)
(e) Patients usually have episodic periods of liver damage and elevated transaminases with symptoms
(f) Cirrhosis or hepatocellular carcinoma may develop (5-30 yr)
(g) Genomic instability and antigenic variability hinder development of an effect HCV vaccine
(h) Treatment with drugs targeting viral protease and polymerase shows 90% success

271
Q

Identify condition

General
(a) Enveloped ssRNA Deltaviridae virus (7 genotypes) (b) Needs co-infection with HBV to cause infection (c) Parenteral transmission (d) Incubation: 4-7 weeks (e) Vaccination against HBV prevents HDV infection

**differentiate acute co-infection vs superinfection

A

Hepatitis D virus (HDV)
A. ACUTE CO-INFECTION - with acute Hep B
i) Follows exposure to serum with both HBV and HDV ii) HBV infection needed to establish first to
provide HBsAg for development of complete HDV virions
iii) See IgM HBcAg and IgM HDAg (then IgG of each)
iv) Clinically indistinguishable from acute hepatitis B
v) Usually self-limited infection (as in hepatitis B)

B. SUPERINFECTION with chronic Hepatitis B patients
i) Persistence of HBsAg and HDV Ab (IgM & IgG)
ii) Chronic HDV occurs in 80-90% of patients
iii) May present as severe acute hepatitis in an
HBV carrier or exacerbation of preexisting chronic HBV
iv) Almost all these patients develop chronic
HDV infection which progresses to cirrhosis and sometimes HCC

272
Q

Identify condition

(a) Fecal-oral transmission of water-borne infection (b) Virus with some animal reservoirs (monkeys, cats,
pigs, dogs)
(c) Unenveloped ssRNA Hepeviridae virus
(d) Average incubation period: 4-5 weeks

  • *Clinical
  • bad or self limited?
  • what age group?
  • what is found in stool and blood before onset
A

HEPATITIS E Virus (HEV)

Clinical
(a) Mostly a self-limited illness
(b) Mostly seen in young and middle-aged adults
(c) High mortality (20-25%) in pregnant women (d) HEV RNA and HEV virions found in stool and blood before the onset of clinical illness
(e) Symptoms, elevated aminotransferases and IgM
HEV Ab occur at the same time
(f) Symptoms usually resolve in 2-4 weeks
(g) NOT associated with carrier state or chronic infection except in AIDS and transplant patients

273
Q

Identify condition

(1) Transmitted parenterally by blood, blood products & sexual contact
(2) NOT “hepatotropic” and DOES NOT cause elevated ALT
and AST
(3) Replicates in bone marrow and spleen
(4) Commonly co-infects HIV-positive patients

A

HEPATITIS G VIRUS

274
Q

Clinicopathologic syndromes of Viral Hepatitis

  1. Acute asymptomatic infection with recovery
    - incidental finding?
    - hep A and B?
  2. Acute symptomatic infection with recovery
    * *4 phases vs peak infectivity?
A

Acute asymptomatic infection with recovery

(1) Incidental finding of minimally elevated serum transaminases or presence of antiviral antibodies
(2) Hepatitis A and B infections frequently subclinical in childhood

Acute symptomatic infection with recovery

    • Four phases:
      (a) Incubation period
      (b) Symptomatic preicteric phase (NO JAUNDICE)
      (c) Symptomatic icteric phase
      i) Increased conjugated bilirubin levels
      ii) Dark urine and acholic stools
      iii) Pruritis
      (d) Convalescence

** Peak infectivity- last days of incubation period and early
days of acute illness

275
Q

Identify condition

  • *treatment?
    (1) Causative virus depends on geographic location (2) HAV & HEV (pregnant women) are most common causes globally
    (3) HBV is most cause in Asia and Mediterranean countries
    (4) Survival > 1 week may allow residual hepatocytes to restore some lost parenchyma
A

ACUTE LIVER FAILURE

**Treatment; supportive, transplant

276
Q

Condition

(1) Symptomatic, biochemical or serological evidence of continuing or relapsing hepatic disease > 6 months
(2) Clinical features vary from asymptomatic to fatigue,
malaise, anorexia, mild jaundice
(3) Few physical findings including hepatic tenderness, mild
hepatomegaly and mild splenomegaly

**labs?
Best determinant of disease?
Major risk?

A

CHRONIC HEPATITIS

A. Laboratory studies: May see elevated serum transaminases, prolonged PT, increased immunoglobulins,
hyperbilirubinemia, elevated alkaline phosphatase
B. Occ. in HBV & HCV, see immune-complex disease such as
vasculitis (which one? - PAN polyangitis nodosa) and glomerulonephritis
C. Best determinant of chronic disease- age of the patient
D. Vertical transmission is a major risk for chronic HBV infection

277
Q
  1. Explain CARRIER STATE - best example is Hep B infection
  2. HIV and chronic viral hepatitis
    - what are 2 most common cause of death in AIDs pt
A

Carrier State
(1) Asymptomatic patient +/– non-progressive liver damage who harbors and can transmit the virus
(2) Best example is with hepatitis B infection
(3) Inactive carrier with HBsAg, no HBeAg, HBeAb, low
HBV DNA, normal LFTs and lack of significant inflammation and necrosis on liver bx
(4) Infection early in life e.g. vertical transmission in endemic areas, > 90% become carriers
(5) Carrier state is probably not stable but may be activated by
co-infection, alterations in immune function, etc.

HIV and Chronic Viral hepatitis
(1) Chronic HBV and HCV infections a leading cause of morbidity and mortality in HIV patients, even those on successful anti-HIV tx
(2) Liver disease the 2nd most common cause of death in
untreated or unsuccessfully treated AIDS patients

278
Q

Morphology of acute hepatitis

**what is common to all types (4)

A

Acute Hepatitis (by HAV, HBV, HCV and HEV)
(1) Common to all types
(a) BALLOONING DEGENERATION - cytoplasm appears empty, cell eventually ruptures
(b) Possible CHOLESTASIS with canalicular bile plugs
(c) HEPATOCYTE NECROSIS leave collapsed reticulin
framework and macrophage aggregates marking areas of lost cells (lobular disarray)
(d) APOPTOSIS producing “COUNCILMAN BODIES” (shrunken, eosinophilic hepatocytes with pyknotic, fragmented nuclei)
(e) Severe cases: confluent necrosis around central
veins and BRIDGING NECROSIS (central-portal)

279
Q

Morphology of chronic hepatitis

Mild vs progressive?

    • Hallmark of chronic disease?
  • Specific changes in HBV vs HCV
A

Chronic hepatitis (HBV, HCV, HBV + HDV)

(1) Changes range from mild to severe disease
(2) Mild disease: portal mononuclear inflammation only
(3) Progressive disease: marked by interface hepatitis between portal tract and surrounding parenchyma

(4) Hallmark of chronic disease: FIBROSIS (**remember hepatic STELLATE cells)
(a) First in portal tracts
(b) May eventually extend between portal tracts (bridging fibrosis)
c) Continued scarring and nodule formation = cirrhosis

(5) Increasing scarring coincides with stem cell activation (ductular reaction)
(6) Clinical assessment of extent of damage requires liver biopsy

(7) Specific changes
A. HBV - “Ground glass” hepatocytes (ER is swollen by HBsAg)
B. HCV - portal lymphoid aggregates and macrovesicular steatosis

280
Q

Helpful hints with hepatitis

  • VOWELS A AND E
  • consonants BCD
  • hep b transmission (3)
  • hep C
  • hep D
  • hep E
A
  1. The vowels (hepatitis A and E) never cause chronic hepatitis, only AcutE hepatitis, except HEV in immunocompromised hosts.
  2. Only the consonants (hepatitis B, C, D) have the potential to cause chronic disease (C for consonant and for chronic)
  3. Hepatitis B can be transmitted by blood, birthing, and “bonking” (as they say in the United Kingdom).
  4. Hepatitis C is the single virus that is more often chronic than not (almost never detected acutely; 80% or more of patients develop chronic hepatitis, 20% of whom will develop cirrhosis).
    * *WE DO NOT TREAT ACUTE HEP C
  5. Hepatitis D, the delta agent, is a defective virus, requiring hepatitis B co-infection for its own capacity to infect and replicate.
  6. Hepatitis E is endemic in equatorial regions and frequently epidemic.
281
Q

Identify condition

Morphology
(1) Solitary (from direct invasion or trauma) or multiple (from arterial or portal spread) lesions from millimeters to
centimeters
(2) Subdiaphragmatic or subphrenic amebic abscesses may
cause an empyema or lung abscess
(3) Echinococcal infection with cystic structure and
calcifications in cyst walls, visible on x-ray

Clinical
(1) Fever, RUQ pain, hepatomegaly, jaundice
(2) Rx: antibiotics and percutaneous surgical drainage
(3) Mortality may be 30-90% in elderly patients with
coexistent disease and delayed diagnosis
(4) Early diagnosis and treatment → 90% survival

A

LIVER ABCESS
(1) Usually in developing countries (echinococcal and amebic)
(2) Most secondary to infection elsewhere in the body (E.g appendicitis in GI tract)
(3) Organisms can enter the liver by portal vein, arterial
supply, ascending infection, direct invasion or penetrating injury
(4) In developed countries abscesses usually due to biliary tree
or arterial supply in immunocompromised patients (elderly, chronic illness, immunosuppression, chemotherapy with marrow failure)

282
Q

Identify condition
Morphology
1. Early phase – severe parenchymal destruction
a. Extensive interface hepatitis, perivenular or bridging necrosis b. Prominent lymphocytes and CLUSTERS OF PLASMA CELLS AT THE INTERFACE
2. Rapid fibrosis

A

AUTOIMMUNE HEPATITIS

  1. Chronic progressive hepatitis with features of autoimmune diseases: genetic disposition, association with other autoimmune diseases, presence of autoantibodies and therapeutic response to immunosuppression.
  2. Strong HLA-associations, association with DRB1* alleles in Caucasians
283
Q

Identify condition
**Clinicopathologic features (2 types))

Clinical features
1. Variable clinical course
2. Acute symptomatic patients (40% of cases) usually with significant liver destruction and scarring
3. Mortality: 40% within 6 months in severe untreated cases
4. Cirrhosis in 40% of surviving patients
5. Treatment: immunosuppression
6. Liver transplant indicated in end-stage liver disease
7. Small group of patients: overlap with other autoimmune liver diseases,
primary biliary cirrhosis and less often, primary sclerosing cholangitis

A

AUTOIMMUNE HEPATITIS

Clinicopathologic features
1. Highest incidence is in white, northern Europeans, 1.9:100,000 2. Female predominance (78%)

  1. Two types
    a. Type 1
    (1) Middle-aged to older individuals
    (2) Antibodies: Antinuclear (ANA), anti-smooth muscle actin
    (ASMA)

b. Type 2
(1) Children and teenagers
(2) Antibodies: anti-liver kidney microsome-1 (anti-LKM-1)

284
Q

GENETICS PROBLEMS
**Use equation table in notes

1. In a population in Hardy Weinberg equilibrium, three genotypes are present in the following frequencies:  AA 0.81, Aa 0.18 and aa 0.01. What are the allele frequencies of A and a?
A)   p = 0.9 and q = 0.1 
B)   p = 0.8 and q = 0.2 
C)  p = 0.7 and q =0.3 
D)  p = q = 0.5 
E) p = q=  0.1
A
  1. A
285
Q

Alport syndrome is a rare autosomal recessive disorder caused by defects in the collagen 4 gene and characterized by nephritis and deafness.

If an Alport woman marries a normal Danish man with no family
history, what is the probability that their child will have Alport
syndrome? The genotype frequency of Alport syndrome in Danes
one is 1/8100. Drawing a pedigree and Punnett square will help.
In your calculation, please round p =1.

A. 1/45
B. 1/90
C. 1/180 
D. 1/360 
E. 1/720
A

B = 1/90

1 x 1/2 x 1/45 = 1/90

286
Q

Phenylketonuria is a rare autosomal recessive disorder caused by the inability to convert phenylalanine to tyrosine.

If newborns with type I PKU are placed on low phenylalanine diet at
birth, they have normal mental and physical development. If a patient with PKU marries a normal man from Scotland with no family history, what is the probability that their child will have PKU? The frequency of type I PKU homozygotes in the Scottish population = 1/4900. Round p = 1. Hints: you must determined three probabilities and drawing a pedigree and Punnett square will help A. 1/35 B. 1/70 C. 1/150 D. 1/300 E. 1/700

A

1/70

= 1 x 1/35 x 1/2 = 1/70

287
Q

Tourette syndrome, an autosomal dominant trait with incomplete penetrance, is segregating in the following in the following pedigree:

Using only cases where the genotype can be ascertained, please determine the percent penetrance of the trait

A)  10%
B)  30%
C)  40%
D)  60%
E)  80%
A

D. 60%

Penetrance = # phenotype / # genotype = 6/10 = 60%

288
Q

Retinoblastoma segregates as an autosomal dominant trait.

In a large genotyping study, 200 individuals were shown to carry the defective allele. Of these 200, 20 failed to develop the cancer at any time in their lives. Based on this evidence, what is the percent penetrance of retinoblastoma trait?

A. 10% B. 20% C. 50% D. 80% E. 90%

A

E. 90%

Penetrance = # phenotype / # genotype = 180/200 = 9/10 = 90%

289
Q

Sickle cell disease, an autosomal recessive condition, occurs with a frequency of 1/625 among African Americans. Patricia has a brother George who has sickle cell
disease. Patricia and her parents are clinically normal. Patricia is married to Julius who has no family history of the disease. What is the probability that Patricia and Julius will have an affected child?

A

1/75

1/4 x 2/3 x 1/12.5 = 1/75

290
Q

Jane is a twenty six year old woman brother died of cystic fibrosis. Jane and her parents are both phenotypically normal. Her husband Edward, 30 years of age, is unrelated but has a daughter with CF from a previous marriage (first wife is Rachel). Both Edward and Rachel are clinically normal. What is the probability that Jane and Edward will have a child with CF? (If Edward had no child by a previous marriage, what information would you need?)

A

1/6

1 x 1/4 x 2/3 = 1/6

291
Q

Nathan has an autosomal recessive form of albinism and is married to Nancy who has a brother with albinism. Nancy and her parents are phenotypically normal. Assume that the same genetic locus is the underlying cause in both sides of the family. Determine the probability that Nathan and Nancy will have an affected child.

A

1/3

1 x 2/3 x 1/2 = 1/3

292
Q

Ron and his maternal grandfather Barry both have hemophilia A (an X-linked recessive disorder). Barry has two daughters (Cathy and Cindy). Ron marries Diane whose is the daughter of Cindy (Ron’s maternal aunt). Assume that Barry’s wife is homozygous normal and that Ron’s aunt’s husband is hemizygous normal and that heterozygous phenotypes will be clinically normal. What is the probability that Ron and Diane will have an affected child? What is the probability that Ron and Diane will have an affected daughter? What is the probability of an affected son?

A

Prob affected child = 1/2 x 1 x 1/2 = 1/4

Prob affected son/daughter = 1 x 1/2 x 1/4 = 1/8